Development of nitrogen protecting groups and synthesis and complexation of bridged bis-tetraazamacrocycles by Young, Matthew J
University of New Hampshire
University of New Hampshire Scholars' Repository
Doctoral Dissertations Student Scholarship
Spring 2009
Development of nitrogen protecting groups and
synthesis and complexation of bridged bis-
tetraazamacrocycles
Matthew J. Young
University of New Hampshire, Durham
Follow this and additional works at: https://scholars.unh.edu/dissertation
This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has
been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more
information, please contact nicole.hentz@unh.edu.
Recommended Citation
Young, Matthew J., "Development of nitrogen protecting groups and synthesis and complexation of bridged bis-tetraazamacrocycles"
(2009). Doctoral Dissertations. 613.
https://scholars.unh.edu/dissertation/613
NOTE TO USERS 
This reproduction is the best copy available. 
UMI' 

DEVELOPMENT OF NITROGEN PROTECTING GROUPS 
AND 
SYNTHESIS AND COMPLEXATION OF BRIDGED BIS-
TETRAAZAMACROCYCLES 
BY 
Matthew J. Young 
M.S., University of New Hampshire, 1999 
B.A., Western Connecticut State University, 1996 
THESIS 
Submitted to the University of New Hampshire 
In Partial Fulfillment of 
the Requirements for the Degree of 




UMI Number: 3470122 
All rights reserved 
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted. 
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed, 




Copyright 2010 by ProQuest LLC. 
All rights reserved. This edition of the work is protected against 
unauthorized copying under Title 17, United States Code. 
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346 
This thesis has been examined and approved. 
Dissertation Director 
Gary R. Weisman 
Professor of Chemistry 
W. Rudolf Seitz 
Professor of Chemistry 
Edward H. Wong 
Professor of Chemistry 
Charles K. Zercher 
Professor of Chemistry 
Palligarnai T. Vasudevan 
Professor of Chemical Engineering 
Date 
Dedication 
For Erin and Rowan. 
111 
Acknowledgements 
I would first like to thank Erin, who has worked hard to support us both over 
the past 5 long years. I have never regretted my decision to come back and begin 
work again with Gary Weisman as my advisor and I thank him for all of the guidance 
that he has given me over the years (both '96-'99 and '04-'09). Gary is an excellent 
chemist and teacher, and a good man. This is demonstrated by the large number of 
hours and help sessions he dedicates to his students. I am also lucky enough to have 
another great advisor in Ed Wong, he is always willing to give me whatever advice or 
assistance he can provide. I have enjoyed working with Ed more this time around and 
getting to know him a little more. I would like to thank Chuck Zercher for his 
mentoring with two of my PFF courses. I appreciate Glen Miller's help and advice 
when I was teaching chem. 546 and the fact that he read over my proposal and 
provided some advice also helped me a great deal. I would like to also thank Chris 
Bauer for all of his help with the PFF courses and for the financial assistance that he 
has provided over the years. Professor Bauer is a great educator and I am glad to see 
that he is producing more great educators through his work. And I would like to 
thank the remaining members of my committee, Dr. Seitz and Dr. Vasudevan, for 
your advice and help with my research. 
I would like to thank David Martin for being someone that I could always 
have conversations with about chemistry. It was great to have a free flow of ideas 
where neither of us put our egos in the way and we were both willing to explore new 
iv 
ideas. I also realize that my work is built upon the shoulders of others and I thank all 
of the previous Weisman and Wong group members whose research and hard work 
helped me in my own research. I would like to thank Aida, Alex, Carley, Ian, and of 
course Jane. It was great working with you when I taught the chem. 546 lab and I 
thank you for being so much help to me. Tim, Alex, Jen, Carley, and Ian ("the light 
at the end of the tunnel" and my adopted group members in my final months of 
research), Drew, Kaleen, Matt, and Jim Rainbolt, everyone... thank you for your help 
and friendship over the past few years. 
I have always enjoyed talking to Peggy and Cindi in the chemistry office and I 
thank them for their friendship and all of their help over the years. Thank you 
Kristin, for all of your help in the stockroom, it was always nice talking to you too. 
Bob Constantine has always helped me find whatever I needed in the library. 
Whether I asked Bob for help or not, he was always there to ask what I needed - and 
help find it. I would like to thank Kathy Gallagher, Jeff Simpson, and Pat Wilkinson 
for all of their help with the NMR and giving me whatever help I needed. Thank you 
Pat for your help in finding me a post-doc you've done a great job in filling Kathy's 
shoes. I also appreciate John Wilderman for his help with a variety of things, from 
helping us fix things in the lab to helping me with the NMR. 
v 
Table of Contents 
Dedication iii 
Acknowledgements iv 
Table of Contents vi 
Lists of Figures ix 
Lists of Schemes xii 
List of Tables xvi 
Abstract xvii 
Chapter I - Development of Nitrogen Protecting Groups 
I) Introduction 1 
II) Background 15 
III) Results and Discussion 36 
A) Development of the N-allyl Protecting Group 37 
(1) Synthesis of di-NH cross-bridged cyclam 7 by way of 
deallylation 37 
(2) Synthesis of mono-benzyl cross-bridged cyclen 32 via deallylation 
40 
(3) Synthesis of mono-benzyl cross-bridged cyclam 55 48 
B) Development of the N-PMB Protecting Group 51 
(1) Synthesis of di-NH cross-bridged cyclen 24 via the use of the N-PMB 
protecting group 51 
(2) Synthesis of mono-benzyl cross-bridged cyclen 32 via the use of a N-
PMB protecting group 54 
vi 
(3) Progress toward the synthesis of di-NH cross-bridged cyclam 7 via the 
use of N-PMB protecting groups 56 
C) Investigation of the N-Nap Protecting Group for Cross-bridged 
Tetraamines 58 
(1) Progress toward the synthesis of mono-benzyl cross-bridged cyclen 33 
via the use of an N-Nap protecting group 58 
(2) Synthesis of di-Nap cross-bridged cyclen and cyclam (74 and 75) 59 
(3) Attempted synthesis of di-NH cross-bridged cyclam 7 via the use of an 
N-Nap protecting group 60 
D) Synthetic Utility of the Mono-Benzyl Cross-bridged Cyclam 33 61 
(1) Synthesis of mono-benzyl mono-octyl cross-bridged cyclam 76 62 
IV) Conclusions 63 
Chapter II - Synthesis and Complexation of Bridged Bis-tetraazamacrocycles 
I) Introduction 66 
II) Background 73 
III) Results And Discussion 81 
A) The Complexation ofp-Xylyl-linked Adjacent-bridged Cyclam 102a with 
Copper(II) 82 
B) The Complexation of jt?-Xylyl-linked Cross-bridged Cyclen 94a and m-
Xylyl-linked Cross-bridged Cyclen 94b with Copper(II) 85 
(1) The complexation ofp-xylyl-linked cross-bridged cyclen 94a with 
copper(II) 85 
(2) Discussion of the kinetic and electrochemical analyses of copper(II) 
complexes of 94a and 102a 90 
(3) The complexation of w-xylyl-linked cross-bridged cyclen 94b with 
copper(II) 93 
vii 
C) The Complexation of /?-Xylyl-linked Cross-bridged Cyclen 94a and m-
Xylyl-linked Cross-bridged Cyclen 94b with Zinc(II) 94 
(1) The complexation of/?-xylyl-linked cross-bridged cyclen 94a with 
Zinc(II) 94 
(2) Progress toward the synthesis of a mononuclear Zn(II) • p-xylyl-linked 
cross-bridged cyclen 94a complex 95 
(3) The complexation of m-xylyl-linked cross-bridged cyclen 94b with 
Zinc(II) 97 
D) Synthesis of Crude Diamide p-Xylyl-linked Cross-bridged Cyclen 
105 97 
E) Further Application of the N-Allyl Protecting Group - Synthesis ofp-
Xylyl-linked Cross-bridged Cyclen 31 99 
(1) Synthesis of N,N'-di-allyl/?-xylyl-linked cross-bridged cyclen 
107 100 
(2) Synthesis of ^ -xylyl-linked cross-bridged cyclen 31 101 
F) Progress toward the synthesis of the cross-bridged bis-cyclam 110 104 
G) Investigation of an aliphatic spacer group 109 
IV) Conclusions I l l 
Chapter III - Experimental Section 
I) General Methods 114 
II) Solvents 116 
III) Reagents 118 
IV) Syntheses 120 
Appendix 
A) Spectral Index 153 
B) Compound Index 227 
List of References 234 
viii 
List of Figures 
Figure Page 
1.1 Tetraazamacrocycles of interest to the Weisman/Wong research group: Cyclen 
1, Cyclam2 and Homocyclen3 1 
1.2 The adjacent- and cross-bridged tetraazamacrocycles 4 and 5, respectively... .2 
1.3 A conformation of 5b, where all four nitrogen lone pairs are convergent on a 
cavity and 5b complexed to a metal forming a diamond-lattice conformation 
that is stable and kinetically inert 3 
1.4 Six of the nine configurations of metallo-cyclam complexes 3 
1.5 A schematic of a radiopharmaceutical, which includes a bifunctional chelator 
(BFC) that is complexed to a radioactive metal ion and is also attached to a 
biologically-active targeting molecule 7 
1.6 Ligands 6-10, the 64Cu complexes of these ligands have been tested for their 
in vivo stabilities 8 
1.7 Ligands 11 and 12, the 64Cu complexes of these ligands have been tested for 
their in vivo stabilities 9 
1.8 64Cu complexes of ligands 13-17 have been tested for their in vivo 
stabilities 12 
1.9 Compounds 27 and 28, with functional groups incorporated within the ligand 
framework 22 
1.10 Compounds 29 and 30, where functional groups have been incorporated into 
the ligand framework for linking to biologically active target molecules of the 
radiopharmaceutical. "R" is the functional group that would be linked to the 
targeting molecule 22 
1.11 The di-NH p-xylyl-linked cross-bridged cyclen, 31 23 
1.12 (A): Hyperconjugative effects that may be responsible for the increased 
basicity of the nitrogen adjacent to the quaternary nitrogen, which has its lone 
pair placed within the cleft of the bisaminal for cyclam and cyclen bisaminals 
(cyclam is shown); (B): Empirical evidence of this increased basicity, 
demonstrated in an X-ray crystal structure of the mono-methylated cyclam 
bisaminal salt 44 
IX 
Figure Page 
1.13 An X-ray crystal structure of the BPI14" salt of protonated mono-allyl mono-
benzyl cross-bridged cyclen62 47 
1.14 An X-ray crystal structure of the BPI14" salt of protonated mono-allyl mono-
benzyl cross-bridged cyclam 55 51 
2.1 The adjacent- and cross-bridged tetraazamacrocycles 4 and 5, respectively, 
and cross-bridged (79a and 80a) and adjacent-bridged (79b and 80b) bis-
tetraazabicycles 67 
2.2 The bicyclam 81 (AMD3100), a stem cell mobilizer and anti-HIV agent 68 
2.3 Pendant-armed para- and meto-xylyl-linked cross-bridged systems (82-83) 
synthesized by Handel 70 
2.4 Bis-cyclam complexes, with a variety of spacers, tested for their redox 
behavior 71 
2.5 A bicyclen complex utilized for DNA binding 71 
2.6 The meso and d/1 stereoisomers of 90-91 and their time averaged 
symmetry 74 
2.7 The meso and d/1 stereoisomers of 95a and its time-averaged symmetry 75 
2.8 Time-averaged symmetry (C2V) of 94a 75 
2.9 Possible oligomer (96) and dialkyl (97) byproducts in the synthesis of 90 and 
91 76 
2.10 The electronic spectrum of Cu2 • 102a in 80% ethanol, where A,max = 614 nm 
(Abs= 1.273) 82 
2.11 (A) The electronic spectra and (B) the first order kinetics plot of the acid-
decomplexation of (CuCl2)2(H20)4 • 102a in 5M HC1 at 50 °C 83 
2.12 The (A) cyclic voltammogram and (B) DVP of (CuCl2)2(H20)4 • 102a (0.1 M 
NaOAc,pH=7) 84 
2.13 The electronic spectrum of Cu2 • 94a, in MeCN, where X,max = 632 nm (Abs = 
1.748) 86 




2.15 An X-ray crystal structure of [Cu(CH3CN)(C104)2]2 • 94a (CH3OH) 87 
2.16 (A) The electronic spectra and (B) the first order kinetics plot of the acid-
decomplexation of [Cu(CH3CN)(C104)2]2 • 94a (CH3OH) in 1M HC1 at 30 
°C 88 
2.17 The (A) cyclic voltammogram and (B) DVP of [Cu(CH3CN)(C104)2]2 • 94a 
(CH3OH)(0.1MNaOAc,pH=7) 89 
2.18 The structure of adjacent-bridged cyclam 103 92 
2.19 The electronic spectrum of Cu2 • 94b, in MeOH, where A,max = 658 nm (Abs = 
0.895) 94 
2.20 A comparison of the 'H NMR spectra of the complexed ligand (Zn2 • 94a, 
bottom), the free ligand in D20 solvent (94a, middle), and the crude product 
from the attempted synthesis of the mononuclear Zn(II) complex (top) 96 
2.21 The meso and d/1 stereoisomers of 95a and the time averaged symmetry of 
95a and 31 100 
2.22 The !H NMR spectra comparing the starting material (91a, upper spectrum) 
with the allylated crude product (91a, 108 and the mono-allylated 
intermediate , lower spectrum). The "*" is used to identify the P-methylene 
resonances in the product 108 (and possibly the mono-allylated intermediate). 
107 
2.23 The bis-cyclam 81 109 
XI 
List of Schemes 
Scheme Page 
1.1 The overall synthesis of di-NH cyclen, 24, and di-NH cyclam, 7 15 
1.2 The regioselective process involved in the di-alkylation of 19 16 
1.3 The general synthetic design for functionalizing cross-bridged 
tetraazamacrocycles, such as 7, with two different pendant arms - employing 
orthogonal protecting groups 19 
1.4 The general synthetic design for functionalizing a bisaminal 
tetraazamacrocycle with two different pendant arms - relying on selective 
mono-functionalization of the cross-bridged di-NH intermediate 21 
1.5 The synthetic utility of the mono-benzyl cross-bridged cyclen 32 and cyclam 
33 25 
1.6 Hill's synthesis of the mono-methyl cross-bridged cyclen 45 and cyclam 
46 26 
1.7 Reed's attempted synthesis of mono-benzyl cross-bridged cyclam 33 27 
1.8 The synthetic design for the synthesis of the mono-/-butyl ester cross-bridged 
cyclen 50 28 
1.9 The two synthetic routes used in the attempted synthesis of the mono-t-
butylcarboxymethyl mono-benzyl cyclam bisaminal salt 52 29 
1.10 The proposed synthesis of the mono-7-butylcarboxymethyl cross-bridged 
cyclam 53 29 
1.11 The proposed synthesis of the mono-benzyl cross-bridged cyclam/cyclen 
(32/33) when employing an orthogonal protecting group 31 
1.12 Bist's synthesis of mono-allyl mono-benzyl cross-bridged cyclam, 55 31 
1.13 Bist's unsuccessful attempt at the deallylation of 55 using Pd(PPh3)4 32 




1.15 Bist's unsuccessful attempt at deallylation of 55 using ?-butoxide in 
DMSO 33 
1.16 Widger's unsuccessful attempt at deallylation using Pd(PPh3)4 and sodium p-
toluene sulfinate 33 
1.17 Deallylation conditions employed by David Martin 34 
1.18 The model system and protecting groups that were chosen for 
investigation 36 
1.19 Synthesis of di-allyl cross-bridged cyclam 60, developed by Fagan 37 
1.20 Initial attempts at deallylation, employing microwave heating 38 
1.21 The mechanism for the formation of the enamine, which then hydrolyzes in 
the presence of acid to complete the N-deallylation 39 
1.22 Conditions developed for deallylation of diallyl cross-bridged cyclam 60....40 
1.23 Synthesis of mono-allyl mono-benzyl cross-bridged cyclen 62 41 
1.24 A small amount of deallylation of mono-allyl mono-benzyl bisaminal salt (54, 
61) occurs, followed by reduction - thus yielding adjacent-bridged side-
product (63, 64) 42 
1.25 The mechanism for reductive ring opening of the di-alkylated cyclen/cyclam 
bisaminal salt to form the cross-bridged ligand 43 
1.26 The mechanism for reductive ring opening of the mono-alkylated 
cyclen/cyclam bisaminal salt to form the adjacent-bridged ligand 43 
1.27 Synthesis of mono-benzyl cross-bridged cyclen 32 48 
1.28 Synthesis of mono-allyl mono-benzyl cross-bridged cyclam 55 49 
1.29 Synthesis of mono-benzyl cross-bridged cyclam 33 50 
1.30 Synthesis of di-PMB cross-bridged cyclen 66 52 
1.31 Synthesis of di-NH cross-bridged cyclen 24 via cleavage of the N-PMB bond. 
53 
1.32 The accepted mechanism for cleavage of the N-PMB bond in TFA 53 
xin 
Scheme Page 
1.33 Synthesis of mono-benzyl mono-PMB cross-bridged cyclen 68 54 
1.34 Synthesis of mono-benzyl cross-bridged cyclen 32 55 
1.35 The di-allyl (60) and di-benzyl (23) cross-bridged cyclams proved to be 
unreactive when exposed to the dealkylation conditions used to remove the 
PMB protecting group 56 
1.36 The attempted synthesis of the di-PMB cyclam bisaminal salt 69 56 
1.37 Synthesis of mono-benzyl mono-Nap cross-bridged cyclen 71 59 
1.38 Syntheses of di-Nap cross-bridged cyclen and cyclam (74 and 75) 60 
1.39 Attempted synthesis of di-NH cross-bridged cyclam 7, via the oxidative 
cleavage of the N-Nap bond 61 
1.40 Synthesis of mono-benzyl mono-octyl cross-bridged cyclam 76, via reductive 
amination 62 
1.41 Summary of the protecting group work and the potential use of the mono-
benzyl cross-bridged system 63 
1.42 Work done by Stigers to synthesize 78 63 
1.43 The three alternate methods now available for the synthesis of cross-bridged 
ligands - with sensitivity to acid, base, or hydrogenolysis conditions 64 
1.44 Martin's utilization of the N-allyl protecting group in synthesizing 57 65 
2.1 Synthesis of the di-methyl para- and weto-xylyl-linked cross-bridged bis-
tetraazamacrocycles 73 
2.2 Proposed side reactions - yielding 99 and 100 77 
2.3 Synthesis of the adjacent-bridged bis-tetraazamacrocycles 101 and 102 78 
2.4 Jolly's Complexation of 94a/b with 2 Li(C104) 79 
2.5 Jolly's Complexation of 94a/b with 2 Zn(CH3C02) • 2H20 79 
2.6 Complexation ofp-xylyl-linked adjacent-bridged cyclam 102a with Cu(II)..82 
2.7 Complexation ofp-xylyl-linked cross-bridged cyclen 94a with Cu(II) 86 
xiv 
Scheme Page 
2.8 Complexation of m-xylyl-linked cross-bridged cyclen 94b with Cu(II) 93 
2.9 Complexation ofp-xylyl-linked cross-bridged cyclen 94a with Zn(II) 94 
2.10 The attempted complexation of/7-xylyl-linked cross-bridged cyclen 94a with 
one equivalent of Zn(II) 96 
2.11 Complexation of w-xylyl-linked cross-bridged cyclen 94b with Zn(II) 97 
2.12 Overall synthesis of diamide/»-xylyl-linked cross-bridged cyclen 105 98 
2.13 Overall synthesis of di-allyl /?-xylyl-linked cross-bridged cyclen 107 101 
2.14 Synthesis of di-NH ;?-xylyl-linked cross-bridged cyclen 31 101 
2.15 The proposed synthesis of di-NH p-xylyl-linked cross-bridged cyclam 
110 104 
2.16 The proposed synthesis of the di-allyl p-xylyl-linked cyclam bisaminal salt 
108 105 
2.17 Synthesis of 108, with the mono-allylated intermediate included 106 
2.18 The proposed synthesis of 111 110 
xv 
List of Tables 
Page 
The half-lives of Cu(II) complexes of a 8,11,16 and 17 13 
The half-lives of Cu(II) complexes of a variety of bridged and non-bridged 
tetraazamacrocycles 91 
Electrochemical analysis of Cu(II) complexes of a variety of bridged and non-
bridged tetraazamacrocycles (0.1 MNaOAc, pH=7) 92 
Chromatographic conditions applied toward the purification of 31 103 
The reaction solvents and times for the attempted di-allylation of 91a 106 
The method, incorporating a ramp in power, used for the NaBHU MW-
assisted reduction of 66 133 
The method, incorporating a ramp in power, used for the NaBH4 MW-
assisted reduction of 68 136 
The method, incorporating a ramp in power, used for the NaBtU MW-
assisted reduction of 105 150 
xvi 
Abstract 
Development of Nitrogen Protecting Groups 
And 
Synthesis and Complexation of Bridged Bis-tetraazamacrocycles 
By 
Matthew J. Young 
University of New Hampshire, May, 2010 
The development of nitrogen-protecting groups that are orthogonal to the N-
benzyl group for use in cross-bridged tetraazamacrocycles and the synthesis and 
complexation of bridged bis-tetraazamacrocycles are presented. The allyl, /?-
methoxybenzyl (PMB), and 2-naphthylmethyl (Nap) nitrogen-protecting groups were 
investigated for use on cross-bridged tetraazamacrocycle systems and conditions for 
deprotection were found for the N-allyl and N-PMB protecting groups. The 
conditions applied for the cleavage of the N-allyl and N-PMB groups and the systems 
that these conditions were employed on are illustrated below. This research has 
demonstrated that the N-allyl and N-PMB protecting groups are applicable to a 
variety of systems. These protecting groups have the potential to be utilized in the 
synthesis of novel cross-bridged bis-tetraazamacrocycles where the N-benzyl 
protecting group may not be applicable. These cross-bridged systems can be further 
functionalized, in particular the mono-benzyl cross-bridged cyclam system 33, for a 
xvii 




62, R = Benzyl; n = 0 
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1.) DMSO, f-BuOK, 
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24, R = H 
The N-allyl protecting group was also used to synthesize a cross-bridged bis-
cyclen 31 that can now be further functionalized for a variety of biomedical purposes. 
Copper (II) and zinc (II) complexes of 94a and 94b and the diamide cross-bridged 
bis-tetraazamacrocycle 105 were also synthesized. These bis-tetraazamacrocycle 
systems may find use as potential anti-HIV agents or for stem-cell mobilization. 
.N N 
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I A / — \ 
.N .N / \ NL N \ \ // 
I—\ 
N ^ N . TO W cYj CO N' N 
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\ _ 7 R 
94a, spacer = p-xylyl group 
94b, spacer = m-xylyl group 
31 R — H 
105, R = CH2CONH2 
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CHAPTER I 
DEVELOPMENT OF NITROGEN PROTECTING GROUPS 
I. Introduction 
Polyazamacrocycles, particularly tetraazamacrocycles, are of continuing interest 
due to their ability to selectively form stable complexes with a variety of metal cations. 
Macrocyclic systems often exhibit unique properties that can give rise to complexes 
which are more kinetically inert and thermodynamically stable than their linear, non-
cyclic analogs - this increase in stability is called the "macrocyclic effect".1 With this 
increase in stability the complexes are able to retain their integrity under a variety of 
conditions. 
Lindoy describes macrocyclic molecules as "compounds that contain at least three 
donor atoms where the macrocyclic ring consists of a minimum of nine atoms."2 The 
tetraazamacrocycles that have been the focus of our research are based on the well-
known compounds 1,4,7,10-tetraazacyclododecane (cyclen, 1), 1,4,8,11-
tetraazacyclotetradecane (cyclam, 2), and 1,4,7,10-tetraazacyclotridecane (homocyclen, 
3) shown in Figure 1.1. These compounds have four donor atoms and 12, 14, and 13 atom 
ring sizes, respectively. 
H / \ H 
H-V7-" 
1 
H i H H*l l.H 
H , H H 
,
N N C u^N N^u H I I H H \_, H 
2 3 
Figure 1.1 Tetraazamacrocycles of interest to the Weisman/Wong research group: Cyclen 1, Cyclam 2 and 
Homocyclen 3. 
1 
The work performed by Gary Weisman's research group, in collaboration with 
Edward Wong's research group at the University of New Hampshire, has recently 
focused on the variations of the tetraazabicyclic units 4 and 5, shown below in Figure 1.2. 
Compounds 4a and 4b, where an ethylene bridge connects the two adjacent nitrogens in 
the macrocycle, have received attention3"5 because of their increased "structural rigidity" 
and metal ion selectivity 6 '7 over their non-bridged analogues. 
N N N N O ) C \ ) 
N HN N N 
Where: 
4a and 5a: n = 0 
4b and 5b: n = 1 
R, R' = H, Me, benzyl, etc 
Figure 1.2 The adjacent- and cross-bridged tetraazamacrocycles 4 and 5, respectively. 
Compounds 5a and 5b, in which the two nitrogens located across from each other in the 
macrocycle are joined by an ethylene bridge, are called "cross-bridged" macrocyclic 
Q 
tetraamines and were first synthesized in the Weisman research lab (5a, where R, R' = 
Me was first synthesized by Micheloni, et al.).9 Cross-bridged macrocycles, such as 5a 
and 5b, are flexible ligands that are able to adopt conformations where all four nitrogen 
lone pairs are convergent on a cleft or cavity for complexation to metal ions, as 
represented below in Figure 1.3 (using 5b). These cross-bridged compounds are proven 
to have an increased degree of basicity.8 Ligand 5b is able to take on a diamond-lattice 
conformation when complexed to a metal ion, giving the complex an added degree of 
stability and inertness (demonstrated below on the right of Figure 1.3). This increased 
2 
rigidity and stability is characteristic of the cross-bridged cyclam metal complexes and is 
of great interest to the Weisman and Wong research groups,8'10~16 as well as to others17"19 
because of potential biological, redox, and selective metal complexation applications. 
These cross-bridged ligands form exclusively cis-folded isomers when complexed to 
metals, as demonstrated below in Figure 1.3. 20 
M(ll) £XP& 
Figure 1.3 A conformation of 5b, where all four nitrogen lone pairs are convergent on a cavity and 5b 
complexed to a metal forming a diamond-lattice conformation that is stable and kinetically inert. 
The six configurations of metallo-cyclam complexes are shown below in Figure 
1.4.21 Cross-bridged cyclam is known to form the cis-V coordination exclusively11'12'14' 
' " while the adjacent-bridged cyclam is known to prefer the trans coordination ' of 
transition metal ions. 
- N C „ I ..TTN - H 




trans-l trans-ll trans-l I 
/ 








Figure 1.4 Six of the nine possible configurations of metallo-cyclam complexes.21 
3 
Unlike the cyclam analog, these bridged complexes have the ability to remain in one 
preferred configuration in solution when complexed to a metal and this can be of great 
advantage when utilizing them for particular purposes. If one configuration is preferred 
over others, this can be used to help predict, and hopefully guide, the biological 
properties of their metal complexes. 
Members of the Weisman and Wong research groups have prepared and 
characterized a variety of cross-bridged copper(II) complexes of 5a and 5b.10 '12 '16 '2529 
This research has demonstrated that these ligands are capable of forming stable, inert 
complexes with copper(II) and has led toward the investigation of these ligands in 64Cu-
based positron emission tomography (PET) imaging. Molecular imaging can be defined 
as "the visualization of in vivo biological processes at the molecular or cellular level 
using specific imaging probes"30 and it may be used for investigating the effectiveness of 
drugs, and for the early detection, characterization, and real-time monitoring of disease.30" 
32
 Currently, PET is one of the most sensitive molecular imaging techniques - it has the 
necessary sensitivity to visualize most interactions between physiological targets and 
ligands such as between neurotransmitters and brain receptors.30 Since its inception, 
molecular probes for PET imaging have been developed and employed for diagnostic 
clinical studies, studies aimed toward the understanding of human biochemical processes 
in neurobiology, and in pre-clinical studies where mostly nonhuman primates and rodents 
are used. Most recently, PET imaging has assisted in drug development by giving 
researchers greater insight into the understanding of drug action in the body, helping to 
establish drug dosage regimens for central nervous system drugs and to assist in 
developing drug treatment strategies.30 
4 
In PET imaging, a pharmacologically-active molecule containing a positron-
emitting radionuclide is delivered to the tissue or organ of interest and as this 
radionuclide decays it ejects a positron from its nucleus.33 This positron then travels a 
short distance before being annihilated with an electron, whereupon it releases two 
gamma rays 180° apart from each other that are captured by the detectors of the PET 
scanner - this process results in images of the radiotracer's location within the organism. 
There are several factors that weigh in choosing which radionuclide to use when 
designing a radiopharmaceutical. These factors include: the radionuclide's half-life must 
allow time for sufficient uptake and decay to provide the appropriate contrast and quality 
images; the radionuclide emission energies have to be appropriate for proper detection by 
the equipment; and the availability of the radionuclide.30 Transition metals (including 
94mTc, 66Ga, 68Ga, 86Y, 90Y, 45Ti, and 60/61/62/64Cu) have gained interest in recent years as 
candidate radionuclides due to their increased production and availability. In fact, a great 
deal of research has been dedicated to copper radionuclides since they offer a wide range 
of half-lives and positron energies.30 Also, the coordination chemistry of copper is 
widely studied and well understood and it has been shown to react with a wide variety of 
chelator systems that can be linked to biologically-active compounds such as antibodies, 
proteins, peptides, and other small molecules. 
Since the cross-bridged ligands had been demonstrated to form stable, inert 
complexes with copper(II), ' a collaboration was initiated with Carolyn Anderson (at 
the Washington University School of Medicine) to investigate the cross-bridged ligands 
for use in PET imaging with the 64Cu radionuclide. Current research is focused on the 
64Cu metal ion since it has potential as both a radionuclide for PET imaging and targeted 
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radiotherapy due to its half-life (ty2 = 12.7 h), decay characteristics (P+ = 19% and P" = 
40%), and the fact that it can be produced on a large scale with high specific activity in a 
biomedical cyclotron.29 When choosing a ligand for use with 64Cu in PET imaging it is 
essential that the resulting complex enables high uptake of the copper radionuclide into 
the targeted tissue or organ and that there is as little non-selective binding or 
incorporation into other organs and tissues as possible. Therefore it is crucial that the 
radio-copper complex remains stable in vivo, so that there is no loss of the radionuclide in 
transit in the body. When measuring the stability of the radio-copper complex in vivo, it 
has been found that the kinetic inertness of the copper complex toward decomplexation is 
even more important than its thermodynamic stability.34 Also, since the reduction of 
copper(II) to copper(I) may result in a loss of the metal in vivo, the resistance of the 
radio-copper complex toward Cu(II)/Cu(I) reduction and reversibility under biological 
conditions is an important feature.33 It is also important that the radio-copper complex 
can be formed easily - and so rapid complexation kinetics are desired. Along with these 
three requirements, the ligand in the radio-copper complex must have an available 
functional group that enables covalent linking to targeted peptides, proteins, and other 
biologically-relevant molecules. This ligand would then act as a bifunctional chelator 
(BFC, shown below in Figure 1.5) - a BFC is a metal complexing ligand which has a 
functional group incorporated into its structure that can be used for attachment to a 




Figure 1.5 A schematic of a radiopharmaceutical, which includes a bifunctional chelator (BFC) that is 
complexed to a radioactive metal ion and is also attached to a biologically-active targeting molecule.32 
In collaboration with Carolyn Anderson's research group, the Weisman and 
Wong research groups have studied the use of various cross-bridged ligands as BFCs. 
One prominent tetraazamacrocycle that has been bound to peptides for use in PET 
imaging is 1,4,8,1 l-tetraazacyclotetradecane-1,4,8,11- tetraacetic acid (TETA, 6), shown 
below in Figure 1.6.29 It has been found that 64Cu was dissociated from the TETA-D-
Phe1-octreotide (TETA-OC) bioconjugate in rat liver, in vivo, and bound to superoxide 
dismutase (SOD). Since cross-bridged ligands synthesized in the Weisman and Wong 
research groups have been shown to form kinetically inert complexes with copper(II), 
studies were begun with a variety of these cross-bridged ligands to determine their in vivo 
stability. It has been shown that the stability of 64Cu-ligand complexes can be used to 
gauge the stability of the respective BFCs for these complexes - and, with that in mind, 
the 64Cu complexes of the cross-bridged ligands shown below in Figure 1.6, compounds 
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Figure 1.6 Ligands 6-10, the 64Cu complexes of these ligands have been tested for their in vivo 
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stabilities. 
Copper(II) complexes of the bridged compounds 7-10 were found to be stable in 
serum for up to 24 hours. The positively-charged 64Cu(II) complexes of ligands, 7, 9, and 
10, were found to exhibit rapid uptake into the non-target liver and kidneys, but had slow 
clearance. In comparison, the charge-neutral 64Cu-CB-TE2A 8 complex was found to 
clear rapidly from all tissues, it showed a greater resistance to transchelation than 64Cu-
TETA in rat liver metabolism studies, and it had the most rapid clearance through blood, 
liver, and kidneys in normal rats. It has been shown in the literature that neutral 64Cu(II)-
azamacrocycles demonstrate better clearance through the body. And so, the fact that 
the 64Cu-CB-TE2A complex had the greatest in vivo clearance of the compounds studied 
may be attributed to the neutral charge of the complex, due to the presence of the two 
carboxymethyl pendant arms. 
These initial promising results led to the further study of the 64Cu-cross-bridged 
ligand complex for possible use as a PET imaging agent. The UNH research groups, in 
8 
collaboration with the WUSM group, then studied the in vivo properties of the 64Cu-
complexed cross-bridged analog to CB-TE2A, called CB-D02A (11, Figure 1.7), to gain 
further understanding of the effects of the cross-bridge on the 64Cu-tetraazamacrocycle's 
in vivo properties.27 It was found that the 64Cu-CB-D02A complex had more favorable 
in vivo clearance and decreased transchelation (to proteins such as SOD) than a non-
bridged analog, DOTA (12, Figure 1.7) - which has also been used as a chelator for PET 
imaging.37 These results give further evidence that the addition of the ethylene cross-
bridge to the tetraazamacrocyclic ligand, and the resulting increased kinetic inertness that 
this bridge imparts on the 64Cu complex, yields 64Cu-labelled complexes that have better 
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With this initial research having been done on the 64Cu-tetraazamacrocycle 
complexes, the next step was to test the in vivo properties of CB-TE2A when it was 
utilized as a BFC.38 The targeting molecule that was used in the BFC for this study was 
the somatostatin analog octapeptide Tyr3-octreotate (Y3-TATE). The 64Cu-CB-TE2A-
Y3-TATE radiopharmaceutical was tested and compared to the TETA analog in vivo with 
tumor-bearing rats and these experiments yielded promising results for 64Cu-CB-TE2A-
Y3-TATE. The results were that the CB-TE2A-based radiopharmaceutical demonstrated 
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better liver and blood clearance, which gives higher tumor-to-tissue ratios, and it was 
found to have increased tumor detection sensitivity over the TETA analog. However, it 
was also determined that 64Cu-TETA-Y3-TATE demonstrated greater clearance from the 
kidneys and it is suspected that this difference in uptake may be due to the difference in 
charge between the two BFCs - the 64Cu-TETA-Y3-TATE has a (-)1 charge while the 
64Cu-CB-TE2A-Y3-TATE has a (+)1 charge. Based upon available research, it is 
believed that if the compound were neutral, or even negative in charge, it would clear the 
kidneys more readily.36'39 The above results have focused the efforts of the Weisman 
and Wong research groups toward the goal of altering the charge of the cross-bridged 
ligand, and therefore the resulting BFC. 
In a further effort to reach a better understanding of 64Cu-cross-bridged ligand 
complexes and their in vivo stabilities, the kinetic inertness and electrochemical behavior 
of both 64Cu-CB-TE2A and 64Cu-CB-D02A were studied and compared to their non-
bridged analogs TETA and DOT A, respectively.26 As stated above, both kinetic 
inertness and resistance toward CuII/CuI reduction and reversibility are desired 
characteristics for 64Cu-radiolabelled complexes. These characteristics were studied 
further using acid decomplexation, and both differential-pulse (DPV) and cyclic (CV) 
voltammetry. As stated above, it has been found that the kinetic inertness of the copper 
complex toward decomplexation is more important than its thermodynamic stability34 
when considering in vivo stability and that the resistance of the radio-copper complex 
toward Cu(II)/Cu(I) reduction and reversibility under biological conditions is another 
important feature since the reduction of copper(II) to copper(I) may result in a loss of the 
metal in v/'vo.33 A greater understanding of the kinetic inertness and Cun/Cur reduction 
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characteristics of the copper(II) cross-bridged complexes will give greater insight into 
their in vivo stability. 
It was found that 64Cu-CB-TE2A was the most resistant to acid decomplexation, 
which can be correlated with the kinetic inertness of the metal complex. 64Cu-CB-TE2A 
also maintained the longest-lived Cu(I) complex - meaning that CB-TE2A is most able to 
accommodate the dissimilar coordination preferences of both Cu(II) and Cu(I). These 
results demonstrate that ethylene cross-bridge incorporated into the larger, cyclam 
tetraazamacrocycle, in addition to the two carboxymethyl pendant arms, yield a copper 
complex that is more stable toward acid-assisted and reductive decomplexation. The fact 
that the CB-TE2A was shown to be kinetically inert and stable toward reductive 
decomplexation, two characteristics that have been shown to demonstrate in vivo 
stability,33'3 compares well with what has been found in the in vivo experiments with 
this copper(II) complexed ligand. 
Other cross-bridged tetraazamacrocycles have also been synthesized and 
investigated - these ligands, compounds 13-17, are shown below in Figure 1.8.28'40 The 
cross-bridged monoamides, 13-15, were synthesized as model compounds for the 
peptide-conjugated CB-TE2A. The same acid decomplexation conditions that were 
used for the 64Cu-CB-TE2A complex were employed to determine the kinetic inertness of 
the 64Cu complexes of these 64Cu-cross-bridged monoamide complexes. Unfortunately, 
the amide arms were hydrolyzed under these harsh conditions and so it was not possible 
to directly measure the kinetic stabilities of these complexes. 
11 
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Figure 1.8 64Cu complexes of ligands 13-17 have been tested for their in vivo stabilities.12'25 
However, in vivo studies that were performed on the 64Cu complexes of ligands 13-15 
demonstrated that these complexes, like the 64Cu-CB-TE2A complex, have satisfactory 
clearance from blood, liver, and bone marrow. These results strongly suggest that 64Cu 
complexes of ligands 13-15 share the same improved in vivo stability as the "parent" 
64Cu-CB-TE2 A complex, which is greater than that of the 64Cu-TETA complex. 
In addition to the above research to gain deeper insight into the basic backbone of 
the cross-bridged ligands used, further research was done to explore the influence of the 
pendant arm length on the observed improved in vivo properties, kinetic inertness, and 
redox stability of these cross-bridged complexes. Toward that end, new cross-bridged 
cyclam and cyclen ligands with longer N-carboxyethyl pendant arms (16,17), and their 
respective copper(II) complexes, were synthesized and studied.25 Lengthening the N-
carboxymethyl pendant arm by one methylene group yielded mixed results. Shown 
below in Table 1.1, the results of the acid decomplexation experiments demonstrated that 
Cu-CB-TE2A was about as inert as the copper(II) complex of its analog with lengthened 
N-carboxymethyl pendant arms, 16, and both of these complexes were more stable than 
12 
the analogous cross-bridged cyclen complexes - with Cu-17 being more stable than Cu-
CB-D02A. 
Complex Half-life 
5 M HCI, 90 °C 
CU-CB-TE2A 154(6) h 
Cu-CB-D02A < 3 min 
Cu-CB-cyclam 11.8(2) min 
Cu-CB-D02LA < 3 min 
CU-CB-TE2LA -100 h 
1 M HCI, 30 °C 
CU-CB-D02A 4.0(1) h 
CU-CB-D02LA 37.2(5) min 
12 M HCI, 90 "C 
CU-CB-TE2A 1.6(2) h 
CU-CB-TE2LA 39(5) min 
Table 1.1 The half-lives of Cu(II) complexes of a 8,11,16 and 17.25 
In the electrochemical studies this research has found that the cross-bridged 
cyclam copper(II) complexes of 16 and CB-TE2A gave quasi-reversible 
electrochemistry, while the cyclen complexes were both irreversible. A reversible 
reduction is a sign that the ligand is capable of adjusting coordination in a relatively 
stable manner around Cu(I) and this would imply that the metal is retained within the 
cleft of the ligand and the complex remains relatively stable on the electrochemical time-
scale. Unfortunately, it was found that the cross-bridged cyclam complex with 
lengthened N-carboxyethyl pendent arms, Cu-16, was significantly less resistant toward 
reduction, making Cu-16 more likely to be susceptible to physiological reductants. Once 
Cu(II) has been reduced to Cu(I), the resulting complex should not be as kinetically inert, 
and the copper(I) may dissociate more easily. Consistent with this, the in vivo 
biodistribution studies demonstrated that the longer-armed 64Cu-labelled analogs do not 
clear the body as well as their carboxymethyl-armed homologs. These results suggest 
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that the higher Cu(II) reduction potential of the lengthened N-carboxyethyl pendant-
armed analogs may make them less optimal candidates for PET imaging agents and that 
the lower reduction potential of the Cu-CB-TE2A complex may be essential to its 
superior in vivo performance. 
Thus far, CB-TE2A has proven to be the more promising candidate for PET 
imaging, but further modifications can still be made to improve this ligand. This is a 
major focus of research that is presently taking place in the Weisman and Wong research 
labs. Currently, students in the Weisman research group are performing research that 
includes modifications to the tetraazamacrocycle backbone and the addition of pendant 
arms beyond the carboxymethyl group. This research is also focused on modifying the 
basic CB-TE2A ligand such that when complexed to copper(II) a charge neutral BFC can 
be made, which may improve the resulting radiopharmaceutical's clearance through the 
kidneys. Further modifications may also be made to the attached pendant arms, 
lengthening them to tune the lipophilicity of the ligand - thus modifying the 
biodistribution of the BFC. 
As is demonstrated with the results from the above research, subtle changes to the 
ligand may have more dramatic effects on the biodistribution, clearance, and other 
important in vivo features of the BFC. Consequently, the goal to make these changes to 
the basic CB-TE2A structure has necessitated the development of auxiliary protecting 
groups that enable greater versatility when designing synthetic pathways and target 
molecules. The progress that the Weisman group has made in designing the cross-
bridged cyclam species and, in particular, the work that has been done to add 
differentiated pendant arms will be discussed further in the Background section below. 
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II. Background 
The "di-NH" cross-bridged cyclam 7 (Scheme 1.1) is the basic starting material 
that the Weisman and Wong research groups use to make the most successful of the PET 
imaging agents that have been discussed thus far. The overall synthesis of 7, as well as 
the cyclen analog 24, carried out by Mark Rogers and Dan Hill, was first published in 
1996 by Weisman et al., and is shown below in Scheme 1.1 10,41 
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Scheme 1.1 The overall synthesis of di-NH cyclen, 24, and di-NH cyclam, 7.10'41 
In this synthesis, the macrocycle is first condensed with glyoxal to form a cis-fused 
tetracyclic bisaminal (18,19),42 followed by two consecutive regioselective alkylations to 
yield a bis-quaternary ammonium dibromide salt (20, 21). The final step involves a 
reductive cleavage through iminium ion intermediates to produce a double ring-expanded 
N,N'-dibenzyl bicyclic cross-bridged system (22, 23). 
The Weisman group has studied the regioselectivity of the above alkylations. 
While in solution, the bisaminal (18,19) undergoes a series of four nitrogen inversions 
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and two ring inversions to yield its enantiomer (this process is called enantiomerization), 
shown to the left of Scheme 1.2 for 19. The first alkylation to form 25 occurs on a more 
sterically-accessible exo nitrogen lone pair, which is located on the convex face of the 
bisaminal. Following this first alkylation the structure is locked, due to the inability of 
the quaternary nitrogen to invert, and the process of enantiomerization no longer occurs. 
The second alkylation, generating 26, regioselectively occurs on the other sterically 
accessible exo nitrogen lone pair located on the convex face of the tetracyclic species 
across from the quaternary nitrogen. Scheme 1.2 shows this sequence for 19. The 
process is analogous for 18. 
V 25 26 
Enantiomerization of 19 
Scheme 1.2 The regioselective process involved in the di-alkylation of 19. 
The synthetic route illustrated in Scheme 1.1 has worked well for the Weisman 
research group for some time, but there has long been interest in finding another 
protecting group to use in place of, or in addition to, the benzyl group. In recent years the 
goal of finding a new protecting group has become more of a necessity due to the 
presence of particular functional groups present either in synthetic intermediates or in 
current target ligands. In Scheme 1.1, the bisaminal has to be alkylated on both of the 
nitrogens that are across from each other in the ring in order for the reductive ring 
opening to yield the cross-bridged ligand. If the bisaminal is only mono-alkylated then 
the ethylene bridge will remain between the two nitrogens that are adjacent to each other 
in the macrocycle. This adjacent-bridged mono-benzyl tetraazamacrocycle was first 
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synthesized in the Weisman lab by Christine Elia (see 4b, Figure 2, where R = benzyl). ' 
44
 The mechanism of this reductive ring opening, for both the cross- and adjacent-
bridged ligands, will be discussed below in greater depth (see Schemes 1.25-1.26). 
As mentioned in the introduction, the Weisman and Wong research groups have 
made modifications to the cross-bridged cyclam- and cyclen-based ligands in an effort to 
further fine-tune and optimize the in vivo properties of the resulting radiopharmaceuticals 
they are incorporated into. There are two ways to modify the cross-bridged ligands for 
further optimization - either by attaching different pendant arms to the nitrogens in the 
cross-bridged macrocycle or by modifying the macrocycle's frame itself. The greatest 
limitation to the modifications that can be made to the tetraazamacrocycle is that 
whatever new functional groups are incorporated into the ligand must be amenable to the 
current basic synthetic pathway of dialkylation, followed by reductive ring opening, then 
deprotection and further functionalization. Any necessary modifications to this basic 
synthetic strategy (shown in Scheme 1.1) should be reasonably efficient in design - that 
is to say, yields should be moderate to high and only a minimum number of steps are 
preferred. 
When considering options for adding pendant arms to the cross-bridged ligand, 
these arms can be added either before or after the reductive ring opening. If a pendant 
arm is added before the reduction, then this pendant arm must be able to survive the 
rigors of the reduction (and the corresponding workup) as well as the conditions for 
debenzylation (if one benzyl is employed) - i.e., the second and third steps shown above 
in Scheme 1.1. To further complicate this issue, alkylation of the bisaminal depends 
upon precipitation of the mono- or di-alkylated bisaminal salt from solution as it is 
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produced. This precipitation of the product drives the reaction toward completion, and 
without it a mixture of products (most likely consisting of starting material, and mono-
and di-alkylated product along with the unreacted alkylating agent) is often obtained. 
There are two basic synthetic sequences that can be utilized to generate a ligand 
that has two different pendant arms. Both pathways necessitate the use of protecting 
group(s). The first method employs two orthogonal protecting groups (i.e., one 
protecting group can be removed without removing the other), shown below in Scheme 
1.3. In this general synthetic strategy the bisaminal is first mono-alkylated, then 
alkylated with a different alkylating agent to yield a bisaminal with two separate pendant 
arms, both of which can survive the conditions used for reductive ring opening (shown in 
Steps 1-3). One pendant arm is then selectively removed, the mono-alkylated cross-
bridge is then functionalized with another pendant arm that could not have survived the 
conditions used for reductive ring opening and/or the initial deprotection (Step 4-5) and 
this second mono-alkylated cross-bridge (the product from Step 6) is then further 
functionalized with another pendant arm that may have complicated the initial synthetic 
steps (Steps 1-6). The final product would be a cross-bridged ligand that has two 
different pendant arms, with unique functional groups. 
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Scheme 1.3 The general synthetic design for functionalizing cross-bridged tetraazamacrocycles, such as 7, 
with two different pendant arms - employing orthogonal protecting groups. 
When employing the synthetic sequence shown in Scheme 1.3 there are several 
complications that may arise. First, the mono-alkylated bisaminal must not over-alkylate. 
This is normally achieved by using a solvent that the mono-alkylated bisaminal salt is 
insoluble in, thus precipitating it from solution and preventing further alkylation. This 
precipitation of product also serves to drive the alkylation, which may be an equilibrium 
process, toward product. In addition to this, when the second protecting group is added 
in Step 2, this dialkylated product must also precipitate from solution. The precipitation 
of the di-protected bisaminal in Step 2 not only helps to drive the reaction toward product 
but it also serves to inhibit any de-alkylation and re-alkylation of the product. If any de-
alkylation occurs and PGi is removed in this process, then under the reaction conditions 
employed in Step 2 it is more likely that any re-alkylation will lead to a di-PG2 armed 
product rather than the desired mono-PGi mono-PG2 product. Finally, the protecting 
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groups employed should have the same basic characteristics of most protecting groups -
they must have high-yielding reactions when applied to the molecule as well as when 
they are clipped - that is to say, it should be efficiently added and removed. 
Scheme 1.4, below, shows the synthetic pathway that is employed if two different 
pendant arms R and R' are added to the basic cross-bridged di-NH ligand (e.g., 7). If the 
pendant arms were added after the reductive ring opening and de-protection then they 
would not be limited to functional groups that must survive Steps 1-3. However, this 
pendant arm R must be one that, upon addition to the cross-bridged species in Step 4, 
promotes precipitation or through some other manner renders the mono-alkylated species 
less reactive. If the reaction is not driven toward completion in this manner, then the 
other secondary nitrogen available in the di-NH cross-bridged macrocycle may also be 
alkylated. If further alkylation occurs, then this process may yield a mixture of mono-
and di-alkylated cross-bridged species, in addition to any unreacted di-NH cross-bridge 
(i.e. a low-yielding mixture could be obtained). If Step 4 efficiently synthesizes mono-
alkylated cross-bridge, then the next step would be to add the second pendant arm to 
obtain the final product. In other words, this route depends upon the viability of Step 4. 
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Scheme 1.4 The general synthetic design for functionalizing a bisaminal tetraazamacrocycle with two 
different pendant arms - relying on selective mono-functionalization of the cross-bridged di-NH 
intermediate. 
As stated above, there is also the possibility of placing a functional group within 
the actual backbone of the cross-bridged macrocycle itself- represented by the Y in both 
Schemes 1.3 and 1.4. If Y is a functional group that is more reactive than methylene 
(which is more likely than not), then the conditions used for alkylation, reduction, and the 
protection/deprotection steps must also be compatible with this new functional group. 
This functional group within the framework of the ligand could be used to link the ligand 
to the biologically-active targeting molecule of the radiopharmaceutical (see Figure 1.5, 
above). If this linker is a part of the ligand framework, then it allows for greater freedom 
in choosing what pendant arms may be attached. Most importantly it would allow both 
pendant arms to be free for coordination to the copper(II) metal - thus leading to a more 
kinetically inert metal complex. 
Members of the Weisman group have worked on incorporating functional groups 
within the ligand framework that are capable of linking to the biologically-active 
targeting molecule of the radiopharmaceutical. Examples of this type of cyclam-based 
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Figure 1.9 Compounds 27 and 28, with functional groups incorporated within the ligand framework. 
The target molecules that Weisman group members have worked on are the dibenzo-
annelated cyclam 29 and the (3-functionalized 30, both analogs of CB-TE2A - which 
David Martin (29) and Antoinette Odendaal (30) have made progress on.49'50 These 
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Figure 1.10 Compounds 29 and 30, where functional groups have been incorporated into the ligand 
framework for linking to biologically active target molecules of the radiopharmaceutical. "R" is the 
functional group that would be linked to the targeting molecule.49'50 
The dibenzo-annelated cyclam analog of CB-TE2A , 29, is an example of a 
system where the conditions used for alkylation, reduction, and the protection/ 
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deprotection steps were not compatible with the new functional group present in the 
ligand. There are two benzylic sites within the ligand framework of 29, labeled with an 
asterisk "*" in Figure 1.10. If the general synthetic strategy that is shown above in 
Scheme 1.1 were employed to make 29 then the presence of these benzylic sites (i.e., 
those labeled with *) would make the debenzylation step a concern since it is expected 
that there would be little or no differentiation between the benzylic sites within the ring 
and those that are present in the benzylic pendant arms that would be applied as 
protecting groups. The dibenzo-annelated system, 29, is a good example of how 
changing the structure of the cross-bridged ligand framework necessitated the 
development of an alternative to benzyl protecting group. Following critical work by Jeff 
Condon51 and Yijie Peng,52 David Martin made much progress in further developing the 
synthesis of 29, but his synthetic method did not involve the steps that are used in 
Scheme 1.1 - a different reducing agent and other newly-developed methods were 
utilized. The synthetic scheme used to synthesize the di-NH precursor of 29 will be 
further discussed below in the Conclusion of this chapter (see section IV, Scheme 1.44). 
Another application for a protecting group whose removal will not cleave N-benzylic 
sites is in the synthesis of the di-NH/?-xylyl-linked cross-bridged cyclen, 31 - shown 
below in Figure 1.11. This compound is of great interest in other areas of this author's 
research, and will be discussed further in Chapter 2 of this dissertation. 
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Figure 1.11 The di-NH /j-xylyl-linked cross-bridged cyclen, 31. 
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Work has also been done to try to follow the basic design laid out in Scheme 1.3-
where mono-alkylation of the bisaminal was performed, then a second alkylation (the 
protecting group), followed by a reductive ring opening, and finally removal of the 
protecting group. This method leaves open a secondary nitrogen on the cross-bridged 
ligand that can then be functionalized with a variety of groups (beyond the 
carboxymethyl) capable of linking to the biologically-active targeting molecule of the 
radiopharmaceutical. Scheme 1.5 illustrates the synthetic utility of this mono-benzyl 
cross-bridged cyclam/cyclen ligand (32/33). In Reaction (A), two moles of 32/33 could 
be linked using a di-acid chloride and, following reduction, this linked system (34) could 
be debenzylated to yield an aliphatically linked di-NH bis-tetraazamacrocycle (as 
opposed to the para- and weto-xylene linked systems that the Weisman group has 
synthesized in the past).53"55 In Reactions (B) and (C), the "shor-armed" and "long-
armed" phosphonate esters (35 and 36, respectively) could be further modified and 
explored for use as PET imaging agents. Weisman group member Dannon Stigers has 
made great progress on these phosphonate-armed cross-bridged systems in his doctoral 
research.56 The phosphonate-armed cross-bridged ligands would be capable of balancing 
the charge of the bifunctional chelator - thus yielding a neutral BFC. 
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Scheme 1.5 The synthetic utility of mono-benzyl cross-bridged cyclen 32 and cyclam 33. 
Reaction (D) alkylates the secondary nitrogen on 32/33 via reductive alkylation. If a long 
alkyl chain is attached (e.g., R= (CF^s), as with 37, then this will affect the lipophilicity 
of the BFC - possibly leading to an improvement in the resulting BFC's in vivo 
biodistribution. And finally, as shown in Reaction (E), the addition of a 7-butoxycarbonyl 
(BOC) protecting group, to form 38a, would yield a compound that can be debenzylated 
to give a mono-BOC-protected cross-bridged ligand 38b that can be further 
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fiinctionalized and subsequently deprotected under acidic conditions. These few 
examples demonstrate the possible utility of the mono-benzyl cross-bridged ligand. 
The methodology used to prepare a mono-alkyl cross-bridged cyclam via a 
process analogous to what was shown above in the first four steps of Scheme 1.3 was 
first developed by Dan Hill.41 As shown below in Scheme 1.6, Hill synthesized mono-
methyl cross-bridged cyclam 45 and cyclen 46 by first mono-benzylating the bisaminal 
macrocycle (18,19), then regioselectively methylating the product (39, 40) with methyl 
iodide. 
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Scheme 1.6 Hill's synthesis of the mono-methyl cross-bridged cyclen 45 and cyclam 46.41 
The penultimate step employed standard reductive ring opening conditions, using NaBH4, 
to yield di-alkylated cross-bridged intermediates (43, 44). Finally, debenzylation of 43 
and 44 by way of hydrogenolysis afforded the mono-methylated cross-bridged 
tetraazamacrocycles (45, 46). 
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Following Hill's work, David Reed attempted to prepare the mono-benzylated 
cross-bridged cyclam 33 by direct monobenzylation of the di-NH cross-bridged cyclam 7. 
It was hoped that, once 7 was mono-benzylated, the resulting product (33) would be 
protonated (by the HBr that results from the alkylation) and therefore be less likely to 
undergo further SN2 chemistry with any remaining benzyl bromide in solution. 
Unfortunately, as seen below in Scheme 1.7, this did not occur and a mixture of 
unreacted starting material (7), mono-benzylated (33), and di-benzylated (23) products 
were obtained. 
.N . N N N Ph N N N N 
r \ } B e n z y i b r ° m i d e , r ~\ ~) • ( \ ~) + (~] "} 
H' N N MeCN, reflux, P h . ^ N N P h ^ N N ,N N' 16h k^ k^ Hk^ 
7, di-NH 23 33 7, di-NH 
57 Scheme 1.7 Reed's attempted synthesis of mono-benzyl cross-bridged cyclam 33. 
Then, in a further effort to have the mono-benzylated product (33) precipitate from 
solution, Reed altered the reaction conditions to use toluene (a less polar solvent) and ran 
the reaction at room temperature. In this case, however, Reed obtained a white solid that 
was found to be 23, the di-benzylated product. 
Since the f-butylcarboxymethyl pendant arm is of great interest to our research, a 
year later Jeff Condon began investigating conditions to that would append this group on 
one of the nitrogens, with a benzyl group on the other non-adjacent nitrogen.51 Condon 
developed the synthesis, shown below in Scheme 1.8, on cyclen. Cyclen, currently the 
less expensive analog of cyclam, is commonly used to work out the conditions that will 
be used in our synthetic methods. Unfortunately, Condon ran into problems with the 
hydrogenolysis and was unable to fully develop the final step to synthesize 50. 
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Fortunately, Peng was able to determine the proper hydrogenolysis conditions and 
synthesized 50, and Peng then went on to work on the addition of other pendant arms. 
Unfortunately, problems were encountered when work was repeated on the cyclam 
analog.52 
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Scheme 1.8 The synthetic design for the synthesis of the mono-/-butyl ester cross-bridged cyclen 50.51 
Peng applied two routes to synthesize the mono-f-butylcarboxymethyl mono-
benzyl cyclam bisaminal salt 52. In Route 1 the goal was to alkylate the bisaminal with 
the f-butyl bromoacetone first and then benzylate (A in Scheme 1.9, below). While in 
Route 2 the bisaminal was benzylated first and then the plan was to alkylate with f-butyl 
bromoacetone (B in Scheme 1.9, below).41'52 Unfortunately, both routes yielded 
mixtures of products and were abandoned due to these difficulties. 
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Scheme 1.9 The two synthetic routes used in the attempted synthesis of the mono-/-butylcarboxymethyl 
mono-benzyl cyclam bisaminal salt 52.52 
The next logical step was the synthesis of the mono-f-butylcarboxymethyl cross-
bridged cyclam, 53, by alkylating the cross-bridged di-NH cyclam - this synthesis is 
shown below in Scheme 1.10. 
r i i - - -°- ^ v X^ N U 
^ N ^ N > Na2C03, MeCN, rt, / ^ O ^ ^ i | 
H ' I J 14 h \ ^ 
53 
7, di-NH 
Scheme 1.10 The proposed synthesis of the mono-?-butylcarboxymethyl cross-bridged cyclam 53.52 
Peng attempted to synthesize the mono-?-butylcarboxymethyl cross-bridged cyclam using 
conditions typically used in the group to alkylate our cross-bridged ligands and, not 
unexpectedly, met with a statistical alkylation. The crude product was 45-50% mono-
alkylated product (with a mixture of di-alkylated product and unreacted di-NH) and a 
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39% yield was obtained after purification. While Peng was able to isolate 53 and 
perform further research with it, the yield of the reaction is not ideal. 
The difficulties that have been encountered in synthesizing a mono-f-
butylcarboxymethyl cross-bridged cyclam led to even greater interest in the development 
of another protecting group that can be used as an alternative to, or is complementary to, 
the N-benzyl group. In searching for a protecting group, there are certain features that 
are essential in prospective candidates. Not only must the protecting group be efficiently 
added by alkylation and removed from the ligand, but other conditions must also be met. 
First, the deprotection conditions employed must not react with any other functional 
groups on the ligand and, second, the protecting group must survive the rigorous reaction 
conditions (i.e., the reductive ring opening) used to make the cross-bridged 
tetraazamacrocycles. Especially important for the synthesis of a mono-alkylated cross-
bridged cyclam is that any chemistry involved with this new protecting group must not 
interfere with the N-benzyl protecting group. That is to say, any additional chemistry 
used to add or remove the protecting group must not cleave the N-benzyl bond. The 
general synthesis of the mono-benzyl cross-bridged cyclam (and cyclen) is shown below 
in Scheme 1.11. 
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Scheme 1.11 The proposed synthesis of the mono-benzyl cross-bridged cyclam/cyclen (32/33) when 
employing an orthogonal protecting group. 
58 There are many N-protecting groups to choose from in the literature, but one 
that has been investigated previously by two Weisman group members is the N-allyl 
group. The reason that the N-allyl protecting group has been chosen is that there are 
several available routes for removal established in the literature - many of which should 
leave the N-benzyl group intact.58'59 Shanta Bist was the first to investigate the versatile 
N-allyl protecting group and, toward this end, synthesized the mono-allyl mono-benzyl 
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Scheme 1.12 Bist's synthesis of mono-allyl mono-benzyl cross-bridged cyclam, 55. 
The synthesis of 40, first developed by Hill41 (see Scheme 1.6), is followed by a 
regioselective allylation in MeCN for 11 days - to yield 54. This salt, 54, is then 
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reduced using the reductive ring opening conditions previously developed in the 
Weisman group.8 [Note: These conditions for the reductive ring opening of 54 were 
later found to lead to unwanted side-products - for further information see part A, section 
3 in the Results and Discussion section of this chapter] With 55 in hand, Bist then went 
on to attempt the deallylation of 55. Her first attempt at deallylation was using 
tetrakis(triphenylphosphine)palladium(0) and morpholine,60 shown below in Scheme 
1.13. Unfortunately, this did not lead to the deallylation of 55. 
^ O C Y ^ I PCHPC|3)4, < 0 H ^ O 
^ 0 N ^ N T 2h,35°C ^ N S 
55 33 
Scheme 1.13 Bist's unsuccessful attempt at the deallylation of 55 using Pd(PPh3)4. 
The next unsuccessful attempt at deallylation was using hydroxide to promote 
deallylation from protonated cross-bridged mono-allyl mono-benzyl cyclam, 55. This 
reaction (along with the proposed electron pushing demonstrating the deallylation) is 
shown below in Scheme 1.14. 
N > N v i i f 1 NaOH/H20, N N r 1 > iNaun/n2u, I  [ " U ^ *- ( \ 
r > f N + NT pH*10,2days ^ N ^ N 
~: OH H(55)+ 33 
Scheme 1.14 Bist's unsuccessful attempt at deallylation of 55, utilizing slightly basic pH conditions. 
Bist's final attempt at deallylation involved the use of f-butoxide in DMSO to 
promote a 1,3-hydrogen shift - yielding an enamine.60 This enamine would then be 
hydrolyzed upon treatment with acid, followed by a basic workup - to give the mono-
benzyl cross-bridged cyclam, 33. The overall reaction is shown below in Scheme 1.15. 
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Unfortunately, Bist had only limited success with this method. After running with a 
"large excess" of r-butoxide at reflux for 12 days only a small amount of what was 
believed to be the enamine was observed in the *H NMR spectrum. It was determined 
that most of what was in the crude product was unreacted starting material. 
Unfortunately, this reaction was not reproducible when run a second time, and Bist did 
not have time to further investigate these conditions. 
N N ' ^ V ^ 1-) '-BuOK, DMSO, I I 
f " l "1 [I J reflux, 2-6 days / N \ N 
^ v ^ N N 2.)aq.HC! % ^ N 
K^y 3.) aq KOH/PhCH3 H I J 
5 5
 33 
Scheme 1.15 Bist's unsuccessful attempt at deallylation of 55 using /-butoxide in DMSO. 
Peter Widger later attempted a deallylation61 using tetrakis(triphenylphosphine)-
palladium(O) [Pd(PPli3)4], employing reaction conditions that were similar to those used 
by Bist.60 However, in this case sodium p-toluenesulfinate was employed as an allyl 
scavenger rather than morpholine, which had been used by Bist. This reaction is shown 
below in Scheme 1.16.61 Unfortunately, some debenzylation also seemed to have 
occurred under these reaction conditions, and so this method was abandoned. 
/^v. 2 eq. tosic acid N
^ N^ 7i i sodium p-toluene sulfinate ^N^ N 
... . . ^ sodium p-toiuene sumnate ^ x 
^ O N V NT Pd(PPh3)4, CH2CI2 ^ N ^ N 
55 33 
Scheme 1.16 Widger's unsuccessful attempt at deallylation using Pd(PPh3)4 and sodium p-toluene 
sulfinate. 
Some years later, David Martin attempted palladium-catalyzed N-deallylation of 
56, utilizing a different allyl-scavenger and set of phosphine ligands than those employed 
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by Bist and Widger.49 The reaction conditions, shown below in Scheme 1.17, involved 
the use of 2-mercaptobenzoic acid and tris(dibenzylideneacetone)dipalladium(0) 
(Pd2(dba)3) in the presence of 1,4-bis-(diphenylphosphino)butane (dppb), refluxed in 
THF for two hours. Martin's analysis of the crude material by !H NMR demonstrated that 
a significant degree of deallylation did occur. Unfortunately, this crude reaction mixture 
was found to contain not just di-NH, but also mono-N-allyl and di-N-allyl species 
(estimated at 4.7/1.4/1 ratio, respectively) - thus demonstrating that the reaction was 
incomplete under these conditions. However, these results were promising and these 
reaction conditions can be revisited and possibly optimized if the need should arise in the 
future. 
N H^^^ 2-Mercaptobenzoic acid I 1 H J. J . ^ 
\ \ I Pd(dba)2, DPPB, THF ^ N N . ^ N ^ N ^ 
% S r reflux, 2h ,N 2 ^ N k J ^ N ^ N ^ 
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Scheme 1.17 Deallylation conditions employed by David Martin. 49 
Further work can still be done with the N-allyl protecting group, due to the fact 
that there are numerous methods available to remove it that have not yet been 
attempted.58'59 Also, applying microwave irradiation to heat a reaction mixture, rather 
than conventional heating, has been shown to improve reaction yields and efficiencies.62" 
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 Therefore, this relatively new technology can be utilized to re-visit previously 
explored reaction conditions to see if these reactions may still be viable methods for 
protection/deprotection. Beyond applying new technology, there are also several other 
protecting groups available in the literature that have demonstrated themselves to be 
34 
orthogonal in relation to the N-benzyl group. These candidates will be discussed further 
in the Results and Discussion section below. 
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III. Results and Discussion 
Several examples of nitrogen-protecting groups that have been added and 
removed in the presence of an N-benzyl group can be found in the literature5 - but any 
candidate must also meet the qualifications discussed above. That is, the prospective 
candidate must survive the conditions used to make the cross-bridged tetraazamacrocycle 
and any new reaction conditions that are employed to add or remove this new protecting 
group must not react with any functional groups already present on the cross-bridged 
tetraazamacrocycle. In searching the literature,58'66 the candidates that were chosen for 
investigation were the aforementioned N-allyl group 59, 60, 67-72 as well as the ~N-para-
methoxybenzyl (PMB)73"77 and N-2-naphthylmethyl (Nap)78"84 groups - shown below in 
Scheme 1.18. In each case the strategy was to synthesize the mono-protected mono-
benzylated cross-bridged cyclen as a model system and subject this compound to the 
selective deprotection conditions in order to test the efficiency of the reaction conditions. 
Selective 
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Scheme 1.18 The model system and protecting groups that were chosen for investigation. 
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A. Development of the N-allyl Protecting Group 
(1) Synthesis of di-NH cross-bridged cyclam 7 by way of deallylation 
As summarized above in the Background section of this chapter, several methods 
of deallylation have already been investigated in the Weisman research group. In light of 
the fact that the application of microwave-assisted heating can sometimes yield better 
results in reactions where conventional heating had been utilized, some previously 
investigated methods of deallylation were first re-visited. Di-allyl cross-bridged cyclam 
(60, shown below in Scheme 1.19) was used as a model compound for testing the 
conditions used for deallylation. 
The synthesis of di-allyl cross-bridged cyclam 60 was carried out by employing 
the method developed by Maureen Fagan (Scheme 1.19).85 The reductive ring opening 
was performed conventionally via Fagan's method. Microwave-assisted heating (78 °C, 
20 min, open-vessel) was also employed to perform this reductive ring opening of 59. 
This small-scale experiment yielded cross-bridged product 60 of equal purity to what had 
been found when conventional heating was employed and, in the future, microwave-
assisted heating can be employed to perform this reductive ring opening. 
1.)xsNaBH4, 95%EtOH 
r V > S xs ^ B r , r N T ^ ^ys,rt . r S S 
%>V MeCN ^ " ^ V
 0 2.)aq.HCI % ^ 
I I l"' I \ 2Br 3.) aq KOH/PhCH3 f I \ 
19 59 60 
Scheme 1.19 Synthesis of di-allyl cross-bridged cyclam 60, developed by Fagan.85 
Microwave-assisted chemical reactions, while not yet fully understood, ' ' 
have demonstrated great potential for performing chemistry more efficiently than 
conventionally heated reactions.63"65 The deallylation reaction conditions that were first 
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revisited were what could be considered the "simplest" methods run by Bist as a part of 
her research.60 As mentioned in the Background, it was hoped that the ligand would be at 
the appropriate pH for the allylated nitrogen to be protonated and that hydroxide present 
in the solution would deallylate this nitrogen. First the ligand was placed into a Discover 
microwave 10 mL reaction tube with water, sealed, and heated at 150 °C for 30 minutes. 
In the first attempt the pH was pre-adjusted, using a solution of HC1, to 9.5 and in the 
second attempt the pH was not adjusted at all (pH«12) - shown below in Scheme 1.20. It 
was hoped that these conditions would facilitate deallylation, but in both cases no 
reaction occurred and starting material was recovered. Since these reaction conditions did 
not lead to any deallylation at all, the reaction conditions that employed /-butoxide in 
DMSO were then investigated. 
r^ >^ '/ 1-) Reaction Conditions 
((j K MW, 150 °C, 30 min. 
f H ^ I "1 closed vessel, H2Q ^ Unreacted 
^ _ £ N © N 2.) aq KOH/PhCH3 
PdH H ( 6 ° ) + 
Reaction Conditions: 
A: pH =9.5 (adjusted by adding HCI) 
B: pH =12 (after adding the ligand to H20, no acid added) 
Scheme 1.20 Initial attempts at deallylation, employing microwave heating. 
Methods for de-allylation of both N-allyl and O-allyl groups using f-butoxide in 
DMSO are found in the literature.59'60'67 The mechanism, illustrated below in Scheme 
1.21, involves 7-butoxide deprotonating DMSO to form the dimsyl anion, which then 
goes on to facilitate the 1,3-hydrogen shift that results in the formation of the enamine. 
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Scheme 1.21 The mechanism for the formation of the enamine, which then hydrolyzes in the presence of 
acid to complete the N-deallylation. 
Fortunately, the reaction conditions of J-butoxide in DMSO employing 
microwave irradiation were found to deallylate 60. The optimal conditions were 
determined to be heating 60 (0.36 mM in DMSO) for 45 minutes at 100 °C in an open-
vessel (under nitrogen) with 1.5 molar equivalents of f-butoxide (1.17 mM in DMSO) per 
allyl group - as presented below in Scheme 1.22. The pH of the crude reaction mixture 
was then lowered to pH~0 by adding HCl - thus hydrolyzing the enamine to yield the 
crude di-NH cross-bridged cyclam HCl salt. The free ligand 7 is then extracted from a 
basic solution (pHM4) using toluene. Based upon what has been found in the literature 
the DMSO reaction solvent, often difficult to remove, remained in the aqueous layer 
when performing the toluene extraction (if residual DMSO still remained after 
concentrating the sample, then it could be removed by performing another extraction with 
39 
toluene from basic water). SAFETY WARNING: The heating of DMSO with f-butoxide 
(2.09 mM in DMSO) under pressure led to an explosion and should be avoided. 
Therefore, open-vessel microwave conditions must be employed. There is some 
literature precedent of explosions occurring with DMSO when heated under pressure 
over 220 °C89 and when DMSO is reacted with compounds such as sodium hydride to 
form the dimsyl anion.90"9 
With these conditions worked out for the model system, 60, the next step was to 
perform the deallylation in the presence of an N-benzyl group to determine if the N-
benzyl group is stable to the reaction conditions. 
1.) 3 eq f-BuOK (1.17 mM), DMSO, ^ - - \ 
M M - MW, open vessel, I 1 ,H 
^
N N N N 100°C,45min / N ^ N ^ 
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0.36 mM ' 
Scheme 1.22 Conditions developed for deallylation of diallyl cross-bridged cyclam 60. 
(2) Synthesis of mono-benzyl cross-bridged cyclen 32 via deallylation 
Once the conditions for deallylation had been developed for di-allyl cross-bridged 
cyclam 60, they were applied to the mono-allyl mono-benzyl cross-bridged cyclen 
system. The synthesis of mono-allyl mono-benzyl cross-bridged cyclen is based on the 
synthesis of the cyclam analogue, first developed by Bist.60 The synthesis, shown below 
in Scheme 1.23, involves the benzylation of cyclen bisaminal 18 using the procedure 
developed by Hill41 followed by regioselective allylation of 39 using excess allylbromide 
to yield 61. Unfortunately, difficulties were met when performing the reductive ring 
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opening employing the conditions commonly used- excess sodium borohydride in 95% 
ethanol.12'14 
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Scheme 1.23 Synthesis of mono-allyl mono-benzyl cross-bridged cyclen 62. 
Use of NaBtLt resulted in a small amount of deallylation (3-10%) of 61, which 
occurred prior to the reduction of the bisaminal. This deallylation is caused by the 
presence of hydroxide or ethoxide present in the solution. In the 95% ethanol reaction 
solvent some NaBtU will react with the water present, as well as ethanol, to yield NaOH 
and NaOEt.94 This NaOH and NaOEt will then act as nucleophiles reacting further with 
the N-allylated bisaminal salt to cleave off the allyl group from a quaternary nitrogen. 
Once this allyl group is cleaved, the mono-benzylated cyclen bisaminal salt would then 
reductively ring open to the mono-benzyl adjacent-bridged macrocycle - as shown below 
in Scheme 1.24 for 61. 
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Scheme 1.24 A small amount of deallylation of mono-allyl mono-benzyl bisaminal salt (54, 61) occurs, 
followed by reduction - thus yielding adjacent-bridged side-product (63, 64). 
It is known that these mono-alkylated salts reduce to form the adjacent-bridged 
tetraazabicycles.43'44 The mechanism for the reductive ring opening of the di-alkylated 
cyclen and cyclam bisaminal to form the cross-bridged ligand is shown below in Scheme 
1.25. This mechanism proceeds via the formation of an iminium ion that is reduced by 
NaBtLt - this reduction occurs twice in the molecule to afford the cross-bridged 
tetraazabicycle. 
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Scheme 1.25 The mechanism for reductive ring opening of the di-alkylated cyclen/cyclam bisaminal salt 
to form the cross-bridged ligand. 
A possible mechanism for the formation of the adjacent-bridged tetraazabicycle begins 
with protonation of the nitrogen adjacent to the quaternary nitrogen in the ring as shown 
below in Scheme 1.26. This nitrogen is believed to be the most basic of the nitrogens 
within the ring system. 
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Scheme 1.26 The mechanism for reductive ring opening of the mono-alkylated cyclen/cyclam bisaminal 
salt to form the adjacent-bridged ligand. The rationale for the increased basicity of the nitrogen adjacent to the quaternary nitrogen 
is based upon hyperconjugative stabilization as shown below in Figure 1.12A. This 
.9 
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rationale is supported by the literature since an X-ray crystal structure of the protonated 
mono-methylated cyclam bisaminal salt, shown below in Figure 1.12B, demonstrated that 
this nitrogen is protonated. Following the protonation of this nitrogen the mechanism is 
similar to the reductive ring opening of the cross-bridged analog. The process of the 
iminium ion forming followed by its reduction occurs twice after the initial protonation to 
yield an adjacent-bridged product - as shown above in Scheme 1.26. 
Figure 1.12 (A): Hyperconjugative effects that may be responsible for the increased basicity of the 
nitrogen adjacent to the quaternary nitrogen, which has its lone pair placed within the cleft of the bisaminal 
for cyclam and cyclen bisaminals (cyclam is shown); (B): Empirical evidence of this increased basicity, 
demonstrated in an X-ray crystal structure of the mono-methylated cyclam bisaminal salt.22 
Alternative reducing agents were investigated by this author and David Martin 
(who was having similar problems with a di-allylated bisaminal precursor of 56) for use 
in the reductive ring-opening step. Sodium triacetoxyborohydride (NaBH(OAc)3) and 
sodium cyanoborohydride (NaBH^CN)) were investigated since they are more mild 
reducing agents that are less reactive with water and reasonable alternatives to NaBH,*. 
Both NaBH(OAc)3 and NaBH3(CN) are less basic than NaBH4, and therefore less likely 
to cause the formation of "OH (as well as "OEt or "OMe, when in EtOH or MeOH, 
respectively) in solution. Martin's research lead to the development of NaBH3(CN) for 
use on a dibenzo-annelated system.49 It was also found that NaBH3(CN) in MeCN was a 
viable alternative to NaBH4 in 95% EtOH when performing the reductive ring opening to 
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yield 62. An aprotic non-polar solvent, MeCN, was chosen over 95% EtOH since 
running the reaction in this solvent eliminates the potential for the side reactions that 
yielded the NaOH and NaOEt - which were responsible for the deallylation of the 
macrocycle that subsequently lead to the unwanted adjacent-bridged side products. 
These reaction conditions (NaBH^CN) in MeCN) were not only found to be applicable 
for the reduction of 61 but also for 31 and 54 - as described later in this dissertation. The 
conditions used to reduce 61, shown above in Scheme 1.23, have also been adapted for 
use in the microwave reactor (MW-assisted reaction conditions: 0.066 mM 61 and 2.7 
mM NaBH3(CN) in MeCN; closed vessel, 110 °C for 30 min). The conditions, which 
yield comparable results, for running this reduction in the microwave involve performing 
the reaction in a closed vessel at 110 °C for 30 minutes. Unfortunately, when run in an 
open-vessel in the microwave the deallylated product was slightly less pure - with small 
peaks present in the baseline of the 'H NMR spectrum. This small difference in purity of 
product, and the fact that it is preferred not to run this reaction in a closed vessel (due to 
the possible evolution of HCN) lead to the use of conventional heating when performing 
this reductive ring opening. 
It was also found that sodium triacetoxyborohydride (NaBH(OAc)3) could be a 
viable alternative for NaBtLt as well as NaBH3(CN). The reduction did not proceed 
toward product when employing abs. EtOH and 95% EtOH with analogous molar 
equivalents of starting ligand (0.025 mM 61) and reducing agent (1.0 mM NaBH(OAc)3) 
- which are commonly used when utilizing NaBH4 (see the experimental section, where 
NaBH4 is used in 95% EtOH). The reductions were run at room temperature for 17 h (in 
both abs. EtOH and 95% EtOH) and 3 weeks (in 95% EtOH) and in each case mostly 
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unreacted starting material was recovered (note: this "unreacted starting material" has the 
bisaminal carbons cleaved out to produce mono-allyl mono-benzyl cyclen during the 
basic workup - as seen in the H and C NMR spectra that are obtained from crude 
product). Also, no 62 was observed in the crude products obtained after workup under 
these reaction conditions. Therefore, when considering the success that was recently 
found when employing NaBH3(CN), MeCN was explored as an alternative solvent. 
Conditions that gave the best results when using MeCN were those run in an open vessel 
(under N2) in the microwave at 82 °C for 90 min - with a 0.023 millimolar concentration 
in terms of starting material 61 and a 0.94 millimolar concentration of NaBH(OAc)3 in 
MeCN. These reaction concentrations are more dilute compared to the reaction 
concentrations that employ NaBH3(CN) (0.035 mM 61, and 1.38 mM NaBH3(CN)) 
which will slow the reaction. These conditions yielded product in «90% purity (69% 
crude yield), with some of the impurities determined to be unreacted starting material 
(again, as was the case with the reactions employing NaBH(OAc)3 above, this 
"unreacted starting material" was mono-allyl mono-benzyl cyclen - as determined by !H 
and 13C NMR analysis). The fact that product is yielded in «90% purity (the low yield 
could be improved when reaction conditions are modified) shows that NaBH(OAc)3 is a 
viable alternative to NaBH3(CN) and that it should be further investigated. A variety of 
possible experiments could be run to optimize this reduction, including: running the 
reaction longer in the microwave; applying conventional heating for 1-3 days; or running 
the reaction at higher concentrations (the molar concentrations of the starting material 
and NaBH(OAc)3 were diluted due to the fact that NaBH(OAc)3 has a higher molar mass 
than NaBH4 and NaBH3(CN) and, if the same number of molar equivalents of 
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NaBH(OAc)3 toward the di-allyl salt are used, the reaction mixture becomes more like a 
thick slurry). Further, sodium triacetoxyborohydride would be a preferred alternative to 
NaBH3(CN) due to its toxicity and the fact that the production of HCN is a concern when 
dealing with NaBH3(CN). 
During the process of purifying 62, an X-ray grade crystal of its tetraphenyl 
borate salt was obtained which allowed its structural determination - shown below in 
Figure 1.13. Note that one of the bridging nitrogens (N2) is protonated, implying that the 
intramolecular H-bonding pattern in the solid state is most favorable for protonation at 
the bridgehead. It is interesting to note that Nl, N3, and N4 all have their lone pairs 
convergent into the cleft of the macrocycle - implying that these nitrogens are helping to 
stabilize the proton that is bonded to N2. 
Figure 1.13 An X-ray crystal structure of the BPru" salt of protonated mono-allyl mono-benzyl cross-
bridged cyclen 62. 
With mono-allyl mono-benzyl cross-bridged cyclen 62 synthesized, the 
deallylation conditions that were developed for di-allyl cross-bridged cyclam 60 were 
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applied to 62. For 1.5 eq. 7-butoxide in DMSO, it was found that the reaction was 
complete after 25 min of heating (via microwave irradiation) at 100 °C in an open vessel, 
under nitrogen (Scheme 1.27). Purification by Kugelrohr distillation gave 32 in 77% 
1 1 ^ 
yield. There was no evidence of debenzylation in the H and C NMR spectra. It should 
be noted that one reported literature method of cleaving an N-benzyl group utilizes 
potassium ^-butoxide and oxygen in DMSO (at room temperature for 20 minutes) to 
cleave the N-benzyl bond on a variety of systems.95 So, it is fortunate that no 
debenzylation was observed under the reaction conditions used in Scheme 1.27, since no 
special precautions were taken to remove ambient oxygen from the DMSO used (the 
reaction was run under nitrogen). 
. _ 1.) 1.5 eqf-BuOK, DMSO, ^ ^ ^ 
, / \ . / ~ ^ - h ~ \ MW, open vessel, / \ / - - - { \ \ 
N N \ J ioo-C ,2Smin. ^ " ^ l j 
^ N N 2.)aq.HCI ^ N NT 
^ ^ \ / 3.) aq KOH/PhCH3 H' \ / 
62 77% yield 32 
Scheme 1.27 Synthesis of mono-benzyl cross-bridged cyclen 32. 
(3) Synthesis of mono-benzyl cross-bridged cvclam 55 
Two former Weisman group members had developed all but the final deprotection 
step of the synthesis of mono-benzyl cross-bridged eye lam 55 (Scheme 1.28). Hill was 
the first to synthesize the mono-benzyl cyclam bisaminal salt 40,41 but he recorded a 62% 
yield.44 This yield was increased to 94% by this author in the course of repeating this 
synthesis. The percent yield was improved by not only filtering the crude reaction 
mixture of 40 as originally instructed by Hill, ' but by also working to recover product 
from the resulting filter cake. More product was obtained from the filtrate by removing 
the solvent under reduced pressure and then washing the concentrated filtrate (now a 
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white solid) with toluene then filtering. The resulting washed filter cake was then 
combined with the original filter cake (after confirming its purity via !H NMR analysis) 
to improve the percent yield. Apparently nearly a third of the product was being lost to 
the filtrate during the original workup. The regioselective allylation of 40 was first 
performed by Bist as was the reductive ring opening of 54 using NaBH4.60 
Vk jSk S& > ^ a C T * l - ^ . B r NON r r 1 bromide>r Y«n U » ^ D r , M 
^ M ^ N T Toluene k N ^ N ^ Q M e C N ^ § ^ M -
^ • 11 days | | Br 14days <ss*v^N ?
 O D © 
94% yield v 80% yield 




reflux, 24 h, N2 NL N (A 2.)aq. HCI , ^ \ J N N' 
3.) aq KOH/PhCH3 ' I J 
94% yield
 g 5 
Scheme 1.28 Synthesis of mono-allyl mono-benzyl cross-bridged cyclam 55. 
Unfortunately, difficulties similar to what were seen in the synthesis of 62 (see Part A 
Section 2 above) were encountered when employing NaBFU to reduce 54. The same 
process of deallylation followed by reduction to form the adjacent-bridged mono-benzyl 
tetraazamacrocycle (in this case 64, shown above in Scheme 1.24) was found to have 
occurred when reducing 54 with NaBtLi. The percentage of adjacent-bridged side-
product was less than was seen in the case with the cyclen-based synthesis (ranging from 
4-6%, with a higher percentage of side-product in the larger scale reactions). In fact, a 
singlet from adjacent-bridged side-product (attributed to benzyl protons, found at «3.5 
ppm) can be seen in the 'H NMR spectrum of 55 in Bist's thesis, but it was present to 
such a small extent that it was misinterpreted as being part of a nearby multiplet and the 
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presence of 64 was obscured by noise in the accompanying C NMR spectrum. 
However, when running this reduction on a larger scale, the amount of side-product is 
increased and not as easily dismissed. Fortunately, NaBH3(CN) proved to work just as 
well in performing this reductive ring opening, giving product in a 94% yield after 
workup. 
The same reaction conditions that were used for the deallylation of 62, 1.5 eq. t-
butoxide in DMSO for 25 min at 100 °C (in an open-vessel), were applied to the cyclam-
based system 55 (Scheme 1.29). The product was obtained in 90% yield after 
purification by Kugelrohr distillation. No debenzylation was observed. 
r ^ \ 1.) 1.5 eqf-BuOK, DMSO, / \ 
N N ^ ^ V " ^ MW, open vessel, \ \ 
f I M ] 100°C, 25min. ^ ^ 
^ N ^hT 2.)aq.HCI
 H .N k N 
' I J 3.) aq KOH/PhCH3 " l^J 
55 9 0 % y'e l d 33 
Scheme 1.29 Synthesis of mono-benzyl cross-bridged cyclam 33. 
Fortunately, these deallylation conditions were found to work on all three N-allyl 
cross-bridged systems (55, 60, and 62) and they were also found to have utility with a 
bis-tetraazabicycle system (31, vide infra). Further, the use of this protecting group was 
also applicable on the dibenzo-annelated cyclam system 56, as demonstrated by David 
Martin.49 
During the process purifying 55, an X-ray grade crystal was obtained of its 
tetraphenylborate (BPh4~) salt (Figure 1.14). In this case, its structure revealed that the 
nitrogen (N61) attached to the benzyl group is protonated, implying that the 
intramolecular H-bonding pattern in the solid state is most favorable for protonation at 
this site. It is also interesting to note that the nitrogens N60 and N62 have their lone pairs 
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pointed into the macrocycle's cleft, while N63 has its lone pair pointed outside of the 
cleft. This implies that N60 and N62 are helping to stabilize the proton that is bonded to 
N61, while N63 does not interact with this proton at all. While work was being done on 
the development of an N-allyl protecting group, efforts were also put into developing the 
N-PMB and N-Nap protecting groups. 
Figure 1.14 An X-ray crystal structure of the BPh/ salt of protonated mono-allyl mono-benzyl cross-
bridged cyclam 55. 
B. Development of the N-PMB Protecting Group 
(1) Synthesis of di-NH cross-bridged cyclen 24 via the use of the N-PMB 
protecting group 
There are two methods known to cleave the N-PMB bond without cleavage of 
nearby N-benzyl bonds. These include oxidative removal using l,2-dichloro-4,5-
dicyanoquinone (DDQ) and its removal from nitrogen in triazoles, imidazoles, indoles, 
and pyrazoles using trifluroacetic acid (TFA). " ' However, before these conditions 
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were applied to our systems a model compound was synthesized, di-PMB cross-bridged 
cyclen 66 (Scheme 1.30). 
. / \ , xs p-Methoxy benzyl I \ /—~~-£ ~ \ 
N
^ ^ bromide ^ V S ^ l ^ . , , v , . , ^ / "V 
^ N ^ N T MeCN,3days / ° Y ^ \ ^ N ^ N 
\—/ 89% yield ^ / " ^ \ / 2Br° 
18 65 
1.)xsNaBH4, 95%EtOH 
MW, open vessel, I '. , 
78°C, 10min. / N isk \^^~~-Q/ 
2.)aq.HCI ^'°"f\ N^ ^ 
3.) aq KOH/PhCH3 v-^/"~"^ \ / 
98% yield 66 
Scheme 1.30 Synthesis of di-PMB cross-bridged cyclen 66. 
The dialkylation of 18 proceeds in 3 days, similar to the analogous di-benzylation 
reaction, to afford product in an 89% yield. The microwave-assisted reductive ring 
opening was then performed using NaBtLi, to obtain product with a 98% yield [Note: 
when running a reduction in the microwave using NaBH4 in 95% EtOH, there are 
potential hazards associated with foaming of the reaction mixture - see the appropriate 
endnote]97 
With model compound 66 in hand, cleavage of the N-PMB group was 
investigated. The procedure (shown below in Scheme 1.31) is based upon the conditions 
used to remove PMB from N-PMB pyrrole.75'76 The reaction is run neat in TFA, heated 
for 18 hours at 60 °C, and anisole was added as a scavenger for the /?-methoxybenzyl 
carbocation. Conditions utilizing microwave-assisted heating were also developed. It 
was found that this same reaction could be run at 85 °C for 10 minutes (closed vessel, 
due to the boiling point of TFA, 72 °C) to afford product in comparable yields. 
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/°V» N N 
66 
^ ~ o 
/ 1.) xs Trifluoroacetic acid, Anisole, 60 °C, 18 h 
2.) aq. HCI/PhCH3 





24 47% yield 
>97% pure after distillation 
Scheme 1.31 Synthesis of di-NH cross-bridged cyclen 24 via cleavage of the N-PMB bond. 
The accepted mechanism for this deprotection, proceeding via the formation of a 
para-methoxybenzyl carbocation, is shown below in Scheme 1.32. As demonstrated 
below, the para-methoxy group stabilizes the carbocation intermediate. Without an 
electron-donating substituent to stabilize the benzylic carbocation, these conditions are 
far less likely to cleave an N-benzyl bond - proven experimentally as shown below in 
Schemes 1.34 and 1.35. 
© % 
F,A? 
v^^  o- o 
Scheme 1.32 The accepted mechanism for cleavage of the N-PMB bond in TFA. 
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The anisole is employed as a scavenger for the carbocation, shown in the mechanism in 
Scheme 1.32, and its use did result in a cleaner crude product. 
(2) Synthesis of mono-benzyl cross-bridged cyclen 32 via the use of a N-PMB 
protecting group 
The above conditions were then applied to mono-benzyl mono-PMB cross-
bridged cyclen system 68 in an attempt to synthesize mono-benzyl cross-bridged cyclen 
32 and determine if the N-benzyl group would be cleaved under these reaction 
conditions. The synthesis, similar to analogous mono-benzyl mono-alkylated cross-
bridged cyclen procedures, is shown below in Scheme 1.33. The regioselective 
alkylation was carried out for 6 days in MeCN to afford mono-benzyl mono-PMB cyclen 
bisaminal salt 67 in 92% yield. Reductive ring opening of 67 was then performed using 
NaBH4 via microwave-assisted heating at 78 °C for 10 minutes give 68 in a 79% yield 
after extractive workup. [Note: when running a reduction in the microwave using 
NaBH4 in 95% EtOH, there are potential hazards associated with foaming of the reaction 
mixture - see the appropriate endnote] 
J V./"""~~~1\S\ x s P-Methoxybenzyl / \./~"~~--<(\ 
rNvg^i \J bromide , rNY©^ w> 
^ N A N J MeCN, 6 days /°^f\}-^H^ 0 
W B r® 92% yield W ^ V _ / 2BrU 
39 67 
1.)xsNaBH4, 95% EtOH 
MW, open vessel, / \ 
78°C, 10min. ^ N ^ % \J> /^°v \^ I I J 
2.)aq. HCI / \ \V N N 
3.) aq KOH/PhCH3 ^ / ^ \ / 
79% yield 6 8 
Scheme 1.33 Synthesis of mono-benzyl mono-PMB cross-bridged cyclen 68. 
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The method used to cleave the N-PMB bond in the di-PMB system 66 was then 
applied to 68 (Scheme 1.34). Product was obtained in 72% yield (=97% pure) after 
Kugelrohr distillation. No debenzylation was observed in the H and C NMR spectra -
thus demonstrating that the N-PMB group is a viable orthogonal protecting group to the 
N-benzyl system. 
I—\ / ^ - T / 5 ^ 1-) xs Trifluoroacetic acid, / \ ^ ^ ^ X v ^ 
N N . \\ J Anisole, 60 °C, 18 h ^ N ^ N \ \ ^ 
y°^f^\ L U 2.) aq. HCi/PhCH3 ^ N ^ 
W ^ > - - / \ / 3.) aq KOH/PhCH3 H' \ / 
6 8 72% yield 32 
>97% pure after distillation 
Scheme 1.34 Synthesis of mono-benzyl cross-bridged cyclen 32. 
In order to test if these reaction conditions would also remove the N-allyl group, 
di-allyl cross-bridged cyclam 60 was also put through the same reaction conditions with 
no reaction - represented below in Scheme 1.35. This result is important since it 
demonstrates that the N-PMB protecting group is orthogonal to both the N-benzyl group 
and the N-allyl group. Also, the reaction conditions used for this deprotection were 
applied to the dibenzyl cross-bridged cyclam 23, and again only starting material was 
recovered. This experiment confirms that the N-benzyl bond would not be cleaved from 
cross-bridged cyclam either, thus this method of deprotection could also be applied to 
cyclam-based systems. Therefore, the PMB group could be added and removed from 
molecules having both N-benzyl and N-allyl groups present - making it an important 
addition to the synthetic tools available for the production of azamacrocycles that contain 
a variety of functional groups. 
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<-N v, N v, Anisole, 60 °C, 18 h C \ ) * 
^ N N 2.) aq. HCI/PhCH3 
R
' I I 3.) aq KOH/PhCH3 
^ No 
Reaction 
R = allyl (60) or benzyl (23) 
Scheme 1.35 The di-allyl (60) and di-benzyl (23) cross-bridged cyclams proved to be unreactive when 
exposed to the dealkylation conditions used to remove the PMB protecting group. 
(3) Progress toward the synthesis of di-NH cross-bridged cyclam 7 via the use of 
N-PMB protecting groups 
An attempt was also made to synthesize di-NH cross-bridged cyclam 7 via the use 
of N-PMB protecting groups. Unfortunately, this work did not move beyond the first 
step. Following the same synthetic method as was applied for the cyclen-based system 
(Scheme 1.30, vide supra), the first step in the synthesis was to di-alkylate the cyclam 
bisaminal 19 to give di-PMB cyclam bisaminal salt 69 (Scheme 1.36). 
^ ^ ^ k^ 2Br 
19 69 
Scheme 1.36 The attempted synthesis of the di-PMB cyclam bisaminal salt 69. 
The reaction mixture was stirred at room temperature for 11 days and a milky 
white precipitate was observed. This precipitate was separated from the reaction solvent 
via centrifugation and washed with Et20 before removing residual solvent under reduced 
pressure. Once isolated, the white precipitate was analyzed via *H NMR spectroscopy in 
D2O. Surprisingly, the spectrum for the precipitate matched with the spectrum of cyclam 
bisaminal 19 (which is deuterated when in D20) and no evidence of alkylation (mono- or 
di-alkylation) was observed. The *H NMR spectrum of the supernatant appeared to be 
unreactedpara-methoxybenzyl bromide and 19, as well as other impurities that included 
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another set of ;?ara-methoxybenzyl aromatic multiplets. Later the puzzling results of this 
reaction were made clear when Kaitlyn Dugan and Gary Weisman worked toward the 
synthesis of a mono-benzyl mono-PMB cyclam bisaminal salt.9 A white precipitate was 
obtained as a crude product and this precipitate was analyzed in D2O, as had been done 
when working toward the synthesis of 69. Similar to what had been seen when analyzing 
the precipitate that was found as a result of the reaction shown in Scheme 1.36, Dugan 
and Weisman found the unreacted starting ligand 40 in the 'H and 13C NMR spectra. It 
was then determined that the product, a mono-benzyl mono-PMB cyclam bisaminal salt, 
had in fact been synthesized, but that the product was hydrolyzed shortly after being 
dissolved in the D2O. This lead to lH and 13C NMR spectra that contained "recovered" 
mono-benzyl cyclam bisaminal salt 40 and what is believed to be para-methoxybenzyl 
alcohol. Therefore this work can be revisited and further investigated since the 
precipitate from the reaction shown in Scheme 1.36 was most likely 69 and another 
solvent such as deuterated DMSO (which worked for Dugan and Weisman when 
analyzing the mono-benzyl mono-PMB cyclam bisaminal salt product) could be used to 
analyze this precipitate. However, once 69 has been made, the conditions used to 
perform the reductive ring opening would probably have to be modified so that 95% 
EtOH is not used as the reaction solvent - since the PMB group may be cleaved in this 
solvent as well. Perhaps NaBHaCN or NaBH(OAc)3 in MeCN could be explored as an 
alternative. But, since the cyclen analog, 66, worked just as well in testing the viability 
of this protecting group and synthesis of di-NH cross-bridged cyclam 7 has already been 
well developed, this research direction was not further pursued. 
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Alongside this work, and the work that was being done on the N-allyl protecting 
group system, efforts were put into the development of a potential N-Nap protecting 
group. The results for this protecting group did not meet with such success, as described 
below. However, the synthesis of the N-Nap cross-bridged tetraazamacrocycles was 
straightforward and successful. 
C. Investigation of the N-Nap Protecting Group for Cross-bridged Tetraamines 
(1) Progress toward the synthesis of mono-benzyl cross-bridged cyclen 33 via the 
use of an N-Nap protecting group 
The N-Nap group was the third candidate investigated for use as a protecting 
group. These Nap-armed cross-bridged tetraazamacrocycle target molecules are also 
interesting for other applications. Tetraazamacrocycles in the literature have had pendant 
arms incorporating large aromatic systems, such as 1- or 2-naphthylmethylene, appended 
to them for possible fluorescence applications99' 10° and the di-Nap and mono-benzyl 
mono-Nap cross-bridged tetraazamacrocycles may have some applications in this area as 
well. 
There are a few methods (both oxidative and reductive) known to cleave the N-
Nap bond selectively over the N-benzyl bond.78~84 In order to test the selectivity of these 
methods in cleaving the N-Nap bond over the N-benzyl bond in cross-bridge tetraamines, 
mono-benzyl mono-Nap cross-bridged cyclen 71 was synthesized. The strategy for 
synthesis of 71 is shown below in Scheme 1.37. Mono-benzyl cyclen bisaminal salt 39 
was regioselectively alkylated using excess 2-(bromomethyl)naphthalene in MeCN, and 
crude 70 was washed with Et20, though excess alkylating agent was not fully removed in 
this process. The reductive ring opening was then performed with excess NaBtU in 95% 
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EtOH stirred for 6 days - affording 71 in 94% yield after extraction. If there is renewed 
interest in this compound in the future, the microwave-assisted conditions that have been 
developed could also be applied in making this reductive ring opening more efficient. 
The conditions for cleaving the N-Nap bond will first be tested on a di-Nap cross-bridged 
species before testing these conditions on the mixed armed species 71, and so these di-
Nap cross-bridged species were also synthesized using similar conditions as were used in 
Scheme 1.37. 
J V i '—t f / 5 S a \ xs 2-Bromomethyl- > ^ / V , / ^ ^ 5 ^ 
f Y ® 1 V ^ naphthalene ^ ^ ^ f Y ® ^ l ^ ^ 
* N ' ~ N '
 Q MeCN \\ ^ N ' ^N n \ / B r u 6 days W ^ / \ / 2Br 0 
94% yield 
39 >95% pure 70 
1.)xsNaBH4 
95% EtOH, 6 days 
2.)aq. HCI 
3.) aq KOH/PhCH3 
94% yield 71 
Scheme 1.37 Synthesis of mono-benzyl mono-Nap cross-bridged cyclen 71. 
(2) Synthesis of di-Nap cross-bridged cyclen and cvclam (74 and 75) 
While work was being done to synthesize the mixed armed cross-bridge (71) for 
use in testing deprotection conditions in the presence of an N-benzyl group, work was 
also directed toward the synthesis of the di-Nap cross-bridged cyclen/cyclam systems. 
The synthesis of the di-Nap cross-bridged cyclen 74 and the di-Nap cross-bridged cyclam 
75 are shown below in Scheme 1.38. The syntheses went smoothly for the di-alkylated 
salts of both the cyclen and cyclam analogs (72 and 73). The only problem with the 
purification of 72 was that residual alkylating agent was difficult to remove when 
washing with MeCN. However, this impurity did not prove to be a problem when 
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performing the reductive ring opening of 72, the next step in the synthesis. The reductive 
ring openings of these systems, yielding 74 and 75, were successful, giving reasonable 
yields after extraction. Microwave-assisted conditions were also found to be successful 
for ring-expansion of these N-Nap systems. 
r*i 
. N . , N . xs 2-Bromomethyl-r ^ ' V " ^ naphthalene 
w •" MeCN 72 - 3 days 
90% yield, 
>95% pure 
(n = 0) -18 7 3 - 6 days 
(n = 1)-19 74% yield 
V 
(n = 0) - 72 
(n = 1)-73 
(n = 0) - 72 
(n = 1)-73 
1.)xsNaBH4, 
95% EtOH 
MW, open vessel, 
78°C, "lOmin. 
2.)aq. HCI 
3.) aq KOH/PhCH3 
74 - 76% yield 
75 - 95% yield (n = 0) - 74 (n = 1)-75 
Scheme 1.38 Syntheses of di-Nap cross-bridged cyclen and cyclam (74 and 75). 
(3) Attempted synthesis of di-NH cross-bridged cyclam 7 via the use of an N-
Nap protecting group 
With 74 and 75 in hand, cleavage of the N-Nap was investigated. The first 
method attempted was the oxidative cleavage of the N-Nap bond using DDQ based upon 
literature methods.78 As shown below in Scheme 1.39, 75 was stirred with DDQ for 3.5 
hours in a 4:1 mixture of CF^CVMeOH - following what have been described as 
"typical" reaction conditions in the literature.78 Unfortunately, no reaction was observed 
and only starting material was obtained. 
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CI JL CN 1)CH2CI2/MeOH(4:1), 
" ^ ^ " 3.5 h . N2 v * - Unreacted 
/ v 75 + 6 c ^ CN 2.) aq. base/PhCH3 
O 
(DDQ) 
Scheme 1.39 Attempted synthesis of di-NH cross-bridged cyclam 7, via the oxidative cleavage of the N-
Nap bond. 
This reaction was only run once and further work can still be done in this area. 
Either these conditions could be more fully developed (e.g., run longer or with heat, 
exploring different solvent systems, etc.) or other methods of cleavage could be used. 
Q 1 
There are selective reductive methods of deprotection in the literature (using H2, Pd/C) 
as well as other agents that can be explored for oxidative cleavage (such as cerium(iV) 
ammonium nitrate (CAN)).83 However, since the conditions to cleave both the N-allyl 
and N-PMB bonds had proven successful, work toward developing the N-Nap 
deprotection was not pursued further. 
D. Synthetic Utility of the Mono-Benzyl Cross-bridged Cyclam 33 
As discussed above in the Background, the secondary nitrogen in the mono-
benzyl cross-bridged cyclam can be substituted with a variety of potential pendant arms 
(see above in Scheme 1.5). These pendant arms can be used to modify the ligand for a 
variety of purposes. In Reaction D in Scheme 1.5, a long alkyl chain is added to the 
mono-benzyl cross-bridged cyclam to increase to the ligand's lipophilicity. Increasing 
the lipophilicity of the ligand will alter its biological properties and biodistribution, 
possibly in beneficial ways. Toward this end, the secondary nitrogen was alkylated with 
a long hydrocarbon chain via reductive alkylation. 
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(1) Synthesis of mono-benzyl mono-octyl cross-bridged cyclam 76 
A common method of alkylating a secondary nitrogen is to perform a reductive 
alkylation using a mild reducing agent such as NaBH3(CN)101,102 or NaBH(OAc)3.103 
The reaction using the former (Scheme 1.40) was straightforward, yielding 79% crude 
material (>90% purity) after acid wash and extraction from base using toluene. The 
<10% impurities are unknown, but the impurities in the H and C NMR spectra of the 
crude product 76 do not match with unreacted starting material 33. Chromatography 
was investigated as a method for purification of this material. Thin-layer 
chromatography experiments were performed using CH2Cl2:MeOH:(28% aq) NH3 
(10:2:0.25; 10:3:0.25; 15:2:0.25; on basic alumina) but, as is often the case with amines, 
the crude material streaked and ran together at reasonable Rf values. Other conditions for 
chromatography could be investigated or recrystallization could be attempted (possibly 
via an HBr salt, etc.) as methods to purify this material further. Once purified this 
compound may give insight into what effects altering the lipophilicity of the cross-
bridged cyclam ligands could have on their properties as PET imaging agents (e.g., how 
its biodistribution my be affected) and 76 could also be complexed to copper(II), to study 
its properties. 
1.)3eqNaBH3(CN) MeCN 
^ N N \ l| ^ Acetic Acid, 10 eqOctanal ^ N N 
H ' [ j 2.) aq. HCI/PhCH3 wash ^ ^ f j 
V 3.) aq KOH/PhCH3 extraction v 
33 76 
* * 79%, >90% pure 
Scheme 1.40 Synthesis of mono-benzyl mono-octyl cross-bridged cyclam 76, via reductive amination. 
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IV. Conclusions 
The work described in this chapter has led to the development of two protecting 
groups that can be used to aid in the synthesis of a variety of new, unsymmetrically 
functionalized bridged tetraazamacrocycles. Mono-benzyl cross-bridged cyclen 32 or 
cyclam 33 can now be synthesized employing two different protecting groups, N-PMB or 
N-allyl, and the resulting secondary nitrogen can then be used to perform further 
chemistry making a variety of mixed-arm cross-bridged species as demonstrated below in 
Scheme 1.41. The mono-benzyl mono-armed species could then be hydrogenolyzed to 
remove the N-benzyl group, leaving open the resulting NH for further functionalization if 
desired. Hill, Peng, and Bist have already utilized this type of elaboration to a mix-armed 
41,52,60 
species. ' ' 
(PG = allyl) 
1.5 eq f-BuOK, DMSO, MW, 
open vessel, 100°C, 25 min r ^ ^ i l i 
C\N?0 J rY^TU •-'• - f"\ 
^ N N ^ N ^ - M ^ Functionalization V N ^~ 
* "> Trifluoroacetic acid, X-% v% 
(n = 0 ) . cyclen Anisole, 60° C, 18hrs ! n = ? ' ' " (n = 0> 
(n=1)-cyc lam (PG = PMB) (n = 1), 33 (n = 1) 
Scheme 1.41 Summary of the protecting group work and the potential use of the mono-benzyl cross-
bridged system. 
Dannon Stigers has specifically utilized 33 (made by this author via the use of an N-allyl 
protecting group) to synthesize a mono-phosphonic acid pendant-armed cross-bridged 
cyclam 78 - shown below in Scheme 1.42.56 
f N ^ N " 1 i f J P ( ° - / B u ) 3 ' ^ ^ f N v l " N Y j 6M HCI, reflux, f ^ S " 
S \ ^ ^ DryTHF,N2 ,4days* E t 0 _ B ^ N ^ ^ 1 day, N2 " H O - P O N ^ N 
H
'kJ ^KJ ™KJ 
33 77 78 
Scheme 1.42 Work done by Stigers to synthesize 78.56 
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As illustrated below in Scheme 1.43, there are now three potential protecting 
groups that can be added and removed from tetraazamacrocyclic systems - one of these 
groups can be removed using reductive methods, another using basic conditions, and the 
third using acidic conditions. This affords greater synthetic versatility when modifying 
our systems by allowing researchers to add a variety of functional groups that may have 
sensitivity to acid, basic, or reductive reaction conditions to the frame of the 
tetraazamacrocycle. 
rY^ rY^ ,pG 
r " N V N ^ Protectin9 r " N V © S Reductive Ring 
'N^lsT G r o u p ^ f T " h T <=> Opening 






Y = (CH2), (CH2)2, and / or 




3 eq f-BuOK, DMSO, MW, . N N, 
open vessel, 100°C, 45 min 
Trifluoroaccetic acid, 
Y 
various functional groups Anisole, 60° C, 18 hrs 
Scheme 1.43 The three alternate methods now available for the synthesis of cross-bridged ligands - with 
sensitivity to acid, base, or hydrogenolysis conditions. 
Indeed, the deallylation conditions have already found utility in David Martin's synthesis 
of di-NH cross-bridged dibenzo-annelated cyclam 57 - shown below in Scheme 1.44.49 
The N-allyl protecting group has also been applied successfully to the p-xylyl-linked 
cross-bridged cyclen system - discussed in Chapter II. 
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1.) 3 eq f-BuOK, DMSO, 
CO 





^ 100°C, 15min 
:N N 2.)aq. HCI 
3.) aq KOH/PhCH3 
' \ ) 
56 57 
Scheme 1.44 Martin's utilization of the N-allyl protecting group in synthesizing 57.49 
While the conditions for removal of the N-Nap moiety were not found, more work 
can be done toward this goal if the need for this protecting group should arise. As stated 
above, further research could include revisiting the conditions utilizing DDQ (see 
Scheme 1.39) or investigating reductive methods for removal. These Nap pendant-
armed systems may also be of interest for applications in fluorescence research.99' 10° 
It is this author's hope that these protecting groups, and the methods developed to 
remove them, will continue to find use in the Weisman and Wong research groups and by 
others. Though the N-allyl and N-PMB protecting groups have proved successful with 
several cross-bridged systems, the work done here does not end the search for other 
protecting groups that can be used on cross-bridged tetraazamacrocycles. Novel 
protecting groups, and novel removal methods of pre-existing protecting groups, are 
constantly being developed - as is evidenced by the large number of protecting group 
related research found in the literature as well as the continued publication of the ever-
larger monographs on the topic. 
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CHAPTER II 
SYNTHESIS AND COMPLEXATION OF BRIDGED BIS-
TETRAAZAMACROCYCLES 
I. Introduction 
Linked tetraazamacrocycles have added chemical utility over their non-linked 
analogs in that they are capable of binding to two separate metal ions simultaneously. 
These bis-tetraazamacrocycles, with their ability to place two separate metal ions near 
each other, can create complexes with unique electronic, catalytic, and redox properties. 
The resulting bimetallic complexes can also serve as models for the charge transfer, 
electron transport, and allosteric behavior found in many metal-containing biochemical 
systems.104"106 Bis-tetraazamacrocycles are also of interest for use as potent anti-HIV-1 
and HIV-2 agents.107"113 Depending on the choice of linker, the type of pendant arm 
attached, and the size of the macrocycle, the chemical properties of the bis-
tetraazamacrocycle can be fine-tuned for particular applications.114"122 
The bis-tetraazamacrocycles of interest in this author's research are based on 
compounds 4 and 5 (shown again in Figure 2.1), discussed in Chapter I. In the pursuit of 
more stable and selective bis-tetraazamacrocycles, this research incorporates the use of 
cross-bridged and adjacent-bridged tetraazamacrocycles 4 and 5. Also, the linkers or 
"spacers" that are incorporated into these bis-tetraazamacrocycles are either para- or 
weto-xylyl units, thus creating compounds of the general design shown in Figure 2.1. 
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These cross-bridged (79a and 80a) and adjacent-bridged (79b and 80b) type bis-
tetraazabicycles will be discussed in greater detail below. 
N N N N o) m 
N HN 2]N N V RV 
Where: 
4a and 5a: n = 0 
4b and 5b: n = 1 
R, R' = H, Me, benzyl, etc 
/ — H - -\—W—\ r^r-f^n. 
R'V_7 \ _ / R R' L j U R 
79a ^ - ^ 80a ^ ^ 
V_yR R'V_V L J R R U 
79b ^ ^ 80b ^ ^ 
R = H or Me 
Figure 2.1 The adjacent- and cross-bridged tetraazamacrocycles 4 and 5, respectively, and cross-bridged 
(79a and 80a) and adjacent-bridged (79b and 80b) bis-tetraazabicycles. 
Compounds similar to 79a/b and 80a/b have been investigated in recent years for 
use in a variety of applications.105'107''14 They have received a great deal of attention in 
the literature for their biological applications, including their aforementioned anti-HIV-1 
and HIV-2 properties. Below in Figure 2.2 is the bicyclam AMD3100 (81, formerly 
JM3100), which has generated attention for its possible applications - mostly due to its 
potent activity against the virus. ' Unfortunately, the compound was found to have 
significant cardiac side effects and has been withdrawn for consideration as an anti-HIV 
agent.124 However, the compound continues to spark interest in other applications. 
67 
Recently it was investigated for use as a ligand in a possible PET imaging agent125 and in 
late 2008 the FDA approved 81 (under the name MOZOBIL and, most recently, 
Plerixafor - owned by Genzyme Inc.) for use as a stem cell mobilizer.12 '127 
NH N ^—^ N HN 
NHHN NH HN 
i^J 81 • 8 HCI l^J 
119 123 Figure 2.2 The bicyclam 81 (AMD3100), a stem cell mobilizer and anti-HIV agent. 
The ability of 81 to act as an anti-HIV agent and a stem cell mobilizer is based on 
its ability to interact with the CXCR4 chemokine receptor on a cell. Much research has 
been directed toward understanding this interaction between bis-polyazamacrocycles and 
this receptor so as to produce optimal activity with minimal physical side effects. 
Bridger, De Clercq, and others have studied the structural characteristics that are required 
111 119 11Q 19^ 198 1"? A 
for these bis-tetraazamacrocycles to be active against the virus. * 
Further information on this topic can be found in this author's original Master's thesis55 
as well as in research published on bicyclam complexes by Sadler and Liang.106'126,137~139 
Initial work by Bridger and coworkers also investigated the activities of a series 
of metal complexes of AMD3100. 1 2 3 ' 1 2 4 The following order of activity was found: 81-
Zn2n > AMD3100 > 81-Ni2n > 81-Cu2n » 81-Co2m » 81-Pd2n It should also be noted 
that not only does the Zn(II)2 complex of AMD3100 exhibit greater anti-HIV activity 
than the free ligand, but it also has lower toxicity. On the other end of the spectrum, the 
Pd(II)2 complex inactivates the drug's activity.140 Research by Sadler et al. has further 
elucidated the relationship between the metal complexes of AMD3100 and the CXCR4 
receptor, with a focus on the complexation of Zn(II).137"140 Sadler's investigations into 
how the metallomacrocycles interact with the CXCR4 receptor may aid in tailoring bis-
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tetraazamacrocycles that have activity similar to that of AMD3100, but lack the adverse 
physical side effects. And, in recent years, there has been interest from other researchers 
in the field to develop bridged bis-tetraazamacrocycles, and their metal complexes, for 
this purpose. 
Since this author's Master's research was completed it should be noted that some 
of these compounds have been published in the literature by other researchers. The 
adjacent-bridged para- and meta-xylyl-linked cyclen (101a, and 101b, respectively, 
shown below in Scheme 2.3) were the first to be studied (called a "side-bridged" system 
by the author).141 Other authors have also found interest in both the Zn(II) and Cu(II) 
complexes of the/?ara-xylyl-linked adjacent-bridged cyclam-based ligand 102a for use as 
an anti-HIV agent - and these complexes were found to have notable anti-HIV 
activity.110'112'113 Most recently, a Cu(II) complex of the di-methyl para-xylyl-linked 
cross-bridged cyclam-based ligand (95a, in Scheme 2.1 below) has also been found to 
have significant anti-HIV activity in in vitro testing.111 While these results are promising 
and demonstrate the potential of these systems for use as anti-HIV agents it is still not 
certain how well these ligands would be able to retain the copper and zinc cations in vivo. 
The loss of these metals from the ligand due to transmetallation, yielding the free ligand, 
within the body may lead to health problems due to similar cardiac issues as were found 
for 81 in clinical trials.124 Therefore, these bis-tetraazamacrocycles will have to be 
further modified (i.e., through the addition of pendant arms that could aid in securing the 
metal in place) and studied before they could be seriously considered for such 
applications. This fact also necessitates the development of an alternate protecting group 
to the N-benzyl group (and the currently used N-methyl group) for use on these bis-
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tetraazamacrocycles. Handel has also synthesized and studied pendent-armed para- and 
meta-xylyl-linked cross-bridged cyclen-based systems - shown below in Figure 2.3. 
These systems are the cyclen- and cyclam-based bridged systems that are currently found 
in the literature. 
N N \ ^ N N 82a: para, R=CH2COOEt 
f ^l ^ ( ( \ 82b: meta, R=CH2COOEt 
L L © J <®J J 83a: para, R=CH2CH2OH 
N N
- , , <=) -N N- 83b: meta, R=CH2CH2OH 
X= Br, CI 
Figure 2.3 Pendant-armed para- and weta-xylyl-linked cross-bridged systems (82-83) synthesized by 
Handel.109 
There has also been research investigating the redox behavior of metal complexes 
of bis-cyclams114 and bis-cyclens.142,143 For example, Ciampolini and coworkers tested 
the redox behavior of [Ni(II)2(bis-cyclam)](C104)2 complexes with a variety of spacers, 
as shown in Figure 2.4.144 In these experiments, the AEy2 of the stepwise oxidation of the 
[Ni(II)2(bis-cyclam)](C104)2 complexes varied according to the type of spacer joining the 
two cyclam rings. They discovered that the potential difference was the largest with the 
shortest spacer system, and that the AEy2 decreased with the increase in separation 
between the rings. Research such as this indicates that the cyclam and cyclen ring 
systems may serve as convenient and versatile building blocks in the production of multi-
electron redox systems. This research also demonstrates the importance of the type of the 
spacer used when designing the bis-tetraazamacrocycles. The length and rigidity of the 
linker will play a significant role in determining how far apart the metals that are bound 
to the bis-tetraazamacrocycles will be and this will help in determining the redox and 
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Figure 2.4 Bis-cyclam complexes, with a variety of spacers, tested for their redox behavior. 144 
Eiichi Kimura and coworkers have carried out significant research into the 
interaction of bis-cyclen metal complexes is with biologically-relevant compounds.108,145, 
146
 Complex 88, shown below in Figure 2.5, has the ability to interact with a variety of 
such compounds including DNA in aqueous solution at physiological pH.108,145'147"151 
Their research has also revealed that the meta-xylyl analog of 88 shows similar promise 
for a variety of related biological applications.108'145 
HoO 
/ / ^ 
H,0 
I—\ 
r N H | N V = / NX HN 
NH HN NH HN' 
88 
Figure 2.5 A bicyclen complex utilized for DNA binding.108,145 ' ,47"151 
Biomimetics is another area where bis-tetraazamacrocycles have a great potential 
for use. Dinuclear metal complexes have been investigated for such biomimetic 
purposes152"156 and bis-tetraazamacrocycles have a great deal of potential. One enzyme 
of interest in the literature is superoxide dismutase (SOD).157"159 SOD catalyzes the 
dismutation (the process of simultaneous oxidation and reduction) of the superoxide 
anion (O2'") and plays an important role in the protection of cells from oxidative 
damage.160 The active site of the Cu-Zn SOD enzyme has a bimetallic center with one 
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Cu(II) and one Zn(II) ion bridged by an imidazolate moiety. Several researchers have 
designed and investigated systems where the Zn(II) and Cu(II) metal complexes are 
placed in the appropriate distance from each other, bridged by imidazolate moieties, for 
possible activity as SOD biomimetic agents.161*168 Bis-tetraazamacrocycles have a 
possible application in this area of research, due to the fact that the linked macrocycles 
have the ability to place two metals (e.g., Cu(II) and Zn(II)) in close proximity and these 
complexes could be further modified as an SOD-mimic. 
The substantial amount of literature documenting the synthesis of bis-
tetraazamacrocycles55' 169'170 to date involves modifying these ligands so that they can 
better interact with the CXCR4 receptor for use as anti-HIV agents,171"178 and as stem cell 
mobilizers.106'119'127'179185 These compounds also have a great deal of potential for use 
in bimetallic chemistry.105,173> 174'176~178,186"188 A key advantage to the use of bis-
tetraazamacrocycles is their versatility - they are easily functionalized and their 
structures can be altered in subtle ways leading to considerable changes in the stability of 
their resulting metal complexes. The addition of an ethylene bridge to each macrocycle 
of these bis-tetraazamacrocycles, to add structural rigidity to the resulting complexes, is 
one modification that has been made and deserves further investigation. Below, in the 




Our synthetic design of the cross-bridged bis-tetraazabicycles is based on 
previous research involving the synthesis of mono-benzyl mono-methyl analogs. This 
original research, carried out by Mark Rogers and Dan Hill,41 was further developed by 
Christine Elia43'44 to synthesize the adjacent-bridged mono-benzylated cyclam. Weisman 
et al. have adapted these methods to develop the synthesis of linked macrocyclic systems. 
The basic synthetic design developed is shown below in Scheme 2.1.54 ,55 ' I89 
k J MeCN,50°C S ^ r T ^ - F 5-6 days k N - ^ N ^ ^ N ' S T HV'H * - V Br V 26r V 
1:n = 0 n = 0 18 8 9 a / b 90a/b(n = 0) 
2:n = 1 n = l ' l 9 91a/b(n = 1) 
89a = a.ot'-Dibromo-p-xylene (a compounds incorporate this spacer) 
89b = a.a'-Dibromo-m-xylene (b compounds incorporate this spacer) 




 MeCN ^ A N J ^ J 95o/oEtOH L N L N J L N J N J 
24hrs / ^ j
 4 | C ^ 2 d a y s ^ ^ 
llal£ Jn = 9} 94a/b (n = 0) 
93a/b(n = 1) 95a/b(n = 1) 
Scheme 2.1 Synthesis of the di-methyl para- and weta-xylyl-linked cross-bridged bis-
tetraazamacrocycles.54'55'189 
Anthony Harris began work on the synthesis of the cross-bridged bis-tetraazabicycles by 
synthesizing 91a and as well as crude 93 a and 91b. This author continued that work by 
synthesizing and fully characterizing 94a, 95a, 95b, and 102a (see Scheme 2.3 for 102a). 
This author also synthesized 101a and 102b, but did not complete their characterization 
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(see Scheme 2.3 for 101a and 102b). Sam Jolly continued the project and was able to 
fully characterize 94b. 54 
As discussed in Chapter I, the regioselectivity of the alkylations of 18 and 19 has 
been studied thoroughly by the Weisman group. This process is also shown in Scheme 
1.2 and discussed in the Background of Chapter I. In terms of stereochemistry, there are 
three possible isomeric products for 90/91 and 92/93 - each has possible meso and the d/1 
configurations. Figure 2.6 shows the time-averaged symmetry of 90/91 (meso) and 90/91 
(d/1). The meso form of 90/91 has a a plane; while the d/1 enantiomers of 90/91, have C2 
symmetry. An X-ray grade crystal of 91a was obtained and analyzed in this author's 
M.S. research (Figure 1.20, page 31 of the M.S. thesis).55 The crystal was the meso 
isomer (misreported as the d/1 isomer in the actual M.S. thesis), implying that the mother 
liquor was enriched with the d/1 isomer and that the meso isomer crystallized first under 
the conditions used (i.e., slow evaporation of D20). This same symmetry is carried on 
into the methylation products (i.e., 92 and 93) as well as the reductive ring opened 
bridged compounds 95a and 95b (which are conformational diastereomers) - shown 
below in Figure 2.7 for 95a. 
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Figure 2.6 The meso and d/1 stereoisomers of 90-91 and their time averaged symmetry. 
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95a (meso) 
Figure 2.7 The meso and d/1 stereoisomers of 95a and its time-averaged symmetry. 
While it can be said with relative certainty that both the respective meso and d/1 
diastereomers are produced, the !H and 13C NMR analysis of 90a and 92a gave no 
evidence of their existence. It is believed that this is simply due to the fact that the NMR 
resonances associated with the diastereomers happen to be isochronous, and not that a 
single diastereomer is being formed. 
The cross-bridges of the cyclen-based bis-tetraazamacrocycles, 94a and 94b, are 
of particular interest due to the fact that a single stereoisomer is formed upon reduction of 
92a/92b. As shown below in Figure 2.8 for 94a, the time-averaged symmetry (C2V) 
inherent in the molecule rules out the possibility of a diastereomeric mixture. 
<2z ^H 
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Figure 2.8 Time-averaged symmetry (C2v) of 94a. 
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The fact that the compound exists as one single isomer is fortunate, since there is no need 
to worry about further purification of diastereomers in order to use it in metal 
complexation and other, possibly biological, applications. 
The synthetic route for the cross-bridged bis-tetraazabicycles, shown above in 
Scheme 2.1, is analogous to that for the non-linked systems. The macrocycle (1 or 2) is 
first condensed with glyoxal to form a cis-fused tetracyclic bisaminal (18/19), which is 
then alkylated with one half an equivalent of a,ot'-dibromo-p-xylene, 89a (or ot,ot'-
dibromo-m-xylene, 89b). Upon washing with MeCN, a diastereomeric mixture of the 
dibromide salt (90/91) is >95% pure at that point and gives yields ranging from 83% -
94% yield. It is believed that over-alkylation, i.e., the formation of an oligomer (96) or a 
dialkyl salt (97), is circumvented (or greatly reduced) due to the fact that when 90/91 is 
produced it precipitates from solution, making it essentially inert toward further 
substitution. Possible oligomer or dialkyl salt side-products are shown below in Figure 
2.9. 
-N. .N© ^ ©N N l i ^ T - 4 I 
X J \\ 
0 f M , L N^ ^ 
11 1 \ i 1 © 
K^ ©N N 2B r 
V 3Br V ^Br v ^ ^ Br 
96 / (n = 0) for cyclen \ 97 
I (n = 1) for cyclam ) 
Figure 2.9 Possible oligomer (96) and dialkyl (97) byproducts in the synthesis of 90 and 91. 
The penultimate step, shown above in Scheme 2.1, is the synthesis of 92/93. The 
reaction mixture, consisting of 90/91 with an excess of Mel in MeCN, is stirred for 24 
hours in a sealed flask. This process affords product, as a mixture of diastereomers, in 65-
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90% crude yield. This wide range in yield is due to the difference in solubility between 
92 and 93. The more soluble the salt is in MeCN, the greater the likelihood that the 
iodide (or bromide) will act as a nucleophile to de-alkylate the bis-tetraazamacrocycle 
(shown below in Scheme 2.2) - thus regenerating 18/19 and a mono-alkylated 
tetraazamacrocycle, 98. 
X .O 




X" = Br, or I" 
n = 0 for cyclen 









Scheme 2.2 Proposed side reactions - yielding 99 and 100. 
Compound 18/19 is then di-methylated by excess Mel in solution. The mono-alkylated 
product 98 also goes on to be alkylated by excess Mel in solution, then de-alkylated, re-
alkylated, etc. Compounds 98 and 100 are not seen in either the supernatant or the 
washed precipitate due to their solubility in MeCN. It is believed that 98 and 100 would 
also react in a similar way as 90/91 in solution to yield more 92/93. Also, while Br" is the 
stronger nucleophile in MeCN, the abundance of I" in the solution means that both are 
probable nucleophiles. Evidence of this process taking place is demonstrated in the fact 
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that the major component observed in the 5H and 13C NMR spectra of the concentrated 
supernatant matches the spectra of previously synthesized 99. 
The final step in the synthesis (shown above in Scheme 2.1) involves the 
reductive ring opening of 92/93. This reaction has been performed using excess NaBHU 
at room temperature for 2 days in 95% EtOH. The process gives moderate yields ranging 
from 52-79% after extraction. These crude products are >95% pure before purification. 
Chromatography was needed to further purify compounds 95a and 95b, while 
compounds 94a and 94b were pure enough to be fully characterized without the need of 
further purification. 
The synthesis of the adjacent-bridged bis-tetraazamacrocycles, shown below in 
Scheme 2.3, is similar to that of the cross-bridged analog. The dibromide salt (90/91) 
was reduced using excess NaBtU at room temperature for 2 days in 95% EtOH. The 
crude material is reasonably pure (>90%). Unfortunately, 102a and 102b were not fully 
characterized, but preliminary TLC experiments reveal that chromatography should work 
to purify these compounds. Fortunately, 101a was readily recrystallized using hot MeCN 
in 64% yield facilitating its full characterization.55 
fNT'V fgTN]XSNaBH4 • f N 1 N i r rS 
^N-^NT „ N^hT 95% EtOH ^
 N ^ ^ N L J 
V 2B° V V'H H 'V 
90a (n = 0) 101a (n = 0) 
91a/b(n = 1) 102a/b(n = 1) 
a compounds incorporate the 89a spacer 
b compounds incorporate the 89b spacer 
Scheme 2.3 Synthesis of the adjacent-bridged bis-tetraazamacrocycles 101 and 102 55 
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Upon completion of this author's M.S. degree, Sam Jolly continued work on the 
bis-tetraazamacrocycle research with some additional development in ligand synthesis as 
well as complexation studies.54 As mentioned above, Jolly was able to complete the 
characterization of 94b. The main focus of Jolly's research was on the synthesis and 
complexation of the para- and me/a-xylyl-linked 94a and 94b with lithium and zinc(II). 
Below, in Scheme 2.4, are the conditions that Jolly used to synthesize 94a/b. He 
analyzed the product by !H NMR spectroscopy and confirmed that he had the desired 
complex by comparing his results with work done by Hill on the non-linked, mono-
benzyl mono-methyl cross-bridged cyclen analog.4 
k N V V N^ CD3CN k N V V < 
'' \-J \-J / \-J \-J 
94a/b 2 Li(CI04) • 94a/b 
Scheme 2.4 Jolly's Complexation of 94a/b with 2 Li(C104).54 
Jolly also complexed 94a and 94b with zinc(II) acetate, as shown below in 
Scheme 2.5.54 Taking steps to avoid water in the reaction mixture, he was able to 
synthesize the target compounds, Zn2-94a/b, and confirm their presence using H and C 
NMR as well as IR spectroscopy. 
S ^ N ^ S - ^ rT anhydrous MeOH, *~ I L J L J . J 
94a/b 
2 Zn(CH3C02) • 2H20 • 94a/b 
Scheme 2.S Jolly's Complexation of 94a/b with 2 Zn(CH3C02) • 2H20.54 
79 
This brief synopsis of where the Weisman and Wong groups' research relating to 
the synthesis and complexation of bis-tetraazamacrocycles stood upon this author's return 
to graduate school reveals that there was a clear opportunity to begin complexing these 
ligands with Cu(ll) and further investigate their complexations with Zn(II). Also, there is 
obvious utility for the N-allyl protecting group developed in the work covered in Chapter 
I with these xylyl-linked bis-tetraazamacrocycles. While the N-methyl group itself can 
be utilized as a protecting group,58 conditions for its deprotection are not selective enough 
for use with these compounds. 
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III. Results and Discussion 
There is a great deal of work that can be done with bis-tetraazamacrocycles -
whether it be varying the linker, the pendant arms, or the nature of macrocycles that are 
incorporated into the system. Upon this author's return to the Ph.D. program at UNH, 
this chemistry was picked up from where Jolly had left off and metal complexation of the 
systems was first explored. If these systems are to be used in biological systems one day, 
then work toward a greater understanding how these ligands complex to biologically 
relevant metals such as copper(II) and zinc(II), metals that have been well-studied when 
complexed to their non-linked analogs in the Weisman and Wong research groups, was 
clearly the next step. Also, though much work had been done to develop the synthesis of 
the cross-bridged bis-tetraazamacrocycles, most of the systems had been synthesized with 
methyl groups in place in order to have the reductive ring opening of the system generate 
a cross-bridged system. Therefore there was interest in the development of a protecting 
group to be used in the place of the methyl group, one that could be removed to allow the 
synthesis of a "di-NH" cross-bridged bis-tetraazamacrocycle. Once methyl groups have 
been replaced with hydrogens in systems such as 94 and 95, these bis-
tetraazamacrocycles can then be functionalized with a variety of pendant arms or these 
cross-bridged bis-tetraazamacrocycles themselves (e.g., 31, Figure 1.11) can be 
investigated for their possible anti-HIV properties and whatever other biomedical 
applications they might have. 
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A. The Complexation of p-Xylyl-linked Adjacent-bridged Cyclam 102a with 
Copper(H) 
The synthesis for the starting material, 102a, shown above in Scheme 2.3, was 
performed following the method developed in this author's Master's research.55 Once 
102a was in hand, the di-Cu(II) complex was synthesized following the reaction 
1 0 
conditions shown below in Scheme 2.6. The resulting Cu(II) complex was analyzed by 
UV-vis spectroscopy and found to have octahedral coordination about Cu(II) in solution 
(in 80% ethanol). The electronic spectrum of Q12 • 102a is shown below in Figure 2.10. 
f ^ ^ C > / ~ ^ i l 1.) 2.4eqCuCI2»2H20 f ^ ^ A > ^ ( l 
N N ^-^ N N MeOH, reflux, 2 h ^ N N ^-^ N N 
^ • N ^ N^_ ^ N N 2.) 80% EtOH / (benzene/Et20) ^ N ^ N f % ^ N 
H
 I j diffusion chamber I J H H I \ W 
102a 2CuCI 2 - 102a 
Scheme 2.6 Complexation of/?-xylyl-linked adjacent-bridged cyclam 102a with Cu(II). 
Figure 2.10 The electronic spectrum of Cu2 • 102a in 80% ethanol, where Xmax = 614 nm (Abs = 1.273). 
Professor Ed Wong performed acid dissociation experiments on (CuCl2)2(H20)4 • 
102a in 5M HC1 at 50 °C under pseudo-first order conditions. The results, shown below 
in Figure 2.11, demonstrated that the half-life for decomplexation under these conditions 
was 1.6(1) hours. 
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Electronic Spectra of Cu 2 • 102a 
400 500 600 700 
Wavelength 
800 900 1000 
First-order Non-linear Fit of Experimental Data for Cu2 • 102a 
50 100 150 200 250 300 350 400 
o Time (min) 
Figure 2.11 (A) The electronic spectra and (B) The first-order non-linear fit (monitored at 585 nm) of the 
experimental absorbance/time data for the acid-decomplexation of (CuCl2)2(H20)4 • 102a in 5M HC1 at 50 
°C. 
Professor Wong also performed electrochemical analyses of (CuCh^CEbO^ • 102a. The 
resulting cyclic voltammogram of (CuC^CtbO^ • 102a yielded an irreversible 
reduction at -0.71 V as illustrated below in Figure 2.12A. Also, the differential pulse 
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voltammogram, obtained by Wong, resulted in reduction of (0102)2(^0)4 • (102a) at 
-0.67V - shown below in Figure 2.12B. 
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Figure 2.12 The (A) cyclic voltammogram and (B) DVP of (CuCl2)2(H20)4 • 102a (0.1 M NaOAc, pH=7). 
As mentioned above, other researchers have also demonstrated interest in these 
compounds for their anti-HIV properties. In 2007 a copper(II) complex of 102a was 
published by Archibald and coworkers; synthesized in a similar manner.'n It was found 
that the complex of Cu2 • 102a had better anti-HIV activity than the copper(II) complex 
of the bis-cyclam analog 81 (AMD3100) as well as better activity toward the virus over 
the free ligand 102a. However, the Cu2 • 102a complex was found to have lower anti-
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HIV activity than the Zinc(II) complex of the same ligand - also made by the authors.113 
Archibald, Sadler, and Hubin have continued work in these adjacent- and cross-bridged 
ligands for their potential anti-HIV activity - most recently publishing the synthesis and 
analysis of the copper(II) complex of cross-bridged analog, 95a.111 
B. The Complexation of p-Xvlyl-linked Cross-bridged Cvclen 94a and /w-Xvlvl-
linked Cross-bridged Cyclen 94b with CopperflD 
(1) The complexation of p-xvlvl-linked cross-bridged cvclen 94a with copper(II) 
The synthesis for the starting material, 94a, shown above in Scheme 2.1, was 
performed following the method developed by this author.55 Once 94a was in hand, the 
Cu(II) complex was synthesized following similar reaction conditions that are typically 
applied to make a Cu(II) complex of the cross-bridged di-benzyl cyclam analogs - shown 
below in Scheme 2.7.u After purification by crystallization, the product was obtained in 
65% yield as dark-blue crystals. The resulting Cu(II) complex was analyzed by UV-vis 
spectroscopy and found to have octahedral coordination in solution (in MeCN). The 
electronic spectrum of 94a is shown below in Figure 2.13. Its molar absorptivity was 
determined to be 280 M_l cm-1. This is nearly twice the molar absorptivity of the 
analogous di-benzyl cross-bridged cyclen (22, shown below in Figure 2.14) copper(II) 
complex synthesized by Weijun Niu (A,max(e) = 647 nm (162 M"1 cm"1), in MeCN) which 
is attributed, in part, to the fact that there are two times the copper(II)-complexed ligands 
per molecule in Cu2 • 94a.190 
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\ \ / / \ / \ 1 •) 2 e q Cu(CI04)2 ' 6 H20 
N N^ ^ — ^ „N . N . MeOH, reflux, 2 h c.\j a j .NL N ^ / N ^ N . 
'N N ~c\j a J 
94a 
N . N ^ 2.) MeCN / (benzene/Et20) ^ N ^ ^ N . 
\ / "^ diffusion chamber / \ / \ / 
64% yield 2 Cu(CI04)2 • 94a 
Scheme 2.7 Complexation of p-xylyl-linked cross-bridged cyclen 94a with Cu(II). 






Figure 2.14 Di-benzyl cross-bridged cyclen 22, which was complexed to Cu(II) by Weijun Niu. 
Recrystallization of Cu2 • 94a from MeCN and benzene/Et20 (1:1, diffusion 
chamber), gave an X-ray grade crystal. The crystal structure was initially determined by 
Arnold L. Rheingold (University of California - San Diego, La Jolla, CA) and James A. 
Golen (University of Massachusetts Dartmouth, North Dartmouth, MA). Jonathan M. 
White (University of Melbourne, Parkville, Australia) and Gary Weisman carried out 
some further refinements. The structure, shown below in Figure 2.15, illustrates that the 
ligand is in a square-pyramidal geometry around the copper(II) in the solid state - where 
N103 (Cu36-N103 bond distance = 2.134 A) is the apical nitrogen and the remaining 
nitrogens in the ring (along with a nitrogen in the coordinated MeCN) are the basal 
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nitrogens (Cu-N bond distances ranging between 1.949-2.079 A) in the pyramid. The 
Addison and Reedjick x-parameter, for describing five-coordinate geometries along the 
Berry rearrangement between a trigonal bipyramid and a square pyramid, can be used to 
demonstrate that the geometry is in fact square pyramidal.191 The equation yielded a 
value of T = 0.052 [where x = ((3-a)/60, with x = 1 for trigonal bipyramidal and x = 0 for 
square pyramidal; the values for p and a are taken from the two largest N-Cu-N angles in 
the complex]. This x value sets the complex well within the region where it would be 
considered to have square pyramidal geometry. It is also interesting to compare the 
similarity in the intramolecular distance between the two copper(II) cations for Q12 • 94a, 
which is 11.59 A, to that of an analogous />ara-xylyl-linked non-bridged cyclen 
copper(II) perchlorate complex synthesized by Handel et al. where the distance is 11.54 
A. 1 0 5 
Figure 2.1S An X-ray crystal structure of [Cu(CH3CN)(C104)2]2 • 94a (CH3OH). 
Acid dissociation experiments on [Cu(CH3CN)(C104)2]2 • 94a (CH3OH) in 1M 
HC1 at 30 °C under pseudo-first order conditions were also performed by Professor 
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Wong. The results, shown below in Figure 2.16, revealed that the half-life for 
decomplexation in these conditions were 18.8(2) min. 
Electronic Spectra for Cu2 • 94a 
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Figure 2.16 (A) The electronic spectra and (B) the first order kinetics plot of the acid-decomplexation of 
[Cu(CH3CN)(C104)2]2' 94a (CH3OH) in 1M HC1 at 30 °C. 
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Electrochemical analyses of [Cu(CH3CN)(C104)2]2(CH30H) • 94a was also performed by 
Wong. The resulting cyclic voltammogram of [Cu(CH3CN)(C104)2]2(CH3OH) • 94a 
yielded an irreversible reduction at -0.69 V - as shown below in Figure 2.17A. Wong 
also obtained a differential pulse voltammogram that gave reduction of 
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Figure 2.17 The (A) cyclic voltammogram and (B) DVP of [Cu(CH3CN)(C104)2]2 • 94a (CH3OH) (0.1 M 
NaOAc, pH=7). 
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(2) Discussion of the kinetic and electrochemical analyses of copperdD 
complexes of 94a and 102a 
The kinetics and electrochemical results from Professor Wong's work can be 
compared to what has been found in the literature for similar bridged and non-bridged 
tetraazamacrocycles. Aqueous acid-assisted decomplexation of Cu(II) complexes of 
tetraazamacrocycles is an indicator of the kinetic inertness of these complexes. Listed 
below in Table 2.1 are the results of acid decomplexation studies of Cu(II) complexes of 
analogous tetraazamacrocycles. The adjacent-bridged cyclam complex Cu2 • 102a was 
found to have a longer ty2 (1.6(1) hours, in 5M HC1 at 50 °C) than the di-methyl cross-
bridged cyclen analog (Cu2 • 94a) when Cu2 • 102a is exposed to less acidic conditions at 
lower temperatures (18.8(2) minutes, in 1M HC1 at 30 °C). As seen below in Table 2.1, 
the Cu(II) complexes of cross-bridged cyclen are not as kinetically stable as their bridged 
and non-bridged cyclam analogs. This decrease in kinetic inertness is attributed mainly 
to the fact that the cyclen ring is smaller, and thus the Cu(II) metal does not fit as snugly 
into its cleft as it does for the cyclam analog. However, as would be expected, the Cu-
CB-D02A (Cu • 12) complex is more stable than Cu2 • 94a due to the two carboxymethyl 
pendant arms that coordinate to the Cu(II) and help to hold the metal in the cleft. The 
adjacent-bridged Cu2 • 102a complex is not as stable as Cu-TETA - its half-life is only 
half that of Cu-TETA (1.6 h for Cu2 • 102a compared to 3.2 h for Cu-TETA). Adjacent-
bridged cyclam (103, shown below in Figure 2.18) has been found to be about as stable 
as its non-bridged analog (i.e., cyclam) in the literature.192 Fabbrizzi and co-workers 
found that the half-life of Cu • AB cyclam 103 was only slightly more kinetically inert 
than Cu • cyclam - ty2 = 23.5 (±2.1 days) compared to t>/2 = 22.0 (±2.0 days) for cyclam in 
1M HCIO4 at 60 °C. Therefore, unlike the ethylene bridge that joins non-adjacent 
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nitrogens (i.e., the "cross-bridge"), the ethylene bridge that joins the adjacent nitrogens 
(i.e., the "adjacent-bridge") does not add any significant kinetic inertness to resulting 
metal complexes with copper(II). The adjacent-bridge does however lend selectivity to 
the cyclam frame (as well as cyclen) for particular metals over others and for trans-
coordination to metals (see Figure 1.4, page 4, for coordination geometry 
nomenclature).6'7'45''I3,134'192"194 In fact, it was demonstrated that both adjacent-bridged 
cyclam macrocycles of 102a coordinate in a trans-II fashion when complexed to 
Zn(II).113 
Complex Half-life 
5 M HCI. 90 "C 
CU-CB-TE2A 154(6) h 
Cu-CB-D02A < 3 min 
Cu-TETA 4.5(5) min 
Cu-DOTA < 1 min 
Cu-CB-cyclam 11.8(2) min 
Cu-CB-D02LA < 3 min 
CU-CB-TE2LA -100 hr 
12 M HCI. 90 °C 
CU-CB-TE2A 1.6(2) h 
Cu-CB-TE2LA 39(5) min 
5 M HCI. 50 °C 
Cu-TETA 3.2(1) h 
Cu2-102a 1.6(1) h 
5 M HCI. 30 °C 
Cu-TETA 3.5(2) days 
Cu-CB-cyclam 18.5(7) days 
Cu-CB-D02A < 2 min 
Cu-cyclam 2.7(1) days 
1 M HCI. 30 °C 
CU-CB-D02A 4.0(1) h 
Cu2-94a 18.8(2) min 
CU-CB-D02LA 37.2(5) min 




Figure 2.18 The structure of adjacent-bridged cyclam 103. 
The electrochemical results for several cross-bridged and non-bridged cyclen and 
cyclam copper(II) complexes are listed below in Table 2.2, along with the results 
obtained for Cu2 • 94a and Cu2 • 102a.25'26 The cross-bridged cyclam compounds have 
been found to have quasi-reversible reductions, and a Cu(I) complex of cross-bridged di-
benzyl cyclam has been characterized in the literature,23 thus demonstrating that some 
cross-bridged cyclam macrocycles have the ability to adjust coordination to both 
copper(II) and copper(I). This is not the case for the cross-bridged cyclen Cu-CB-
D02LA, and the non-bridged Cu-DOTA. Both complexes were found to have 
irreversible reductions, unlike cross-bridged analogs of cyclam. The irreversible 
reductions found for both Cu2 • 94a and Cu2 • 102a imply that neither is able to adapt to 



































Table 2.2 Electrochemical analysis of Cu(II) complexes of a variety of bridged and non-bridged 
tetraazamacrocycles (0.1 MNaOAc, pH=7). 
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(3) The complexation of m-xvlvl-linked cross-bridged cyclen 94b with copper(II) 
The synthesis of the starting material, 94b, shown above in Scheme 2.1, was 
performed following the method developed in this author's Master's research.55 After 
synthesizing 94b, the Cu(II) complex was then synthesized following similar reaction 
conditions as were used to make the Cu(II) complex of 94a (Scheme 2.8). After 
purification by crystallization (MeOH/Et20, diffusion chamber), dark-blue crystals were 
obtained in 97% crude yield. The resulting Cu(II) complex was analyzed via UV-vis 
spectroscopy and found to have octahedral coordination in solution (in MeOH). The 
electronic spectrum of Q12 • 94b is shown below in Figure 2.19. Its molar absorptivity 
(in MeOH) was determined to be 202 M-l cm-1. Attempts were made to purify the 
compound by utilizing the same conditions that were used with the p-xylyl-linked 
system, but Q12 • 94b did not crystallize as well. It should be noted that this sample also 
did not pass chemical analysis due to the fact that the %H is off by more than 0.4% of the 
calculated value - however the %C and %N were within the expected range. 
. . . . 1.) 2 eq Cu(CI04)2 • 6 H20 
[""% N 1 I f I MeOH, reflux, 2 h ^ ^ N ^ N ^ . . . . 
N N N N 2.) MeOH/Et20 ^ N N N N 
' \ / \ / x diffusion chamber y \ / \ — / x 
ft7o, A • SA 2 Cu(N03)2 • » 4 H20 • 94b 
97% crude yield v 6U i 
Scheme 2.8 Complexation of m-xylyl-linked cross-bridged cyclen 94b with Cu(II). 
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Figure 2.19 The electronic spectrum of Cu2 • 94b, in MeOH, where A,max = 658 nm (Abs = 0.895). 
C. The Complexation of p-Xylyl-linked Cross-bridged Cyclen 94a and w-Xylyl-
linked Cross-bridged Cyclen 94b with Zinc(II) 
(1) The complexation of p-xylyl-linked cross-bridged cyclen 94a with ZincflD 
The complexation of 94a with Zn(II) was performed following similar reaction 
conditions that were applied to make Zn(II) complexes of the cross-bridged cyclam 
analogs1' as well as those used by Jolly in his research54 - shown below in Scheme 2.9. 
The !H and 13C NMR spectra matched those obtained by Jolly in his research. A 94% 
crude yield is reported since recrystallization experiments did not yield purified product. 
The most promising system, using a water and acetone diffusion chamber did not 
consistently yield purified crystals. This could be due to the fact that Zn(II) may be 
readily displaced from the metal-ligand complex in time in water, forming Zn(OH)2 and 
the protonated ligand. 
.NL N ^ // 
I—\ 




2 eq ZnCI2 ,NL N 
/ — \ 
N . N . 
MeCN, reflux, 24 h 
94% crude yield 
N N N N 
— ' 2ZnCI2*94a — 
Scheme 2.9 Complexation of/7-xylyl-linked cross-bridged cyclen 94a with Zn(II). 
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(2) Progress toward the synthesis of a mononuclear Zn(II) * jp-xylyl-linked cross-
bridged cyclen 94a complex 
An effort was made to synthesize a mononuclear Zn(II) complex of cross-bridged 
bis-cyclen 94a for the purposes of placing a Cu(II) into the other linked macrocycle and 
yielding a bimetallic system with two different metals coordinated within the linked 
system. Zinc(II) was chosen for synthesis of the mononuclear complex since 5H NMR 
spectroscopy could be used to analyze the results - as compared to UV-vis analysis for 
the Cu(II) mononuclear complex, which may yield spectra that are more difficult to 
interpret. The reaction conditions were based loosely on work that had been done by 
Handel in which the adjacent-bridged analog (101a) was complexed to one equivalent 
Cu(II) per bis-macrocycle141 - where Handel had used 0.9 eq of Cu(C10)4 • H2O per 
mole 101a in "frozen ethanol" (i.e., temp = 0 °C) and the mono-nuclear product 
precipitated from solution before further complexation could occur. The conditions used, 
as shown below in Scheme 2.10, involved utilizing 0.9 equivalents of anhydrous ZnCh 
per bis-macrocycle (94a), in MeOH for 24 hours at room temperature. While our 
systems need to be refluxed in order to promote complexation, it was hoped that if the 
reaction were run at room temperature this would be a sufficient temperature to promote 
complexation, but a low-enough temperature that the mono-nuclear complex would 
precipitate from solution. These reaction conditions are diluted to ~ 1/3 the concentration 
of the reaction conditions used for the dinuclear complexation that yielded CU2 • 94a and 
CU2 • 102a - in order to promote precipitation of the mono-nuclear product (Zn • 94a). 
Unfortunately, the product did not precipitate from solution as hoped and the crude 
product was a mixture of non-complexed starting material, complexed ligand, and 
another species - which is most likely the mono-nuclear product Zn • 94a (Figure 2.20). 
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x
— ' ZnCI2 • 94a N —' Scheme 2.10 The attempted complexation ofp-xylyl-linked cross-bridged cyclen 94a with one equivalent 
ofZn(II). 
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Figure 2.20 A comparison of the ]H NMR spectra of the complexed ligand (Zn2 • 94a, bottom), the free 
ligand in D20 solvent (94a, middle), and the crude product from the attempted synthesis of the 
mononuclear Zn(II) complex (top). 
Further work can be done toward the goal of synthesizing a hetero-dinuclear 
complex of 94a. Such work could include altering the reaction conditions to make 
further attempts at the synthesis of the mononuclear Zn(II) • 94a (i.e., change 
concentrations, reaction solvents, etc.) or attempts could be made to synthesize the 
mononuclear Cu(II) • 94a complex prior to adding the Zn(II) metal to the bis-
tetraazamacrocycle. In either case, after the mono-nuclear • 94a complex has been 
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synthesized the next step would be to complex the non-coordinated macrocycle to the 
appropriate metal to make the mono-Cu(II) mono-Zn(II) • 94a complex and to investigate 
this system for its properties. A mono-Cu(II) mono-Zn(II) • 94a system could then be 
investigated and possibly studied as an SOD biomimic. 
(3) The complexation of m-xvlyl-linked cross-bridged cyclen 94b with Zinc(II) 
m-Xylyl-linked cross-bridged cyclen 94b was complexed with Zn(II) following 
the same basic procedure as described above for the /7-xylyl-linked analog, shown below 
in Scheme 2.11. The *H and 13C NMR spectra were consistent with Jolly's results.54 A 
98% crude yield is reported since, as was seen with the p-xylyl-linked analog, 
recrystallization experiments did not yield purified product. Water and acetone were 
again the most promising diffusion chamber solvents used - but purified material was not 
obtained. 
2eqZnCI2 ^ N CO CO MeCN, reflux, 24 h ^ ^ ^ N ^ N N' 
98% crude yield ^
 2 ZnC^ . 9 4 b 
Scheme 2.11 Complexation of/w-xylyl-linked cross-bridged cyclen 94b with Zn(II). 
D. Synthesis of Crude Diamide p-Xvlvl-linked Cross-bridged Cyclen 105 
The synthesis of an amide pendent armed cross-bridged bis-cyclen is of interest 
since the amide pendant arm could potentially coordinate to the metal that is complexed 
to the cross-bridged cyclen - thus potentially adding stability and kinetic inertness to the 
overall ligand-metal complex. This amide pendant arm could also be hydrolyzed, using 
methods previously developed in the Weisman research group,56 to a carboxymethyl 
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pendant arm that would also be capable of coordinating to available sites on the metal 
that is seated within the ligand cleft. The synthesis of diamide cross-bridged bis-cyclen 
105, shown below in Scheme 2.12, is analogous to the synthesis of 94a (above in Scheme 
2.1). 
N N© f V " S xs2-Bromoacetamide. f V ^ f V ^ 
N N
 2B6 ^N^hT 4d^ *" l ^ N ^ N ^ _ ^N^N^J* 
—^I r ^— / 82% crude yield H a N " ^ ^ \ — ' 4Br° ^— / V ~ N H , 
90a, meso and d/l ... . ... l 
diatereomeric mixture ™4- m e s o anc! *> 
diatereomenc mixture 
1.)xsNaBH4,95%EtOH — ^ .,—. — 
MW, open vessel, J ) / V _ J / \ ' N 
_ ^ o ^ ^ ^
 C / ^ o 
2.)aq.HCI U J N rT U N II 
3.) aq KOH/CHCI3 H a N ' ^ " ^ ^— / ^— l NH2 
Quantitative
 1 0 5 
crude yield 
Scheme 2.12 Overall synthesis of diamide p-xylyl-linked cross-bridged cyclen 105. 
A diastereomeric mixture of 90a was regioselectively alkylated with excess 2-
bromoacetamide, to afford 104 in 82% crude yield. The impurities at that point were 
mainly unreacted 2-bromoacetamide, which was difficult to wash away. The resulting 
salt, 104, was then reductively ring opened to 105 using NaBH4 in 95% EtOH under 
microwave-assisted heating at 78°C for 10 minutes (open-vessel). [Note: when running a 
reduction in the microwave using NaBH4 in 95% EtOH, there are potential hazards 
associated with foaming of the reaction mixture - see the appropriate endnote] A 
quantitative crude yield was obtained but this material, which was >90% pure, was not 
purified further. Some experiments exploring potential recrystallization solvents found it 
to be only slightly soluble in hot acetonitrile or insoluble in toluene or dichloromethane 
both at room temperature and with heating. Further work can be done to purify this 
compound, possibly using chromatography. After purification, 105 can be complexed to 
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Cu(II) and Zn(II) and compared with the non-linked analogs that have been studied in the 
group. Also, as stated above, hydrolysis of the amide bond would yield the 
carboxymethyl pendant-armed bis-cyclen - another ligand worthy of complexation to 
both Cu(II) and Zn(II) and further study. The added binding of the pendant arm to the 
metal bound to the macrocycle should help to stabilize the metal-ligand complex. 
E. Further Application of the N-Allyl Protecting Group - Synthesis of p-Xylyl-
linked Cross-bridged Cyclen 31 
After having developed the N-allyl protecting group for use with the non-linked 
cross-bridged systems (discussed in Chapter I), it was applied as a protecting group for 
the bis-cross-bridged systems. A parent cross-bridged bis-tetraazamacrocyclic system 
could then be tested for its potential anti-HIV activity, for its biomimetic properties, or a 
variety of other uses where the non-bridged systems have found utility. These cross-
bridged bis-tetraazamacrocycles could also be further functionalized at the NH groups 
with a variety of pendant arms that could modify and optimize the linked system for these 
same potential applications. The advantage of the cross-bridged bis-cyclen 31 over its di-
methyl /7-xylyl-linked cross-bridged bis-cyclam analog (i.e., 95a) is that 31 has a greater 
degree of symmetry (C2V) and is therefore synthesized as a single isomer - unlike 94a, 
which is produced as a mixture of 3 stereoisomers. These isomers, and their time-
averaged symmetry, are illustrated below in Figure 2.21. When synthesizing the cross-
bridged bis-cyclam compounds, unlike the bis-cyclen systems, the product is a meso and 
d/1 diastereomeric mixture. If these bis-tetraazamacrocycles, and their resulting metal 
complexes, are to be used for biomedical applications, then the synthesis of a compound 
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that is one single stereoisomer eliminates the need to purify the active stereoisomer from 
the less active, inert, or even possibly harmful stereoisomers. 








Figure 2.21 The meso and d/l stereoisomers of 95a and the time averaged symmetry of 95a and 31. 
(1) Synthesis of N,N'-di-aHvl p-xylyl-linked cross-bridged cvclen 107 
Synthesis of the di-allyl /7-xylyl-linked cross-bridged cyclen was based upon that 
of the di-methyl analog (94a, shown above in Scheme 2.1). The overall synthesis, shown 
below in Scheme 2.13, began with the regioselective di-allylation of 90a in MeCN with 
excess allyl bromide. The crude di-allyl salt product, which was >95% pure, was then 
reductively ring opened using the same conditions that were applied to the mono-allyl 
mono-benzyl systems (Chapter I). Sodium cyanoborohydride was employed to avoid the 
potential adjacent-bridged side-products that were discussed in Chapter I. Fortunately, 
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the process was straightforward and the material was purified by simple extraction. Once 
107 was in hand, deallylation was attempted employing the conditions applied for the 
non-linked analogs. 
T 2Br Y — - ^ f Y ^ f©Y% 
^ -N^ -V S ^ r T MeCN,14days ^ g ^ V © k N ^ N ^ 
V_7 \ __ / 82% yield ^ ^ \_J 4 B r \ _ y ^ % 
90a, meso and d/l >95% pure
 1 0 6 m e s o a n d d / | 
diatereomenc m,xture diatereomeric mixture 
1.)xsNaBH3(CN) MeCN /—\/—<\ // 
reflux, 24 h ' ^ N N . > — ' M . N 
2-)aq.HCI ^ N ^ J ^ J N ^ 
3.) aq KOH/PhCH3 ^ ^ \ / \ / v ^ % 
61% yield 107 
Scheme 2.13 Overall synthesis of di-allyl/?-xylyl-linked cross-bridged cyclen 107. 
(2) Synthesis of p-xylyl-hnked cross-bridged cyclen 31 
With the di-allyl p-xylyl-linked cross-bridged cyclen in hand, the deprotection 
conditions developed for the non-linked systems (discussed in Chapter I) were applied. 
The reaction conditions are shown below in Scheme 2.14. A longer reaction time was 
necessary for full deallylation to occur than had been the case for the mono-allyl mono-
benzyl analogs (55 and 62), but the deallylation was complete after 45 minutes - the 
same reaction time that was necessary for di-allyl cross-bridged cyclam 60. 
Unfortunately, the product was not as easily purified as the non-linked systems. 
/ = x 1.) 3 eq f-BuOK, DMSO, /=% 
r~^ /—\ /h^ r~\ MW- op e n vesse|. /-^ r \ }—\ /~\ 
N N ^ - ^ N N 100"C,45min N N ^ - ^ M .N 
^ M ^ M ^ ^ i sT M^ 2.)aq. HCI L . L.J L J J 
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Scheme 2.14 Synthesis of di-NH /?-xylyl-linked cross-bridged cyclen 31. 
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The purification of the non-linked analogs (55 and 62) was accomplished by 
performing an extraction followed by Kugelrohr distillation, but the larger molecular 
weight of 31 made distillation more difficult. The product was distilled (with a 61% 
recovery), but the conditions for Kugelrohr distillation were rather harsh since the air 
bath temperature had to be raised to 240 °C (0.1 mmHg). While the crude product was 
purified, at these high temperatures some impurities were also distilled over with the pure 
material - yielding a still impure distillate. An HBr salt was also made of the crude 
material, and this salt was then recrystallized in EtOH/water («3.75:1), but this process 
did not fully remove the color (the crude product lightened from brown to yellow) and 
1 1 ^ 
some impurities still remained as determined as shown in the H and C NMR spectra. 
Since chromatography had worked to purify several of the bis-tetraazabicycles in 
this author's M.S. research, these methods were also investigated for this compound.55'195 
Several chromatographic conditions were investigated via TLC, listed below in Table 2.3. 
Unfortunately, the components of the crude mixture streaked under each set of conditions 
(unless the mixture did not move from the baseline) and no separation was observed. A 
simple basic alumina plug was also employed, but the brown-colored impurity filtered 
through along with the product and no separation was achieved. The ligand was also 
reacted with NH4BF4 to make the HBF4 salt and recrystallizations were attempted in 
MeCN - but these conditions did not yield purified product. An effort was made to 
purify the compound somewhat before distillation by making the HBr salt of the ligand 
first, recrystallizing the HBr salt and then recovering the purified free ligand and 
distilling it. The intention was to purify the ligand to some degree prior to distillation, 
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thus removing some of the impurities that come over with the distillate and reducing the 
amount of residue that remains in the distillation pot, which possibly impedes distillation. 










































propylamine functionalized silica 
propylamine functionalized silica 
Table 2.3 Chromatographic conditions applied toward the purification of 31. 
While this did remove much of the colored impurities and cleaned up the product before 
distillation, the material was still not fully purified after distillation. An attempt was also 
made to sublime the material. The material was heated up to 190 °C (at 0.1 mm Hg) in a 
silicone oil bath. While sublimation did not occur, some product distilled onto the 
sublimation cold finger under these conditions, and this material was pure. 
Unfortunately, this resulted in only a 7% overall yield of product. When the material was 
distilled in the sublimation apparatus at higher temperatures (240 °C), impurities distilled 
over along with the product. 
There are other distillation methods used to separate high boiling compounds for 
purification. A molecular still could be employed as well as a thin-film evaporator - a 
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type of molecular still.196 Like a Kugelrohr distillation apparatus, a thin-film evaporator 
separates volatile materials from non-volatile materials, but this apparatus does so by 
heating the material for only a brief amount of time and with little distance for the vapor 
to travel before it is re-condensed. With less distance for the material to travel, lower 
temperatures are required for the distillation to occur. Since the material was purified at 
190 °C in the sublimation apparatus, this may be a viable method of purification. 
F. Progress toward the synthesis of the cross-bridged bis-cyclam 110 
Once the deallylation conditions had been worked out on the bis-cyclen system an 
effort was made to apply these reaction conditions toward the synthesis of a di-NH cross-
bridged bis-cyclam. The general design of the synthesis, laid out below in Scheme 2.15, 
includes the same basic reaction conditions as were used for the bis-cyclen system. 
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J ^ N ^ r T ^ K T N C ^ . 2.)aq.HCI % ^ \*>
 N ^ 
I j L J 3"*aq K 0 H / P n C H 3 H I j I j H 
109, meso and d/l 110, meso and d/l 
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Scheme 2.15 The proposed synthesis ofp-xylyl-linked cross-bridged cyclam 110. 
Unfortunately, though most cyclen- and cyclam-based systems are comparable in many 
ways, these two systems do not always behave in the same manner under the same 
reaction conditions and difficulties were met in the very first step. The general reaction 
conditions for the first step, to synthesize the di-allyl p-xylyl-linked cyclam bisaminal salt 
108, are shown below in Scheme 2.16. 
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91a, meso and d/l
 1 0 8 , meso and d/l 
diatereomeric mixture diatereomeric mixture 
Scheme 2.16 The proposed synthesis of the di-allyl p-xylyl-linked cyclam bisaminal salt 108. 
This step is an equilibrium that is driven forward by the precipitation or crystallization of 
the product from solution. If the product does not precipitate, or it has some degree of 
solubility in the chosen reaction solvent, then the reaction may not proceed completely to 
product (i.e., it will reach an equilibrium) and some percentage of starting material as 
well as possible intermediates may still remain. With these limitations, several other 
solvents and reaction times were utilized in order to promote precipitation to occur and 
hence increase the reaction yield. 
The reaction solvents, and reaction times, are listed below in Table 2.4. 
Acetonitrile was first used since this is the same solvent that was employed with the 
cyclen analog (i.e., 106). When this was seen to yield very little allylated material, 
dichloromethane was tried, in the hopes that the product would be more likely to 
precipitate from this less polar solvent. Unfortunately, this reaction solvent did not yield 
better results since less allylated product was seen in the *H NMR spectrum. With these 
disappointing results, diethyl ether was added (MeCN / Et20, 80:20) to help facilitate 
precipitation and the amount of MeCN was halved (relative to the dibromide salt) -






MeCN /Et 20 (4:1) 






Table 2.4 The reaction solvents and times for the attempted di-allylation of 91a. 
It is difficult to determine how far the reaction progressed since the !H NMR 
spectrum of the mono-allylated intermediate (where one side of the bis-cyclam salt is 
allylated and the other is not, shown below in Scheme 2.17) will look very similar to the 
!H NMR spectrum of both the non-allylated starting material (i.e., 91a) and the product 
(i.e., 108). 
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Scheme 2.17 Synthesis of 108, with the mono-allylated intermediate included. 
Therefore, it is not as simple as observing the disappearance of the starting material in the 
*H NMR spectrum, since the intermediate will have a very similar spectrum to both the 
product 108 and the starting material 91a. Also, the presence of diastereomers (explained 
in the Introduction, see Figure 2.6) further complicates the !H and 13C NMR analysis. 
Shown in Figure 2.21 is the ]H NMR spectrum of the crude product that employed 
MeCN / Et20 (80:20) solvent mixture (lower spectrum) compared to the starting material 
(91a, upper spectrum). Note that in the lower spectrum the "*" is used to identify the P-
methylene resonances in the product (108) (and possibly the mono-allylated 
intermediate). Also, the allyl resonances of the product (and possibly the mono-allylated 
intermediate) are evident in the 5.8-6.2 ppm region. Figure 2.22 demonstrates that the 
reaction is progressing using the MeCN / Et20 (80:20) solvent system, but these 
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conditions are still not appropriate and further work needs to be done to find the right 
reaction conditions. 
w 1 V- w ' V
 LTJ M 
6.0 5.0 4.0 3.0 2.0 
ppm 
crude reaction mixture 
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Figure 2.22 The 'H NMR spectra comparing the starting material (91a, upper spectrum) with the allylated 
crude product (91a, 108 and the mono-allylated intermediate , lower spectrum). The "*" is used to identify 
the p-methylene resonances in the product 108 (and possibly the mono-allylated intermediate). 
Unfortunately, the proper reaction conditions to synthesize 108 were not found, 
and therefore other conditions would need to be explored or an alternative approach 
found to synthesize di-allyl/7-xylyl-linked cross-bridged cyclam 109. Other solvents can 
be investigated that may enable product to precipitate from solution, such as toluene or 
THF. Another alternative is to change the alkylating agent. David Martin utilized allyl 
tosylate when synthesizing the analogous dibenzo-annelated bisaminal salt precursor to 
56.49 Martin even ran the reaction neat with a large excess of allyl tosylate. Allyl 
bromide was used first, and was the preferred alkylating agent, since it has a lower 
boiling point than allyl tosylate (and is thus easier to remove when the reaction is 
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complete) and allyl tosylate needs to be made prior to use and has a limited shelf-life 
compared to allyl bromide. Therefore, further actions that can be taken to synthesize 108 
is to try the allylation reaction using allyl tosylate - with reaction conditions based upon 
Martin's. Once 108 has been made, the reductive ring opening can be performed, as well 
as the deallylation that follows, both steps should proceed as smoothly as was seen for the 
bis-cyclen analog (107) and the non-linked systems (55 and 62). Also, since the N-PMB 
protecting group has been developed for cross-bridged cyclen systems (see Chapter I, in 
Section B of the Results and Discussion section), a di-PMB p-xylyl-linked cross-bridged 
cyclam could be synthesized as a route toward the di-NH p-xylyl-linked cross-bridged 
cyclam. It has been shown that the TFA deprotection conditions will not remove an N-
benzyl group, and so there should be no cleavage of the N-xylyl bonds. If PMB were 
investigated as a protecting group for this system, then similar problems to what were 
found by Weisman and Dugan may be encountered with this system.98 The PMB group 
may be cleaved in solvents such as H2O, MeOH or EtOH. Since 95% EtOH is the 
solvent used for the reductive ring-opening step when employing NaBH4, this may mean 
that other solvents or reducing agents may be necessary. Perhaps NaBHsCN or 
NaBH(OAc)3 in MeCN could be explored as an alternative. 
The di-NH />-xylyl-linked cross-bridged cyclen system 31, as well as the cyclam 
analog (110, once it has been synthesized), and their Cu(II) and Zn(II) metal complexes 
could all have potential use as anti-HIV agents and could also be used for stem cell 
mobilization just as the bis-cyclam 81 system (shown below in Figure 2.23) has been 
utilized. It could be that these bridged systems will not suffer the same fate as 81, and 
there will be no cardiac problems associated to their use. Also, with the secondary 
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nitrogen available on these bridged systems, 31 and 110 (once it is synthesized) could be 
further functionalized with pendant arms that could be used to aid in complexing (and 
stabilizing) metals that are bound to the bridged macrocycles. As was seen with the non-
linked di-NH systems (7, 24), once the NH group has been deprotected and is available to 
perform further chemistry, a number of options are then open for modifying these ligands 
for a variety of uses. 
NH N ^—y N HN 
NHHN NH HN 
L^J 81 • 8 HCI I ^ J 
Figure 2.23 The bis-cyclam 81. 
G. Investigation of an aliphatic spacer group 
An exploratory effort was made to synthesize a cross-bridged bis-cyclen system 
incorporating an aliphatic linker, with 62 as the starting material. In the approach, shown 
below in Scheme 2.18, two equivalents of 62 were to be linked to one another via homo-
metathesis using Grubb's 2nd generation catalyst.197"199 Unfortunately the results were 
inconclusive. The crude product did not match what was expected - mainly there were 
no distinct signals in the !H and 13C NMR spectra that could be attributed to a carbon-
carbon double bond being present on the molecule. Neither the starting material 62 nor 
what would be expected for the desired product 111 were found in the spectra of the 
crude product. A possible further complication is that similar conditions may also be 
applied for the de-allylation of N-allyl functional groups - as has been demonstrated in 
the literature.59 Although it should be noted that the mono-benzyl cross-bridged cyclen 
32 (the product of the deallylation of 62) was not observed in the crude ]H and 13C NMR 
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spectra of the product. Unfortunately, it is difficult to assign a particular structure to the 
crude 'H and 13C NMR spectra. With these disappointing results, no further attempts 
were made to synthesize 111 via this method. If research to synthesize an aliphatic 
spacer were re-visited, perhaps the same reaction conditions used in Scheme 2.18 could 
be employed at higher concentrations. But, since the first attempt gave no clear 
indication that any product was formed, it may be better to simply try another strategy. 
The reaction conditions utilized in Reaction A in Scheme 1.5 (i.e., linking with a di-acid 
chloride followed by reduction via L1AIH4 to yield 34) are a possible alternative to this 
method that could be explored. 
._ 1.) Grubb's 2nd Gen. catalyst (20 mole %) 
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Scheme 2.18 The proposed synthesis of 111. 
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IV. Conclusions 
Progress was made in both the complexation of the bis-tetraazamacrocycle 
systems that were first synthesized in the Weisman research lab as well as in the 
synthesis of new cross-bridged bis-cyclen systems. Copper(II) complexes of both the 
meta- andpara-xylyl-linked cross-bridged cyclen (94a and 94b) andpara-xylyl-linked 
adjacent-bridged cyclam 102a were synthesized and analyzed and the zinc(II) complexes 
of the meta- and/?ara-xylyl-linked cross-bridged cyclen ligands (94a and 94b) were also 
prepared. The copper(II) /wra-xylyl-linked cross-bridged cyclen system (C112 • 94a) and 
the copper(II) /?ara-xylyl-linked adjacent-bridged bis-cyclam system (Cu2 • 102a) were 
found to be less kinetically inert than a variety of copper(II) cross-bridged cyclam 
tetraazamacrocycle complexes (see Table 2.1). Complexes C112 • 94a and C112 • 102a 
demonstrated irreversible reductions when analyzed using cyclic voltammetry. The fact 
that these copper(II) complexes are not as kinetically inert (demonstrated by their shorter 
half-lives in the same acidic conditions, as illustrated in Table 2.1) and are more likely to 
lose copper upon 1-electron reduction from Cu(II) to Cu(I) as compared to their cross-
bridged cyclam analogs makes them less useful for biomedical purposes. As stated in the 
introduction of Chapter I, it has been found that the kinetic inertness of the copper 
complex toward decomplexation is even more important than the thermodynamic 
stability34 when measuring the stability of the radio-copper complex in vivo and the 
reduction of copper(II) to copper(I) in vivo may result in a loss of the metal, therefore the 
resistance of the radio-copper complex toward Cu(II)/Cu(I) reduction and reversibility 
under biological conditions is an important feature.33 These results demonstrate the need 
to replace the N-methyl group with a protecting group that can be removed to yield 31. 
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With an N-H functional group in place of an N-Me group, the cross-bridged bis-
tetraazamacrocycle 31 can be more easily modified and adapted for particular uses. 
Work toward the synthesis of a mono-zinc(II) complex of the cross-bridged bis-cyclen 
94a did not progress as hoped, but if a mono-Zn(II) complex of 94a is made then work 
toward a mono-Zn(II) mono-Cu(II) complex of 94a could be attempted and this di-
nuclear complex could be investigated as an SOD biomimic. 
The N-allyl protecting group developed in Chapter I was successfully applied to 
the di-allyl/?ara-xylyl-linked cross-bridged cyclen system (i.e., 107). While further work 
should be done to develop a more efficient process for its purification, 31 can now be 
complexed with copper(II) and zinc(II) and the properties of these complexes can be 
studied. Since a variety of linked and non-linked tetraazamacrocycles have been able to 
bind to the CXCR4 receptor, 31 may also be useful as an anti-HIV agent or a stem-cell 
mobilizer. And, unlike the di-methyl bis-cyclam analog 95a, 31 exists as only one 
stereoisomer so there are no concerns about the presence of diastereomers which may be 
less active or potentially harmful to the body. Further work will be necessary to 
synthesize di-NH cross-bridged bis-cyclam 110. Once this compound has been made it 
can be determined if this ligand has improved anti-HIV properties over the copper(II) 
complex of its di-methyl analog (Cu2 • 95a) tested by Hubin.''x 
The diamidepara-xylyl-linked cross-bridged cyclen 105 has also been 
synthesized, but further work needs to be done to purify this compound and complete its 
characterization. This compound, as well as its di-carboxymethyl-armed derivative, can 
also be studied further for its copper(II) and zinc(II) complexation characteristics. It 
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could be that the resulting complexes will be more kinetically stable and therefore have 
greater promise for biological applications. 
While progress has been made with the complexation and synthesis of several 
new bis-tetraazamacrocycles, there is still much more that can be done. These systems 
have great promise for a variety of potential biological applications, many of which are 
based upon their ability to bind with the CXCR4 receptor, but these systems can also be 
used for other possible biomimetic purposes, in PET imaging, and as MRI contrasting 
agents. As stated in Chapter I, tetraazamacrocycles can be modified for a variety of 
purposes by making adjustments to the macrocycle backbone itself as well as by affixing 
a variety of pendant arms. Bis-tetraazamacrocycles can be modified in the same way, but 
can be further altered when changing, or functionalizing, the spacer group between 
macrocycles. Therefore, considering the great deal of versatility of the basic bridged bis-





I. General Methods 
Melting Points (mp) were recorded on a Thomas Hoover capillary melting point 
apparatus and are uncorrected. 
Infrared Spectra (IR) were run on a Nicolet MX-1 FT-IR spectrometer with EZ OMNIC 
6.0a software. Absorptions are reported in wavenumbers (cm"1). 
}H NMR Spectra ('H NMR) were acquired on Varian NMR spectrometer systems 
operating at 500 MHz with VNMR 6.1c software. Chemical shift (8) values are reported 
in parts per million (ppm) relative to Me4Si (TMS) unless otherwise noted. Coupling 
constants (J values) are reported in Hertz (Hz). 
13C NMR Spectra (13C NMR) were acquired on a Varian NMR spectrometer system 
operating at 125.7 MHz with VNMR 6.1c software. Chemical shift (8) values are 
reported in parts per million (ppm) relative to Me4Si (TMS) unless otherwise noted. 
Electrospray Ionization Mass Spectra (ESIMS) was obtained on a Thermoquest LCQ 
mass spectrometer at the University of New Hampshire. 
High Resolution Mass Spectra (HRMS) Compounds were analyzed by the Department of 
Chemistry and Biology at the University of Notre Dame using a JEOL AX505HA high 
resolution mass spectrometer. 
X-Rav Crystallography (X-Ray) was performed by Arnold L. Rheingold (compounds 55 
and 62) and James A. Golen at the University of California, San Diego, La Jolla, 
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California, USA. with some further refinements for compound 31 performed by Jonathan 
M. White and Gary Weisman at the University of Melbourne, Parkville, Australia, 
Microwave Synthesis The CEM Discover research scale manual microwave synthesizer 
using Synergy v. 1.21 software was utilized for microwave-assisted syntheses. 
Centrifugation: was performed on an International Equipment Company International 
Clinical Centrifuge Model CL. 
Elemental Analysis (CHN) was performed by Atlantic Labs Inc., Georgia, USA. 
pH Measurements were performed on a Hanna Instruments HI 221 microprocessor-based 
pH/mV/°C bench meter. 
Ultra-Violet Visible Spectra (UV-Vis) were taken on a Varian Cary 5E UV-Vis-NIR 
spectrophotometer. Absorbance maxima are reported in nanometers (nm). 
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II. Solvents 
Absolute Ethanol (EtOH, ACS/USP grade) was obtained from Pharmco Products Inc. and 
was used without further purification. 
Acetonitrile (CH3CN) was obtained from EMD Chemicals Inc. and stored in an 
Innovative Technology Inc. Pure-Solv Solvent Purification System. Prior to use, the 
solvent was passed through the system's silica column under low pressure to remove 
trace impurities. 
Benzene (C6H6, ACS grade) was obtained from EMD Chemicals Inc. and was used 
without further purification. 
Chloroform (CHCI3, HPLC grade) was obtained from EMD Chemicals Inc. and was used 
without further purification. 
Diethyl Ether (Et20) was obtained from EMD Chemicals Inc. and stored in an Innovative 
Technology Inc. Pure-Solv Solvent Purification System. Prior to use, the solvent was 
passed through the system's silica column under low pressure to remove trace impurities. 
Dimethyl Sulfoxide: (DMSO, ACS grade) was obtained from EMD Chemicals Inc. and 
was stored over 3A molecular sieves. 
Deuterated NMR Solvents were obtained from Cambridge Isotope Laboratories and both 
DMSO-d6 and CDCI3 were stored over 3A molecular sieves. 
Ethanol (95% EtOH, ACS grade) was obtained from EMD Chemicals Inc. and was used 
without further purification. 
Methanol (MeOH, Reagent/ACS/USP/NF grade) was obtained from Pharmco Products 
Inc. and stored in an Innovative Technology Inc. Pure-Solv Solvent Purification System. 
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Prior to use, the solvent was passed through the system's silica column under low 
pressure to remove trace impurities. 
Tetrahvdrofuran (THF) was obtained from EMD Chemicals Inc. and stored in an 
Innovative Technology Inc. Pure-Solv Solvent Purification System. Prior to use, the 
solvent was passed through the system's silica column under low pressure to remove 
trace impurities. 
Toluene (PI1CH3, ACS grade) was obtained from EMD Chemicals Inc. and stored in an 
Innovative Technology Inc. Pure-Solv Solvent Purification System. Prior to use, the 




Allyl Bromide was obtained from Aldrich Chemical Company. 
Alumina: Aluminum oxide powder (activated, basic, Brockmann 1, 150 mesh) "suitable 
for chromatography: was obtained from Aldrich Chemical Co. 
Ammonium hydroxide (28%, NH3 in water) was obtained from Fisher Chemical Co. 
Anisole was obtained from Aldrich Chemical Co. 
Benzyl Bromide was obtained from Alfa Aesar. 
2-(Bromomethyl)naphthalene was obtained from Aldrich Chemical Co. 
Diatomaceous Earth (Celite® 545) was obtained from Aldrich Chemical Company. 
1,3-Dibromopropane was obtained from Aldrich Chemical Co. 
a.q'-Dibromo-m-xvlene was obtained from Aldrich Chemical Co. 
a,a'-Dibromo-p-xvlene was obtained from Aldrich Chemical Co. 
Ethylenediamine was obtained from Aldrich Chemical Company. 
Glyoxal (40% aq) was obtained from Aldrich Chemical Company. 
Hydrochloric Acid (12 M HC1) was obtained from Fisher Chemical Company and was 
used without further purification. 
Hydrobromic Acid (47-49% in water) was obtained from Aldrich Chemical Company. 
p-Methoxybenzylbromide (PMB-Br) was obtained from Aldrich Chemical Company. 
Methyl iodide (Mel) was obtained from Aldrich Chemical Co. 
Potassium Hydroxide (KOH) was obtained from EMD Chemicals Incorporated. 
Potassium carbonate (K2CO3) was obtained from Fisher Chemical Co. 
Potassium ferf-Butoxide (KO'Bu) was obtained from Aldrich Chemical Company. 
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Silica Gel (230-400 mesh ASTM) for column chromatography was, obtained by EM 
Science. 
Sodium Borohydride (NaBFLO was obtained from Aldrich Chemical Company. 
Sodium Cyanoborohydride (NaBF^CN) was obtained from Aldrich Chemical Company. 
Sodium Triacetoxyborohydride (NaBH(OAc)3) was obtained from Aldrich Chemical 
Company. 
Sodium Hydroxide (NaOH) was obtained from EM Science Company. 
Sodium Sulfate (TS^SCv) was obtained from Fisher Chemical Company. 
Sodium Tetraphenylborate (NaBPlu) was obtained from J.T. Baker Chemical Company. 
1,4,7,10-Tetraazacyclododecane (cyclen) was obtained from Strem Chemical Co. 
1,4,8,11 -Tetraazacyclotetradecane (cyclam) was obtained from Strem Chemical Co. 
Trifluoroacetic Acid (TFA, 99%) was obtained from Alfa Aesar. 
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IV. Syntheses 
Note: All routine solvent evaporations were carried out on a standard rotary 
evaporator using aspirator pressure unless otherwise noted. All reactions were carried 
out under N2 atmosphere unless otherwise noted. 
l,4,8,ll-Tetraazabicyclo[6.6.2]hexadecane (7). 4,11 -Diallyl-1,4,8,11-
tetraazabicyclo[6.6.2]hexadecane 60 (0.0510 g, 0.1665 mmol) was massed into a 5 mL 
round-bottomed reaction flask, and to this oil 0.46 mL of dry DMSO (stored over 4A 
sieves under N2) was added via syringe followed by potassium f-butoxide (0.0603 g, 
0.5374 mmol) {NOTE: All reagents were handled under N2 in a dry bag). The reaction 
mixture was stirred under N2 before inserting the reaction flask into a CEM Discover 
microwave reactor, making sure that there were no deposits of potassium f-butoxide 
adhered to the inner wall of the reaction flask. Once in the microwave reactor, the 
reaction flask was fitted with an air condenser with a nitrogen inlet adapter attached and 
the open vessel reaction was run under microwave irradiation at 100 °C for 45 minutes. 
A brown pungent-smelling mixture remained (the sample was capped at all times when 
handled outside of the hood). 6M HC1 was added dropwise to the crude mixture and the 
resulting solution was concentrated to an oil under reduced pressure. [Note: At this 
point, while the crude reaction mixture is still acidic, a wash could be performed using 
the appropriate volume of toluene]. This oil was then dissolved in H2O (8 mL) and KOH 
pellets were added to make the solution strongly basic (pH 14). The basic solution was 
extracted with toluene ( 5 x 8 mL) and the combined extracts were dried over Na2SC>4. 
Solvent was removed under reduced pressure to yield a crude brown oil (0.0280 g, 74.5 
%). The crude brown oil may be further purified via Kugelrohr distillation (100 °C air 
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bath temperature, 0.06 mmHg) to yield a clear oil: The *H NMR spectrum was consistent 
with the literature spectra of pure 7.10'12 
Note: If DMSO is present in the crude sample after toluene extraction, it can be removed 
by re-dissolving the sample in water, making the solution strongly basic (pH «14), and 
extracting the sample again with toluene as above. This procedure can be repeated until 
all of the DMSO is removed. Also, if the deallylation reaction is not complete, the crude 
product can be reacted again with an excess of ^-butoxide in dry DMSO to complete the 
deallylation. 
l,4,7,10-Tetraazabicyclo[5.5.2]tetradecane(24). 4,10-Bis-(4-methoxybenzyl)-
l,4,7,10-tetraazabicyclo[5.5.2]tetradecane 66 (0.2055 g, 0.4685 mmol) in a 10 mL round-
bottomed flask was treated with anisole (93 nL, 0.85 mmol) followed by trifluoroacetic 
acid (2.60 mL). The reaction mixture was stirred, under N2, at 60 °C for 18 h. Upon 
cooling, 75 mL Et20 was added to the resulting light-orange colored reaction mixture (to 
aid in the removal of TFA) and it was concentrated to a thick yellow oil. H2O (20 mL) 
was added dropwise to the crude mixture, followed by 10 mL 6M HC1, and the resulting 
solution was extracted with toluene (5 x 20 mL). The aqueous phase was made strongly 
basic (pH 14) by slow addition of KOH pellets, with cooling, and this basic solution was 
then extracted with toluene (5 x 25 mL). The combined extracts were dried over Na2S04 
and then the solvent was removed under reduced pressure to yield a yellow and white 
solid (0.0766 g, 82% crude yield). The crude product was Kugelrohr distilled (75 °C air 
bath temperature, 0.06 mmHg) to yield a white solid (0.0438 g, 47%): *H NMR and 
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13C{!H} NMR spectra were consistent with reported spectra for 24.10'14 On the basis of 
the spectra, the purity is estimated to be >97%. 
(Note: This reaction can also be run via microwave heating, for 10 min at 85° C.) 
4-[4-(l,4,7,10-Tetraazabicyclo[5.5.2]tetradec-4-ylmethyl)-benzyl]-l,4,7,10-
tetraaza-bicyclo[5.5.2]tetradecane (31). 4-Allyl-10-[4-( 10-allyl-1,4,7,10-
tetraazabicyclo[5.5.2]tetradec-4-ylmethyl)-benzyl]-l,4,7,10-tetraazabicyclo[5.5.2]-
tetradecane 107 (0.8191, 1.415 mmol) in a 50 mL round-bottomed reaction flask was 
treated with 8 mL of dry DMSO (stored over 4A sieves under N2) followed by potassium 
/-butoxide (0.4895 g, 4.362 mmol) {NOTE: all reagents were handled under N2 in a dry 
bag). The reaction mixture was pre-stirred in an oil bath, at about 60 °C, under N2 before 
inserting the reaction flask into a CEM Discover microwave reactor - making sure that 
there were no deposits of potassium f-butoxide adhered to the inner wall of the reaction 
flask. Once in the microwave reactor, the reaction flask was fitted with an air condenser 
with a nitrogen inlet adapter attached and the open-vessel reaction was run under 
microwave irradiation at 100 °C for 45 minutes (maximum power set to 100 W). A 
brown pungent-smelling mixture remained (the sample was capped at all times when 
handled outside of the hood). H2O (10 mL) was added dropwise to the crude mixture, 
followed by 6M HC1 (50 mL) and the resulting solution was concentrated to an oil under 
reduced pressure. This oil was then dissolved in H2O (200 mL) and KOH pellets were 
added to make the solution strongly basic (pH 14). The basic solution was extracted with 
toluene (5 x 150 mL) and the combined extracts were dried over Na2S04. Solvent was 
removed under reduced pressure to yield a light brown solid (0.6195 g, 75 % crude). 
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This crude product was precipitated from a hot EtOH/water («3.75:1) solution as an HBr 
salt, which was then filtered to yield an off-white powder. The crude product was 
recovered from the HBr salt. The salt was dissolved in H20 (10 mL), KOH pellets were 
added to make the solution strongly basic (pH 14), the basic solution was extracted with 
toluene (5x10 mL), and the combined extracts were dried over Na2S04. Solvent was 
removed under reduced pressure and the crude light-yellow solid (0.1934 g) was distilled 
(190 °C, 0.1 mmHg) to yield a white solid (0.0513 g, 7 %*): mp 100-103 ° C; *H NMR 
(500 MHz, C6D6) 5 2.42-2.52 (m, 12H), 2.53-2.64 (m, 12H), 2.64-2.66 (app br s, 8H, 
ethylene cross-bridge), 2.70-2.83 (m, 8H), 3.47 (br s, 2H, Ntf), 3.58 (s, 4H, CH2Ax), 7.46 
(s, 4H, Ar); 13C{'H} NMR (125.68 MHz, C6D6) 8C 48.32, 52.03, 52.90, 53.62, 55.67, 
62.06, 129.91, 138.67; IR 3223, 3035,2910,2839,2794, 1671, 1449, 1369, 1316, 1162, 
1134, 1111, 1037, 1019, 973, 930, 778 cm"1; HRFABMS, m/z (M+H)+ exact mass calcd 
for C28H51N8: 499.4237; Found: 499.4239 (error +0.3 mmu/+0.5 ppm). 
Note: If DMSO is present in the crude sample after toluene extraction, it can be removed 
by re-dissolving the sample in water, making the solution strongly basic (pH «14), and 
extracting the sample again with toluene as above. This procedure can be repeated until 
all of the DMSO is removed. Also, if the deallylation reaction is not complete, the crude 
product can be reacted again with an excess of 7-butoxide in dry DMSO to complete the 
deallylation. 
^h is 7% yield was the first "cut" from the sublimation/distillation. When the 
temperature was increased to 240 °C for the second cut, the rest of the impurities came 
over and the 2nd cut was not as pure (cut #2 was 0.0829 g). This accounts for the lost 
mass, the rest of the material was remaining in the pot and lost to transfer of the samples. 
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4-Benzyl-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane (32). [via N-allyl 
protecting group] 4-Allyl-10-benzyl-1,4,7,10-tetraazabicyclo[5.5.2]tetradecane 62 
(0.6426 g, 1.967 mmol) was transferred into the 25 mL round-bottomed reaction flask, 
and to this oil 5.4 mL of dry DMSO (stored over 4A sieves under N2) was added via 
syringe followed by potassium r-butoxide (0.3298 g, 2.939 mmol) (NOTE: All reagents 
were handled under N2 in a dry bag). This mixture was stirred under N2 before inserting 
the reaction flask into a CEM Discover microwave reactor, making sure that there were 
no deposits of potassium f-butoxide adhered to the inner wall of the reaction flask. Once 
in the microwave reactor, the reaction flask was placed under an air condenser with a 
nitrogen inlet adapter attached and the open vessel reaction was run under microwave 
irradiation at 100 °C for 25 minutes. A brown pungent-smelling mixture remained (the 
sample was capped at all times when handled outside of the hood). H2O (10 mL) was 
added dropwise to the crude mixture, followed by 20 mL 6M HC1, and the resulting 
solution was concentrated to an oil under reduced pressure. This oil was then dissolved 
in H2O (70 mL) and KOH pellets were added to make the solution strongly basic (pH 
14). The basic solution was extracted with toluene (5 x 80 mL) and the combined 
extracts were dried over Na2SC>4. Solvent was removed under reduced pressure and the 
crude brown oil was Kugelrohr distilled (145 °C air bath temperature, 0.1 mmHg) to yield 
a clear, colorless oil (0.4394 g, 77.4 %): 'H NMR (500 MHz, C6D6) 5 2.43-2.79 (m, 
20H), 3.21 (br s, 1H, N/f), 3.58 (s, 2H, CH2?h), 7.09-7.13 (m, 1H, Ph), 120-124 (m, 
2H, Ph), 7.34-7.40 (m, 2H, Ph); nC{]U} NMR (125.68 MHz, C6D6, C6D6 secondary ref. 
(center peak) set to 128.06) 5C 48.83, 52.56, 53.59, 54.03, 56.00, 61.84, 127.17, 128.43, 
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129.82, 140.06; IR 3226 (R2N-H), 3083, 3058, 3026, 2801, 1948, 1876, 1809, 1672, 
1452, 1372, 1160, 1130, 1030, 977, 729, 700 cm-1; HRFABMS, m/z (M+H)+ exact mass 
calcd for C17H29N4: 289.2392; Found: 289.2393 (error+0.1 mmu/+0.4 ppm). 
Note: If DMSO is present in the crude sample after toluene extraction, it can be removed 
by re-dissolving the sample in water, making the solution strongly basic (pH «14), and 
extracting the sample again with toluene as above. This procedure can be repeated until 
all of the DMSO is removed. Also, if the deallylation reaction is not complete, the crude 
product can be reacted again with an excess of f-butoxide in dry DMSO to complete the 
deallylation. 
4-Benzyl-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane (32). [via N-PMB 
protecting group] 4-Benzyl-10-(4-methoxybenzyl)-1,4,7,10-tetraazabicyclo[5.5.2]-
tetradecane 67 (0.2227 g, 0.5451 mmol) in a 5 mL round-bottomed flask was treated with 
anisole (54 uL, 0.49 mmol) followed by trifluoroacetic acid (1.47 mL). The reaction 
mixture was stirred, under N2, at 60 °C for 18 h. Upon cooling, 75 mL Et20 was added 
to the resulting light-orange colored reaction mixture (to aid in the removal of TFA) and 
it was concentrated to a thick yellow oil. H20 (10 mL) was added dropwise to the crude 
mixture, followed by 15 mL 6M HC1, and the resulting solution was extracted with 
toluene (5x15 mL). The aqueous phase then had H20 (10 mL) added and was made 
strongly basic (pH 14) by slow addition of KOH pellets, with cooling. This basic 
solution was then extracted with toluene (5 x 25 mL) and the combined extracts were 
dried over Na2S04. The solvent was then removed under reduced pressure and the 
resulting yellow oil was Kugelrohr distilled (150 °C air bath temperature, 0.1 mmHg) to 
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yield a clear oil (0.1132 g, 72%): *H NMR and "Cf'H} NMR spectra were consistent 
with spectra for 32 reported in this dissertation. On the basis of the spectra, the purity is 
estimated to be >97%. 
(Note: This reaction can also be run via microwave heating, for 10 min at 85° C.) 
4-Benzyl-l,4,8,ll-tetraazabicyclo[6.6.2]hexadecane (33). 4-Allyl-l 1-benzyl-
1,4,8,1 l-tetraaza-bicyclo[6.6.2]hexadecane 55 (0.6367 g, 1.79 mmol) was transferred into 
the 25 mL round-bottomed reaction flask, and to this oil 5.0 mL of dry DMSO (stored 
over 4A sieves under N2) was added via syringe followed by potassium f-butoxide 
(0.3096 g, 2.76 mmol) (NOTE: All reagents were handled under N2 in a dry bag). This 
mixture was stirred under N2 before inserting the reaction flask into a CEM Discover 
microwave reactor, making sure that there were no deposits of potassium f-butoxide 
adhered to the inner wall of the reaction flask. Once in the microwave reactor, the 
reaction flask was placed under an air condenser with a nitrogen inlet adapter attached 
and the open vessel reaction was run under microwave irradiation at 100 °C for 25 
minutes. A brown pungent-smelling mixture remained (the sample was capped at all 
times when handled outside of the hood). H2O (10 mL) was added dropwise to the crude 
mixture, followed by 10 mL 6M HC1, and the resulting solution was concentrated to an 
oil under reduced pressure. This oil was then dissolved in H2O (70 mL) and KOH pellets 
were added to make the solution strongly basic (pH 14). The basic solution was extracted 
with toluene (5 x 95 mL) and the combined extracts were dried over Na2S04. Solvent 
was removed under reduced pressure and the crude brown oil was Kugelrohr distilled 
(145 °C air bath temperature, 0.1 mmHg) to yield a clear, colorless oil (0.5094 g, 89.9 
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%): 'H NMR (500 MHz, C6D6) 5 1.26-1.56 (m, 4H, CH2Cf/2CH2), 2.01-2.10 (m, 2H), 
2.14-2.24 (m, 2H), 2.27 (ddd, 1H, J= 14.0, 11.5, 2.8 Hz), 2.35 (tt, 1H, 7= 11.2, 2.9 Hz), 
2.37-2.56 (m, 7H), 2.65 (ddd, 1H, J= 14.3, 11.4, 3.3 Hz), 2.78 (td, 1H, J= 11.7, 5.9 Hz), 
2.87 (td, 1H, J= 12.3, 4.3 Hz), 2.97 (tdd, 1H, J= 10.9, 5.8, 0.8 Hz), 3.14 (d, 1H, J= 13.1 
Hz, CHHFh), 3.16-3.28 (m, 2H), 3.36-3.43 (m, 1H), 3.57 (d, 1H, J= 13.1 Hz, CH//Ph), 
4.46-4.54 (m, NH, 1H), 7.09-7.13 (m, 1H, Ph), 7.16-7.22 (m, 2H, Ph), 1.24-1.28 (m, 2H, 
Ph); nC{:H} NMR (125.68 MHz, C6D6) 5C 26.08, 28.14, 49.14, 49.34, 49.37, 50.00, 
54.81, 55.19, 57.14, 58.09, 59.17, 59.21, 59.82, 126.79, 128.12, 129.40, 140.51; IR 3238 
(R2N-H), 3084, 3061, 3026, 2799, 1944, 1872, 1804, 1494, 1454, 1360, 1138, 1113, 
1013, 735, 699 cm"1; HRFABMS, m/z (M+H)+ exact mass calcd for C19H33N4: 317.2705; 
Found: 317.2693 (error -1.2 mmu/-3.9 ppm). 
Note: If DMSO is present in the crude sample after toluene extraction, it can be removed 
by re-dissolving the sample in water, making the solution strongly basic (pH «14), and 
extracting the sample again with toluene as above. This procedure can be repeated until 
all of the DMSO is removed. Also, if the deallylation reaction is not complete, the crude 




54 (3.0036 g, 5.8397 mmol) was added in one portion to 169 mL of acetonitrile, under 
N2. This mixture was stirred for several minutes and NaBHsCN (14.7258 g, 234.34 
mmol) was then added in small portions over several minutes. The mixture was stirred at 
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reflux for 24 h (caution HCN evolution!). The solvent was then removed under reduced 
pressure (the rotary evaporator was vented to the hood) to yield a white solid, the solid 
was dissolved in 1:1 (vohvol) MeOH:H20 and 6M HC1 was added dropwise to the 
reaction mixture (to pH 1). (Decomposition of the excess NaBF^CN, with evolution of 
HCN, may take an hour. The absence of bubbles forming in the solution indicates the 
process is complete.) The solvent was then removed under reduced pressure yielding a 
white paste (the rotary evaporator was vented to the hood). Methanol and water were 
then added in portions so as to dissolve all solids (typically requiring a 1:1 (vohvol) 
MeOH:H20 solution). The solution was made strongly basic (pH 14) by slow addition of 
KOH pellets, with cooling, and this basic solution was then extracted with toluene (5 x 
180 mL). The combined extracts were dried over Na2S04 and the solvent was removed 
under reduced pressure to yield clear, colorless product as an oil that required no further 
purification (1.9638 g, 94.3%): !H NMR (500 MHz, C6D6) 5 1.25-1.57 (m, 4H, 
CH2C7/2CH2), 2.16-2.25 (m, 2H), 2.31-2.59 (m, 11H), 2.68-2.79 (m, 3H), 2.95 (ddd, 1H, 
J= 12.9, 11.9, 4.0 Hz), 3.07 (d, 1H, J= 13.5 Hz, CUHPh), 3.15 (ddt, 1H, J= 14.1, 4.8, 
1.7 Hz), 3.22-3.35 (m, 2H), 3.72 (td, 1H, J= 11.6, 4.3 Hz), 3.75 (d, 1H, J= 13.4 Hz, 
GtfHPh), 4.05 (td, 1H, J = 11.7, 3.9 Hz), 5.01-5.05 (dm, 1H, J= 10.2 Hz, 
CH2CH=CH//£), 5.10-5.16 (dm, 1H, J= 17.2 Hz, CH2CH=CH/7Z), 5.87 (dddd, 1H, J= 
11.2, 10.2, 7.7, 4.9 Hz, CH2C//=CH2), 7.09-7.13 (m, 1H), 7.18-7.23 (m, 2H, Ph), 7.33-
7.37 (m, 2H, Ph); 13C{'H} NMR (125.68 MHz, C6D6) 5C 28.44, 28.78, 51.79, 51.99, 
54.24, 54.85, 57.21, 57.24, 57.73, 57.79, 57.97, 58.01, 58.30, 60.33, 116.07, 126.92, 
128.36, 129.25, 137.60, 141.27; IR 3064, 3026, 2910, 2794, 1943, 1867, 1835, 1805, 
1743, 1679, 1642, 1602, 1493, 1453, 1363, 1243, 1125, 916, 733, 699 cm-1; HRFABMS, 
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mfz (M+H)+ exact mass calcd for C22H37N4: 357.3018; Found: 357.3001 (error -1.7 
mmu/-4.8 ppm). 
(8b/?,8ci?)-re/-Decahydro-2a-allyl-6a-benzyl-4a,8a-diaza-2a,6a-diazonia 
cyclopent[/g]acenaphthylenium dibromide (61). Allyl Bromide (11.00 g, 90.91 mmol) 
was added dropwise to a stirred mixture of (8bi?,8ci?)-re/-decahydro-2a-benzyl-4a,6a,8a-
triaza-2a-azoniacyclopent[/g]acenaphthylene bromide 39 (3.32 g, 9.09 mmol) in MeCN 
(145 mL). The reaction mixture was stirred at room temperature for 4 days in a tightly 
stoppered flask, in the dark. The fine white precipitate was then isolated by suction 
filtration and washed with MeCN. Residual solvent was removed under reduced pressure 
to yield 4.11 g of a white solid (93.7 %). (NOTE: The yield of this reaction can be 
increased by concentrating the filtrate, washing it with MeCN, and, if it is of comparable 
purity, combining it with the washed precipitate): mp 178-186 °C (dec); *H NMR (500 
MHz, D20, C#3CN secondary ref. set to 2.05) 8 2.99-3.07 (m, 1H), 3.08-3.21 (m, 2H), 
3.31-3.46 (m, 3H), 3.52-3.70 (m, 4H), 3.72-3.80 (dm, 1H, J= 13.0 Hz), 3.82-3.99 (m, 
3H), 4.07 (ddd, 1H, J= 12.1, 10.5, 4.2 Hz), 4.20 (dd, 1H, J= 12.6, 5.8 Hz, 
C#HCH=CH2), 4.20-4.30 (m, 1H), 4.37 (dd, 1H, J= 13.4, 7.8 Hz, CH#CH=CH2), 4.59 
(d, 1H, QH, J= 2.5 Hz), 4.69 (d, 1H, CH, J= 2.5 Hz), 4.75 (d, downfield line partially 
overlapped with HDO, 1H, J= 12.8 Hz, CMiPh), 4.92 (d, 1H, J= 13.3 Hz, CUHPh), 
5.76-5.82 (dm, 1H, J= 16.9 Hz, CH2CH=CH//Z), 5.79-5.83 (dm, 1H, J= 10.0 Hz, 
CH2CH=CH#£), 6.09 (dddd, 1H, J= 16.9, 10.2, 7.6, 6.9 Hz, CH2C#=CH2), 7.54-7.66 
(m, 5H, Ph); 13C{'H} NMR (125.68 MHz, D20, CH3CN secondary ref. set to 1.70) 8C 
43.25, 43.46, 46.77, 47.01, 55.75, 56.40, 60.83(C-9), 61.48, 61.75 (Benzyl), 61.84, 77.94, 
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77.97, 124.22 (C-ll), 126.82 (ipso-C6H5), 130.38, 130.40, 131.98, 133.14 (o-C6H5); IR 
(KBr) 3430, 3005, 1618, 1438,1401, 1287, 954, 929, 709 cm"1; Anal Calcd for 
C2oH3oN4Br2-1.5H20: C, 46.80; H, 6.48; N, 10.91; Br, 31.13. Found: C, 46.60; H, 6.55; 
N, 10.74; Br, 30.77; HRFABMS, m/z (M)+ exact mass calcd for C20H3oN4Br: 357.3018; 
Found: 405.1665 (error +1.2 mmu/+2.8 ppm). 
4-AUyl-10-benzyl-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane(62). (8bfl,8ci?)-
re/-Decahydro-2a-allyl-6a-benzyl-4a,8a-diaza-2a,6a-diazonia-cyclopent[/^]-
acenaphthylenium dibromide 61 (3.0254 g, 6.2214 mmol) was added in one portion to 
180 mL of acetonitrile, under N2. This mixture was stirred for several minutes and 
NaBHsCN (15.6505 g, 249.53 mmol) was then added in small portions over several 
minutes. The mixture was stirred at reflux for 24 h {caution HCN evolution!). The 
solvent was then removed under reduced pressure (the rotary evaporator was vented to 
the hood) to yield a white solid, the solid was dissolved in 1:1 (vol:vol) MeOH:H20 and 
6M HC1 was added dropwise to the reaction mixture (to pH 1). (Decomposition of the 
excess NaBF^CN , with evolution of HCN, may take an hour. The absence of bubbles 
forming in the solution indicates the process is complete.) The solvent was then removed 
under reduced pressure yielding a white paste (the rotary evaporator was vented to the 
hood). Methanol and water were then added in portions so as to dissolve all solids 
(typically requiring a 1:1 (vohvol) MeOH:H20 solution). The solution was made 
strongly basic (pH 14) by slow addition of KOH pellets, with cooling, and this basic 
solution was then extracted with toluene (5 x 180 mL). The combined extracts were 
dried over Na2SC«4 and the solvent was removed under reduced pressure to yield clear, 
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colorless product as an oil that required no further purification (2.0134 g, 99.7%): *H 
NMR (500 MHz, C6D6) 5 2.57-2.84 (m, 16H), 3.06-3.08 (dm, 2H, J= 6.3 Hz), 3.08-3.19 
(m, 4H, AA'BB', ethylene cross-bridge), 3.59 (s, 2H, C#2Ph), 5.00-5.02 (m, 0.5H, 
CH2CH=CH#), 5.02-5.05 (m, 1H, CH2CH=CHtf), 5.06-5.08 (m, 0.5H, CH2CH=CHtf), 
5.79-5.88 (m, 1H, CH2Gtf=CH2), 7.09-7.13 (m, 1H, Ph), 7.18-7.23 (m, 2H, Ph), 7.28-
7.32 (m, 2H, Ph); nC{xll} NMR (125.68 MHz, C6D6) 8C 56.96, 57.88, 57.99, 58.35, 
58.72,59.94,61.53, 115.99, 126.89, 128.34, 129.11, 137.18, 140.88; IR 3063, 3026, 
2913, 2806, 1944, 1869, 1835, 1806, 1675, 1641, 1493, 1451, 1371, 1104, 1076, 1050, 
1031, 994, 916, 729, 699 cm"1; HRFABMS, m/z (M+H)+ exact mass calcd for C20H33N4: 
329.2705; Found: 329.2707 (error +0.1 mmu/+0.4 ppm). 
(8W?,8c/?)-re/-Decahydro-2a,6a-bis-(4-methoxybenzyl)-4a,8a-diaza-2a,6a-
diazoniacyclopent[/glacenaphthylenium dibromide (65). p-Methoxybenzyl bromide 
(1.3276 g, 6.405 mmol, stabilized with 0.0398 g K2C03) was added dropwise to a stirred 
solution of (8bi?,8ci?)-re/-decahydro-2a,4a,6a,8a-tetraazacyclopent[/^]acenaphthylene 18 
(0.2057 g, 1.0588 mmol) in MeCN (8 mL). The reaction mixture was stirred, under N2, 
at room temperature for 3 days. The white precipitate was then isolated by suction 
filtration and washed with Et20 (6x10 mL). Residual solvent was removed under 
reduced pressure to yield 0.5609 g of product as a white solid (89 %): mp 186-190 °C 
(dec); 'H NMR (500 MHz, D20, CH3CN secondary ref. set to 2.05) 8 3.08-3.16 (m, 2H), 
3.35-3.44 (m, 4H), 3.55-3.66 (m, 6H), 3.80-3.88 (m, 2H), 3.87 (s, 6H, OC#3), 4.20-4.28 
(m, 2H), 4.74 (d, 2H, J= 13.3 Hz, CHflPh), 4.74-4.75 (br s, 2H, CH), 4.91 (d, 2H, J = 
13.3 Hz, CHM>h), 7.09-7.15 (XX' of AA'XX', 4H, Ar\ 7.52-7.57 (AA' of AA'XX', 4H, 
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Ar); 13C{'H} NMR (125.68 MHz, D20, CH3CN secondary ref. set to 1.70) 8C 43.65, 
46.92, 55.42, 56.36, 61.55, 61.63, 78.27, 115.88, 119.22, 134.81, 161.90; IR (KBr) 3475, 
3413, 2963, 2856, 2048, 1612, 1582, 1515, 1284, 1259, 1184, 1044, 1030, 947, 842 cm"1; 
HRFABMS, m/z (M)+ exact mass calcd for C26H36BrN402: 515.2022; Found: 515.2029 
(error +0.8 mmu/+1.5 ppm). 
4,10-Bis-(4-methoxybenzyl)-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane (66). 
(8bi?,8c/?)-re/-Decahydro-2a,6a-bis-(4-methoxy-benzyl)-4a,8a-diaza-2a,6a-diazonia 
cyclopent[/g]acenaphthylenium dibromide 65 (0.4814 g, 0.8072 mmol) was added in one 
portion to 21 mL of 95% EtOH in a 100 mL round-bottomed reaction flask, under N2. 
This mixture was stirred for several minutes and NaBBU (1.2273 g, 31.60 mmol) was 
then added, with cooling, in small portions over several minutes. This mixture was 
stirred under N2 for approximately 25 minutes before inserting the reaction flask into a 
CEM Discover microwave reactor. Once in the microwave reactor, the reaction flask 
was fitted with an air condenser topped by a water condenser with a nitrogen inlet adapter 
and the open vessel reaction was run under microwave irradiation at 78 °C for 10 
minutes. [Note: For this experiment the CEM Synergy software method was written 
such that the microwave irradiation was ramped up in 5 stages, shown below in Table 
3.1. See the appropriate reference for further important safety information. ] The 
reaction flask was removed from the microwave and 6M HC1 was added dropwise to the 
reaction mixture (to pH 1), with cooling. The solvent was then removed under reduced 
pressure to yield a white solid, which was dissolved in water (40 mL). The solution was 
made strongly basic (pH 14) by slow addition of KOH pellets, with cooling, and this 
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basic solution was then extracted with toluene (5 x 30 mL). The combined extracts were 
dried over Na2S04 and the solvent was removed under reduced pressure to yield product 
as a clear oil that required no further purification (0.3481 g, 98%): !H NMR (500 MHz, 
C6D6) 8 2.65-2.86 (m, 16H), 3.23 (s, 4H, ethylene cross-bridge), 3.35 (s, 6H, CH30), 3.58 
(s, 4H, CH2Ai), 6.81-6.85 (XX' of AA'XX', 4H, Ar), 122-1.26 (AA' of AA'XX', 4H, Ar); 
l3C{lH} NMR (125.68 MHz, C6D6) 8C 54.73, 57.00, 58.02, 58.68, 61.22, 113.91, 130.36, 
132.82, 159.14; IR 2995, 2913, 2830, 2061, 1881, 1671, 1611, 1511, 1455, 1368, 1300, 
1246, 1173, 1102, 1035, 820 cm"1; HRFABMS, m/z (M+H)+ exact mass calcd for 
C26H39N4O2: 439.3073; Found: 439.3072 (error-0.1 mmu/-0.2 ppm). 











































Table 3.1 The method, incorporating a ramp in power, used for the NaBH4 MW-assisted reduction of 66. 
(8W?,8cJ?)-/*e/-Decahydro-2a-benzyl-6a-(4-methoxybenzyl)-4a,8a-diaza-2a,6a-
diazoniacycIopent[/g]acenaphthylenium dibromide (67). />Methoxybenzyl bromide 
(9.2028 g, 45.77 mmol) was added dropwise to a stirred mixture of (8bi?,8ci?)-re/-
decahydro-2a-benzyl-4a,6a,8a-triaza-2a-azoniacyclopent[^]acenaphthylene bromide 39 
(2.75 g, 7.52 mmol) in MeCN (120 mL). The reaction mixture was stirred, under N2, at 
room temperature for 6 days. The white precipitate was then isolated by suction filtration 
and washed with Et20 (3 x 25 mL). Residual solvent was removed under reduced 
pressure to yield 3.9216 g of product as a white solid (92 %): mp 179-182 °C (dec); *H 
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NMR (500 MHz, CD3OD, central peak of secondary reference CHD2OD set to 3.31 
ppm) 8 3.22-3.30 (m,2H), 3.35-3.41 (app dm, 2H, J= 13.4 Hz), 3.46-3.51 (dm, 1H, J = 
13.1 Hz), 3.49-3.53 (dm, 1H, J= 13.1 Hz), 3.53-3.64 (m, 6H), 3.78-3.90 (m, 2H), 3.85 (s, 
3H), 4.32-4.46 (m, 2H), 4.89 (br d, X of AX, 1H, J= 13.3 Hz, CHflAr), 4.95 (br d, X of 
AX, 1H, J= 13.3 Hz, CHi/Ar), 5.07 (d, A of AX, 1H, J= 13.3 Hz, CHflAr), 5.08-5.09 
(br app s, 1H, CH), 5.12-5.13 (br app s, 1H, CH), 5.14 (d, A of AX, 1H, J= -13.0 Hz, 
CH/ZAr), 7.06-7.11 (XX' of AA'XX', 2H, p-MeOPh), 7.54-7.60 (m, 3H, Ar), 7.60-7.65 
(AA' of AA'XX', 2H,p-MeOPh), 7.69-7.73 (m, 2H, Ar); 13C{'H} NMR (125.68 MHz, 
CD3OD, central peak of secondary ref. CD3OD set to 49.00) 5C 43.92, 43.95, 47.48, 
47.51, 55.69, 55.81, 56.01, 61.86, 61.92, 61.99, 62.20, 78.85, 79.32, 116.11, 119.72, 
128.21, 130.81, 132.30, 133.74, 135.22, 163.28; IR (KBr) 3435, 2960, 2855, 1611, 1518, 
1404, 1256, 1192, 1044, 1022, 930, 839, 708 cm"1; HRFABMS, m/z (M-Br)+ exact mass 
calcd for C a s ^ B r ^ O : 485.1916; Found: 485.1896 (error -2.0 mmu/-4.0 ppm). 
4-Benzyl-10-(4-methoxybenzyl)-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane 
(68). (8bi?,8aK)-re/-Decahydro-2a-benzyl-6a-(4-methoxybenzyl)-4a,8a-diaza-2a,6a-
diazoniacyclopent[/g]acenaphthylenium dibromide 67 (0.3037 g, 0.5365 mmol) was 
added in one portion to 21 mL of 95% EtOH in a 100 mL round-bottomed reaction flask, 
under N2. This mixture was stirred for several minutes and NaBH4 (0.8121 g, 20.91 
mmol) was then added, with cooling, in small portions over several minutes. This 
mixture was stirred under N2 for approximately 25 min before inserting the reaction flask 
into a CEM Discover microwave reactor. The reaction flask was fitted with an air 
condenser topped by a water condenser with a nitrogen inlet adapter and the open-vessel 
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reaction was run under microwave irradiation at 78 °C for 10 minutes. [Note: For this 
experiment the CEM Synergy software method was written such that the microwave 
irradiation was ramped up in 5 stages, shown below in Table 3.2. See the appropriate 
07 
reference for further important safety information. ] The reaction flask was removed 
from the microwave reactor and 6M HC1 was added dropwise to the reaction mixture (to 
pH 1), with cooling. The solvent was then removed under reduced pressure to yield a 
white solid, which was dissolved in water (35 mL). The solution was made strongly 
basic (pH 14) by slow addition of KOH pellets, with cooling, and this basic solution was 
then extracted with toluene (5 x 25 mL). The combined extracts were dried over Na2S04 
and the solvent was removed under reduced pressure to yield product as a clear oil that 
required no further purification (0.1735 g, 79%): 'H NMR (500 MHz, C6D6) 8 2.63-2.72 
(m, 8H), 2.72-2.85 (m, 8H), 3.14-3.25 (m, 4H, AA'BB', ethylene cross-bridge), 3.34 (s, 
3H, OC//3), 3.57 (s, 2H, C#2Ar), 3.60 (s, 2H, C/f2Ar), 6.80-6.85 (XX' of AA'XX', 2H,/?-
MeOPh), 7.09-7.13 (m, 1H, Ph), 7.18-7.22 (m, 2H, Ph), 7.22-7.25 (AA* of AA'XX', 2H, 
p-MeOPh), 7.28-7.31 (m, 2H, Ph); 13C{'H} NMR (125.68 MHz, C6D6) 8C 54.68, 56.94, 
57.86, 57.93, 58.62, 58.69, 61.17, 61.25, 113.85, 126.89, 128.35, 129.09, 130.28, 132.72, 
140.82, 159.05; IR 3060, 3026, 2912, 2807, 2280, 2064, 1944, 1878, 1806, 1674, 1611, 
1585, 1510, 1452, 1369, 1300, 1246, 1171, 1145, 1103, 1035, 996, 822, 729, 699 cm"1; 
HRFABMS, m/z (M+H)+ exact mass calcd for C25H37N4O: 409.2967; Found: 409.2965 
(error -0.2 mmu/-0.6 ppm). 












































Table 3.2 The method, incorporating a ramp in power, used for the NaBH4 MW-assisted reduction of 68. 
(8bJ?,8ci?)-re/-Decahydro-2a-benzyl-6a-(naphthalen-2-ylmethyl)-4a,8a-diaza-
2a,6a-diazoniacyclopent[/^]acenaphthylenium dibromide (70). 2-(Bromomethyl)-
naphthalene (10.04 g, 45.41 mmol) was added in portions to a stirred solution of 
(8bi?,8ci?)-re/-decahydro-2a-benzyl-4a,6a,8a-triaza-2a-azoniacyclopent[/g]-
acenaphthylene bromide 39 (2.76 g, 7.55 mmol) in MeCN (120 mL). The reaction 
mixture was stirred, under N2, at room temperature for 6 days. The white precipitate was 
then isolated by suction filtration and washed with Et20 (3 x 25 mL) [Note: several 
washes may be required to completely remove unreacted 2-(bromomethyl)naphthalene]. 
Residual solvent was removed under reduced pressure to yield 4.05 g of product as a 
white solid (92%): mp 281-284 °C (dec); !H NMR (500 MHz, CD3OD, central peak of 
secondary reference C//D2OD set to 3.31 ppm) 5 3.27-3.31 (m, 1H, downfield region 
partially overlapped with CMD2OD solvent peak), 3.32-3.36 (m, 1H), 3.36-3.45 (m, 2H), 
3.46-3.52 (dm, 1H, J= 13.14 Hz), 3.53-3.68 (m, 6H), 3.72 (td, 1H, J= 13.2, 1.9 Hz), 
3.80-3.90 (m, 2H), 4.41-4.48 (m, 1H), 4.55 (td, 1H, J= 10.7, 4.2 Hz), 4.99 (d, 1H, J= 
13.0 Hz, CH/fPh), 5.14 (d, 1H, J= 13.1 Hz, CH/JAr), 5.17 (d, 1H, J= 13.1 Hz, CH#Ar), 
5.22 (d, 1H, J= 2.5 Hz, CH), 5.27 (d, 1H, J= 2.5 Hz, CH), 5.33 (d, 1H, J= 13.2 Hz, 
CH#Nap), 7.51-7.64 (m, 5H, Ph), 7.68-7.75 (m, 3H, Nap), 7.91-7.96 (m, 1H, Nap), 7.99-
8.04 (m, 2H, Nap), 8.28-8.31 (m, 1H, Nap); 13C{'H} NMR (125.68 MHz, CD3OD, 
secondary reference CD3OD set to 49.00 ppm) 5C 43.86, 43.94, 47.48, 47.50, 55.59, 
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55.87, 61.83, 62.03, 62.16, 62.22, 79.12, 79.22, 125.32, 128.08, 128.23, 128.81, 129.04, 
129.24, 129.54, 130.60, 130.70, 132.16, 133.61, 134.41 (2 carbons), 135.35; IR(KBr) 
3414, 3009, 2954, 2913, 2843, 1629, 1600, 1456, 1403, 1288, 1199, 1041, 937, 826, 760, 
705, 479 cm"1; HRFABMS, m/z (M-Br)+ exact mass calcd for C28H34BrN4: 505.1967; 
Found: 505.1941 (error-2.6 mmu/-5.2 ppm). 
4-Benzyl-10-(naphthalen-2-ylmethyl)-l,4,7,10-tetraazabicyclo[5.5.2]-
tetradecane (71). (8bi?,8ci?)-re/-Decahydro-2a-benzyl-6a-(naphthalen-2-ylmethyl)-
4a,8a-diaza-2a,6a-diazoniacyclopent[^]acenaphthylenium dibromide 70 (0.1003 g, 
0.01717 mmol) was added in one portion to 6 mL of 95% EtOH in a 50 mL round-
bottomed reaction flask, under N2. This mixture was stirred for several minutes and 
NaBH4 (0.2593 g, 6.6761 mmol) was then added, with cooling, in small portions over 
several minutes. The mixture was stirred under N2 for 4 days. Then 3M HC1 was added 
dropwise to the reaction mixture (to pH 1), with cooling. The solvent was then removed 
under reduced pressure yielding a white solid, which was then dissolved in water (8 mL). 
The solution was made strongly basic (pH 14) by slow addition of KOH pellets, with 
cooling, and this basic solution was extracted with toluene (5x10 mL). The combined 
extracts were dried over Na2SC>4 and the solvent was removed under reduced pressure to 
yield product as a clear oil (0.0691 g, 94%): *H NMR (500 MHz, C6D6) 5 2.60-2.88 (m, 
16H), 3.15-3.27 (m, 4H, AA'BB', ethylene cross-bridge), 3.59 (s, 2H, C7/2Ph), 3.72 (s, 
2H, C#2Nap), 7.09-7.14 (m, 1H, Ph), 7.18-7.24 (m, 2H, Ph), 7.24-7.32 (m, 4H, Ar), 7.51-
7.56 (m, 1H, Nap), 7.62-7.72 (m, 4H, Nap); 13C{'H} NMR (125.68 MHz, C6D6) 8C 
57.01, 57.88, 57.91, 58.75, 58.81, 61.31, 61.74, 125.65, 126.14, 126.96, 127.46, 127.84, 
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128.03, 128.41, 129.15, 133.27, 133.97, 138.50, 140.86; IR 3083, 3056, 3025, 2916, 
2806, 1943, 1914, 1803, 1674, 1601, 1508, 1493, 1452, 1370, 1270, 1143,1103,1053, 
1031, 997, 921, 891, 855, 818, 729, 698 cm"1; HRFABMS, m/z (M+H)+ exact mass calcd 
for C28H37N4: 429.3018; Found: 429.3002 (error-1.6 mmu/-3.7 ppm). 
(8bif,8ci?)-re/-Decahydro-2a,6a-bis(naphthalen-2-ylmethyl)-4a,8a-diaza-
2a,6a-diazoniacyclopent[/g]acenaphthylenium dibromide (72). 2-Bromomethyl-
naphthalene (3.4543 g, 15.623 mmol) was added to a stirred solution of (8b/?,8ci?)-re/-
decahydro-2a,4a,6a,8a-tetraazacyclopent[^]acenaphthylene 18 (0.5057 g, 2.603 mmol) 
in MeCN (19.4 mL). The reaction mixture was stirred, under N2, at room temperature for 
3 days. The white precipitate was then isolated by suction filtration and washed with 
MeCN (6x5 mL). Residual solvent was removed under reduced pressure to yield 
1.4838 g of product as a white solid (90 %): mp 185-189 °C (dec); 'H NMR (500 MHz, 
CD3OD, secondary ref. central peak of C#D2OD set to 3.31) 8 3.33-3.40 (m, 2H), 3.39-
3.45 (dm, 2H, J= 12.9 Hz), 3.49-3.54 (dm, 2H, J= 13.0 Hz), 3.56-3.66 (m, 4H), 3.71 (td, 
2H, J= 13.1, 1.7 Hz), 3.83 (td, 2H, J= 12.5, 2.7 Hz), 4.55 (td, 2H, J= 10.4, 3.2 Hz), 5.17 
(d, 2H, J= 13.1 Hz, CH#Nap), 5.35 (d, 2H, J= 13.2 Hz, CHflNap), 5.41 (s, 2H, CH), 
7.53-7.59 (m, 4H, Ar), 7.66 (dd, 2H, J= 8.4, 1.8 Hz, Ar), 7.82-7.86 (m, 2H, Ar), 7.90-
7.96 (m, 4H, Ar), 8.21-8.23 (m, 2U,Ar), 13C{'H} NMR (125.68 MHz, CD3OD, 
secondary ref. central peak of CD3OD set to 49.00) 8C 44.05, 47.59, 55.96, 62.23, 62.33, 
79.26, 125.21, 128.31, 128.82, 129.12, 129.15, 129.52, 130.67, 134.45, 134.49, 135.48; 
IR (KBr) 3333, 3277, 3055, 3015, 2840, 2128, 1626, 1599, 1337, 1287, 1196, 1040, 934, 
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815, 759, 475 cm"1; HRFABMS, m/z (M-Br)+ exact mass calcd for Csi^BrN*: 
555.2123; Found: 555.2108 (error-1.6 mmu/-2.8 ppm). 
c/s-Decahydro-3a,8a-bis(naphthalen-2-ylmethyl)-5a,10a-diaza-3a,8a-
diazoniapyrene dibromide (73). 2-Bromomethyl-naphthalene (3.0526 g, 13.807 mmol) 
was added to a stirred solution of cz's-decahydro-lH,6H-3a,5a,8a,10a-tetraaza-pyrene 19 
(0.5116 g, 2.3011 mmol) in MeCN (19 mL). The reaction mixture was stirred, under N2, 
at room temperature for 3 days. The white precipitate was then isolated by suction 
filtration and washed with MeCN (5x5 mL). Residual solvent was removed under 
reduced pressure to yield 1.1316 g of product as a white solid (74 %): mp 134-137 °C 
(dec); *H NMR (500 MHz, CD3OD, secondary ref. central peak of CM}2OD set to 
3.31) 5 1.80-1.89 (dm, 2H, J= 14.9 Hz), 2.17-2.32 (m, 2H), 3.10-3.20 (m, 6H), 3.25-3.33 
(m, 2H), 3.45 (dd, 2H, J= 13.3, 3.0 Hz), 3.71-3.80 (tm, 2H, J= 12.4 Hz), 4.08 (td, 2H, J 
= 13.0, 2.8 Hz), 4.51 (td, 2H, J= 12.9, 3.7 Hz), 5.19 (d, 2H, J= 12.9 Hz, CHtfNap), 5.61 
(d, 2H, J= 12.9 Hz, CH#Nap), 5.75 (s, 2H, CH), 7.52-7.58 (m, 4H, Nap), 7.60-7.65 (dm, 
2H, J= 8.5 Hz, Nap), 7.77-1.82 (m, 2H, Nap), 7.83-7.87 (dm, 2H, / = 8.4 Hz, Nap), 7.93-
7.98 (m, 2H, Nap), 8.18-8.22 (m, 2H,^r); ^C^H} NMR (125.68 MHz, CD3OD, 
secondary ref. central peak of CD3OD set to 49.00) 8C 19.78, 46.91, 48.18, 52.41, 61.55, 
63.04, 78.38, 124.05, 128.18, 128.80, 129.10, 129.52, 130.00, 130.26, 134.32, 135.20, 
135.38; IR(KBr) 3396, 3048, 2999, 2952, 2904, 2853, 1628, 1599, 1449, 1437, 1355, 
1133, 865, 821, 756, 481 cm"1; HRFABMS, m/z (M-Br)+ exact mass calcd for 




diazoniacyclopent[^]acenaphthylenium dibromide 72 (0.0755 g, 0.119 mmol) was 
stirred in 4.8 mL of 95% EtOH in a 25 mL round-bottomed reaction flask, under N2. 
NaBH4 (0.1841 g, 4.740 mmol) was then added to the mixture, with cooling, in small 
portions over several minutes. This mixture was stirred under N2 for approximately 0.5 h 
before inserting the reaction flask into a CEM Discover microwave reactor. Once in the 
microwave reactor, the reaction flask was fitted with an air condenser topped by a water 
condenser with a nitrogen inlet adapter attached and the open vessel reaction was run 
under microwave irradiation at 78 °C for 10 minutes. [Note: The maximum irradiation 
power was adjusted until the reaction mixture reached 78 °C. When running a reduction 
in the microwave using NaBFLj in 95% EtOH, there are potential hazards associated with 
foaming of the reaction mixture - see the appropriate endnote] The reaction flask was 
removed from the microwave and 3M HC1 was added dropwise to the reaction mixture 
(to pH 1), with cooling. The solvent was then removed under reduced pressure to yield a 
white solid, which was dissolved in water (6 mL). The solution was made strongly basic 
(pH 14) by slow addition of KOH pellets, with cooling, and this basic solution was then 
extracted with toluene ( 5 x 6 mL). The combined extracts were dried over Na2S04 and 
the solvent was removed under reduced pressure to yield product as a white solid that 
required no further purification (0.0432 g, 76 %): mp 116-119 ° C; 'H NMR (500 MHz, 
C6D6) 5 2.60-2.90 (m, 16H), 3.25 (s, 4H, ethylene cross-bridge), 3.72 (s, 4H, Ci/2Nap), 
7.24-7.33 (m, 4H, Nap), 7.55 (dd, 2H, J = 8.4, 1.6 Hz, Nap), 7.63-7.73 (m, 8H, Nap); 
13C{'H} NMR (125.68 MHz, C6D6) 5C 57.03, 57.91, 58.80, 61.71, 125.66, 126.15, 
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127.46, 127.84, 128.03, 128.16, 133.26, 133.96, 138.49;* IR(KBr) 3048, 2969, 2927, 
2904, 2812, 1668, 1597, 1504, 1445, 1361, 1330, 1102, 1033, 821, 757 cm'1; 
HRFABMS, tn/z (M+H)+ exact mass calcd for C32H39N4: 479.3175; Found: 479.3155 
(error-2.0 mmu/-4.1 ppm). 
4,ll-Bis-(naphthalen-2-ylmethyl)-l,4,8,ll-tetraazabicyclo[6.6.2]hexadecane 
(75). c/5-Decahydro-3a,8a-bis(naphthalen-2-ylmethyl)-5a, 10a-Diaza-3a,8a-diazonia-
pyrene dibromide 73 (0.5055 g, 0.7617 mmol) was added in one portion to 30.3 mL of 
95% EtOH in a 100 mL round-bottomed reaction flask, under N2. This mixture was 
stirred for several minutes and NaBH4 (1.1159 g, 28.731 mmol) was then added, with 
cooling, in small portions over several minutes. This mixture was stirred under N2 for 
approximately 0.5 h before inserting the reaction flask into a CEM Discover microwave 
reactor. Once in the microwave reactor, the reaction flask was fitted with an air 
condenser topped by a water condenser with a nitrogen inlet adapter attached and the 
open vessel reaction was run under microwave irradiation at 78 °C for 10 minutes. [Note: 
The maximum irradiation power was adjusted until the reaction mixture reached 78 °C. 
When running a reduction in the microwave using NaBH4 in 95% EtOH, there are 
potential hazards associated with foaming of the reaction mixture - see the appropriate 
endnote]97 The reaction flask was removed from the microwave and 3M HC1 was added 
dropwise to the reaction mixture (to pH 1), with cooling. The solvent was then removed 
under reduced pressure to yield a white solid, which was dissolved in water (20 mL). 
The solution was made strongly basic (pH 14) by slow addition of KOH pellets, with 
cooling, and this basic solution was then extracted with chloroform (5 x 40 mL). The 
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combined extracts were dried over Na2S04 and the solvent was removed under reduced 
pressure to yield product as an off-white solid (0.3662 g, 95 %): mp 130-134 ° C; *H 
NMR (500 MHz, C6D6) 5 1.32-1.45 (m, 2H), 1.51-1.63 (m, 2H), 2.19-2.26 (dm, 2H, J= 
12.7), 2.30-2.37 (dm, 2H, J= 13.0), 2.43-2.58 (m, 8H), 2.59-2.68 (XX' of AA'XX', 2H, 
ethylene cross-bridge), 2.99 (td, 2H, J= 12.8, 3.6 Hz), 3.25 (d, 2H, J= 13.4 Hz, 
Cf/HNap), 3.38-3.48 (AA' of AA'XX', 2H, ethylene cross-bridge), 3.89 (d, 2H, J= 13.3 
Hz, Gf/HNap), 4.10 (td, 2H, J= 11.8, 3.8 Hz), 7.24-7.33 (m, 4H,Ar), 7.57-7.62 (m, 2H, 
Ar), 7.65-7.73 (m, 8H, Ar); nC{xYi} NMR (125.68 MHz, C6D6) 5C 28.75, 52.26, 55.04, 
57.24, 57.98, 58.03, 60.63, 125.68, 126.17, 127.68, 127.92, 128.07, 128.13, 128.30, 
133.31, 134.03, 138.88; IR(KBr) 3052, 2915, 2798, 1673, 1631, 1599, 1506, 1457, 
1447, 1363, 1245, 1118, 858, 821, 475 cm"1; HRFABMS, m/z (M+H)+ exact mass calcd 
forC34H43N4: 507.3488; Found: 507.3501 (error+1.3 mmu/+2.6 ppm). [Note: The 
NMR spectra indicated that the sample was contaminated (<5%) with toluene and 
silicone grease] 
4-Benzyl-ll-octyl -l,4,8,ll-tetraazabicyclo[6.6.2]hexadecane (76). Acetic acid 
(30.5 \\L, 0.534 mmol) was added dropwise over 5 minutes to a stirred mixture of octanal 
(0.4095 g, 3.194 mmol), 4-benzyl-l,4,8,ll-tetraazabicyclo[6.6.2]hexadecane 33 (0.0968 
g, 0.306 mmol), sodium cyanoborohydride (0.0593 g, 0.944 mmol) and 1.25 inL MeCN 
in a two-neck round-bottomed flask. The reaction mixture was stirred under N2 for two 
hours before adding a second portion of acetic acid (30.5 uL, 0.534 mmol) dropwise over 
2 minutes. The reaction mixture was then stirred under N2 for an additional hour before 
it was concentrated under reduced pressure to a white solid. This solid was dissolved in 
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1:1 (vol:vol) MeOH:H20 and 6M HC1 was added dropwise, to pH 1 {caution HCN 
evolution!). The methanol was then removed under reduced pressure (the rotary 
evaporator was vented to the hood) and H20 (10 mL) and 6M HC1 (to pH 1) were added 
to this solution before washing with toluene (5 x 20 mL). Additional H2O (5 mL) was 
added to the aqueous solution before making it strongly basic (pH 14) by slow addition of 
KOH pellets, with cooling, and this basic solution was then extracted with toluene (5 x 25 
mL). The combined extracts were dried over Na2S04 and the solvent was removed under 
reduced pressure to yield crude product as a clear, colorless oil (0.1041 g, 79% crude): 
!H NMR (500 MHz, C6D6) 5 0.91 (t, 3H, J= 6.95 Hz, C/f3C7H14), 1.22-1.58 (m, 18H), 
2.16 (ddd, 1H, J= 12.5, 8.3, 4.7 Hz), 2.20 (ddd, 1H, J= 13.5, 3.7, 2.2 Hz), 2.27 (ddd, 1H, 
J= 12.9, 4.6, 3.5 Hz), 2.33-2.57 (m, 9H + impurity peaks), 2.57-2.61 (m, 1H), 2.76-2.88 
(m, 2H), 2.97 (td, 1H, J= 12.5, 4.0 Hz), 3.08 (d, 1H, J= 13.4 Hz, CHflPh), 3.30-3.39 (m, 
2H, ethylene cross-bridge), 3.72 (td, 1H, J= 11.8, 4.0 Hz), 3.77 (d, 1H, J= 13.4 Hz, 
C#HPh), 4.10 (td, 1H, J= 11.8, 3.9 Hz), 7.09-7.14 (m, 1H), 7.18-7.24 (m, 2H, Ph), 7.33-
7.38 (m, 2H, Ph); 13C{'H} NMR (125.68 MHz, C6D6) 8C 14.34, 23.01, 28.09, 28.76, 
28.83, 28.94, 29.77, 29.98, 32.23, 51.76, 51.97, 54.88, 55.28, 55.56, 57.20, 57.35, 57.56, 
58.01, 58.52, 59.58, 60.30, 126.87, 128.32, 129.22, 141.22; IR 3061, 3026, 2922, 2852, 
2793, 1942, 1868, 1803, 1722, 1678, 1598, 1494, 1455, 1363,1324, 1244,1159,1125, 
999, 734, 698 cm"1; HRFABMS, m/z (M+H)+ exact mass calcd for C27H48N4: 429.3957; 
Found: 429.3952 (error -1.3 mmu/-0.6 ppm). [Note: the 'H NMR spectrum indicated 
that the sample was 90% pure. Thin layer chromatography experiments were performed 
on the crude product utilizing the following conditions: CH2Cl2:MeOH:(28% aq) NH3 
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(10:2:0.25; 10:3:0.25; 15:2:0.25; on basic alumina) but the crude material streaked and 
ran together at reasonable Rf values.] 
(CuCl2)2(H2O)4«5-[[4-(l,5,8,12-Tetraazabicyclo[10.2.2]hexadec-5-
ylmethyl)phenyl]methyl]-l,5,8,12-tetraazabicyclo[10.2.2]hexadecane (Cu2 • 102a). A 
solution of 0.0666 g (0.3907 mmol) CuCl2 • 2 H20 in methanol (3 mL) was added 
dropwise to a stirred solution of 0.1071 g (0.1930 mmol) 5-[[4-(l,5,8,12-tetraazabicyclo-
[10.2.2]hexadec-5-ylmethyl)phenyl]methyl]l,5,8,12-tetraazabicyclo[10.2.2]hexadecane 
102a in methanol (6 mL). The mixture was refluxed under N2 for 2 hours. The resulting 
dark-blue solution was cooled to room temperature and the methanol was removed under 
reduced pressure to yield a light-blue solid (0.1708 g). This crude solid was then 
dissolved in 9.5 mL of 80% aq ethanol and any undissolved material was removed via 
centrifugation. The supernatant was subjected to slow diffusion from benzene/Et20 (1:1) 
solution yielding dark blue crystals. IR (KBr) 3423, 3118, 2927, 2869, 1630 cm"1; UV-
vis: (80% ethanol) lmaK, 614 nm (s = 661 M"1 cm"'); Anal Calcd for 2(CuCl2>C32H58N8 • 
4H20: C, 42.90; H, 7.43; CI, 15.83; N, 12.51; Found: C, 43.12; H, 7.43; N, 12.57; CI, 
16.25. 
(Note: Compound has been published and fully characterized in the literature.45) 
[Cu(CH3CN)(ClO4)2]2(CH3OH)»4-Methyl-10-[4-(10-methyl-l,4,7,10-
tetraazabicyclo[5.5.2]tetradec-4-ylmethyl)-benzyl]-l,4,7,10-tetraazabicyclo-
[5.5.2]tetradecane (Cu2 • 94a). A solution of 0.1566 g (0.4226 mmol) Cu(C104)2 • 6 
H20 in methanol (3 mL) was added dropwise to a stirred solution of 0.1094 g (0.2078 
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mmol)4-methyl-10-[4-(10-methyl-l,4,7,10-tetraazabicyclo[5.5.2]tetradec-4-ylmethyl)-
benzyl]-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane 94a in methanol (3 mL). The mixture 
was refluxed under N2 for 2 hours. The resulting dark-blue solution was cooled and the 
methanol was removed under reduced pressure to yield a light-blue solid. This crude 
solid was then mixed with 12 mL acetonitrile and any undissolved material was removed 
via centrifugation. The supernatant was subjected to slow diffusion from a benzene/ether 
(1:1) solution to yield dark-blue crystals (0.1499 g, 63.6% yield). IR (KBr) 2938, 2881, 
1484, 1094, 751, 623 cm"1; Anal Calcd for [Cu(CH3CN)(C104)2]2(CH3OH) • C3oH54N8: 
C, 36.06; H, 5.53; CI, 12.16; N, 12.01. Found: C, 36.01; H, 5.61; CI, 12.01; N, 11.60. 
UV-vis: (MeCN) Xmax, 632 nm (s = 280 M-l cm-1). 
[Cu(N03) 2]2(H20)4 • 4-Methyl-10-[3-(10-methyl-l,4,7,10-tetraazabicyclo-
[5.5.2] tetradec-4-ylmethyl)-benzyl] -1,4,7,10-tetraazabicyclo [5.5.2] tetradecane (Cu2 • 
94b). A solution of 0.1005 g (0.423 mmol) Cu(N03)2 • 3 H20 in methanol (3 mL) was 
added dropwise to a stirring solution of 0.1079 g (0.2050 mmol) 4-Methyl-10-[3-(10-
methyl-1,4,7,10-tetraazabicyclo[5.5.2]tetradec-4-ylmethyl)-benzyl]-1,4,7,10-
tetraazabicyclo[5.5.2]tetradecane 94b in methanol (7 mL). The reaction mixture was 
refluxed under N2 for 2.5 hours. After transfer into test tubes, diethyl ether diffusion into 
the dark-blue solutions yielded dark-blue crystals (0.1799 g, 97.3% yield). IR (KBr) 
3442, 3269, 2938, 2879, 1647, 1473, 1399, 1094, 623 cm-1; UV-vis: (MeOH) Xmax, 658 
nm (e = 202 M-l cm-1); Anal Calcd for 2(Cu(N03)2>C3oH54N8 • 4H20: C, 36.99; H, 
6.42; N, 17.26; Found: C, 36.66; H, 5.84; N, 17.34 [Note: This sample does not pass 
145 
chemical analysis due to the fact that the %H is off by more than 0.4% of the calculated 
value]. 
(ZnCyi^-Methyl-lO-I^ClO-methyL-l^^^O-tetraazabicyclofS.S.lltetradec-
4-ylmethyl)-benzyl]-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane (Zn2 • 94a) Anhydrous 
ZnCl2 (0.1072 g, 0.7865 mmol) was added in one portion to a stirred suspension of 
0.2075 g (0.3941 mmol) 4-methyl-10-[4-(10-methyl-l,4,7,10-tetraazabicyclo[5.5.2]-
tetradec-4-ylmethyl)-benzyl]-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane 94a in MeCN 
(25 mL). This mixture was refluxed under N2 for 24 h. The solvent was removed under 
reduced pressure to yield an off-white solid. This crude solid was then mixed with 10 
mL H2O and any undissolved material was separated via centrifugation and washed with 
2 mL H2O. This wash was combined with the supernatant and concentrated under 
reduced pressure to yield a white solid (0.2923 g, 94% crude yield). *H NMR (500 MHz, 
D20, C//3CN secondary ref. set to 2.05) 8 2.68 (s, 6H, CH3), 2.81 (ddd, 4H, J= 15.9, 
12.2, 5.4 Hz), 2.90-3.03 (m, 16H), 3.08-3.24 (m, 16H), 3.61 (dd, 4H, J= 15.5 6.5 Hz), 
4.14 (s, 4H, C/fcPh), 7.52 (s, 4H, Ph); "C^H} NMR (125.68 MHz, D20, CH3CN 
secondary ref. set to 1.70) 8c 48.25, 51.48, 55.88 (degenerate resonances), 55.92, 59.56, 
61.04, 131.83, 135.37; IR(KBr) 3448, 2925, 2875, 1655, 1459, 1400, 1360, 1102, 1073, 
1037, 1001 cm"1. 
(ZnCl2)2«4-Methyl-10-[3-(10-methyl-l,4,7,10-tetraazabicyclo[5.5.2]tetradec-
4-ylmethyl)-benzyl]-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane (Zn2 • 94b). 
Anhydrous ZnCL. (0.1099 g, 0.8063 mmol) was added in one portion to a stirred 
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suspension of 0.2148 g (0.4080 mmol) 4-Methyl-10-[3-(10-methyl-l,4,7,10-tetra-
azabicyclo[5.5.2]tetradec-4-ylmethyl)-benzyl]-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane 
94b in MeCN (25 mL). The reaction mixture was refiuxed under N2 for 24 h. The 
solvent was removed under reduced pressure to yield a light brown solid. This crude 
solid was then dissolved in 10 mL H2O and insoluble material was separated via 
centrifugation then washed with 2 mL H2O. This wash was combined with the 
supernatant and concentrated at reduced pressure to yield a light brown solid (0.3159 g, 
98% crude yield). !H NMR (500 MHz, D20, C/f3CN secondary ref. set to 2.05) 8 2.68 
(s, 6H, CH3), 2.80 (ddd, 4H, J= 15.0, 12.3, 5.4 Hz), 2.89-3.04 (m, 16H), 3.05-3.25 (m, 
16H), 3.61 (dd, 4H, J= 15.4 6.5 Hz), 4.16 (s, 4H, C#2Ph), 7.49-7.56 (m, 4H, Ph)\ 
13C{1H} NMR (125.68 MHz, D20, CH3CN secondary ref. set to 1.70) 8C 48.29, 51.49, 
55.79, 55.87, 55.90, 59.82, 61.02, 129.64, 131.52, 133.91, 135.79. 
(8b/?,8'b5,8c5,8'cif)-rel-6a,6'a-[l,4-PhenyIenebis(methylene)]bis[decahydro-
2a-acetamido-4a,8a-diaza-2a,6a-diazoniacyclopent[^]acenaphthylene] tetrabromide 
[«1:1 mesoldA diastereomeric mixture] (104). 2-Bromoacetamide (7.1211 g, 0.0516 
mol) was added in portions to a stirred mixture of (8bi?,8'b5',8c5',8'ci?)-rel-2a,2'a-[l,4-
phenylenebis(methylene)]bis[decahydro-4a,6a,8a-triaza-2a-azoniacyclopent[^]-
acenaphthylene] dibromide («1:1 mesold/l diastereomeric mixture) 90a (2.1074 g, 3.23 
mmol) in MeCN (50 mL). The reaction mixture was stirred, under N2, at room 
temperature for 4 days. The off-white precipitate was then isolated by suction filtration 
and washed with MeCN (3 x 40 mL). Several more washes with MeCN served to reduce 
the amount of unreacted 2-bromoacetamide in the crude product, but a small amount still 
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remained. Residual solvent was removed under reduced pressure to yield 2.4617 g of 
crude product as a white solid (82 %): The product was >95% pure after washing. It was 
taken on without further purification. This product was analyzed to be a «1:1 mixture of 
meso and d/1 diastereomers, as demonstrated by several doubled peaks in the 13C NMR 
spectrum: crude mp 198-204 °C (dec); !H NMR (500 MHz, D20, C//3CN secondary ref. 
set to 2.05, all signals meso and d/l) 5 3.07-3.18 (m, 4H), 3.18-3.27 (m, 2H), 3.36-3.50 
(m, 6H), 3.55-3.77 (m, 8H), 3.88-3.97 (m, 2H), 4.06-4.33 (m, 10H), 4.53 (d, 2H, J= 15.9 
Hz, C#HCONH2), 4.68 (d, 2H, J= 15.9 Hz, CHH CONH2), 4.71-4.75 (m, 2H, CH), 4.82 
(d, 2H, J= 13.3 Hz, CHHPh), 4.85-4.90 (m, 2H, CH), 5.02 (d, 2H, J= 13.3 Hz, CHEPh), 
7.77 (s, 4H, Ph); 13C{'H} NMR (125.68 MHz, D20, CH3CN secondary ref. set to 1.70 ) 
8C 43.61, 43.64, 46.88, 47.80, 55.65, 55.71, 57.55, 58.80, 60.91, 61.83, 61.89, 64.94, 
78.52, 78.60, 79.67, 130.10, 134.50, 134.52, 165.55; IR (KBr) 3409, 3150, 2964, 2852, 
1693, 1621, 1437, 1403, 1288, 1195, 1042 cm-1; HRFABMS, m/z (M)+ exact mass calcd 
for C32H52Br3Nio02: 845.1825; Found: 845.1803 (error-2.2 mmu/+2.6 ppm). 
2-{10-[4-(10-Carbamoylmethyl-l,4,7,10-tetraaza-bicyclo[5.5.2]tetradec-4-
ylmethyl)-benzyl]-l,4,7,10-tetraaza-bicyclo[5.5.2]tetradec-4-yl}-acetamide(105). A 
(«1:1) mesold/l diastereomeric mixture of (8bi?,8'bS',8c,S',8'ci?)-rel-6a,6'a-[l,4-
Phenylenebis(methylene)]bis[decahydro-2a-acetamido-4a,8a-diaza-2a,6a-diazonia-
cyclopent[/g]acenaphthylene] tetrabromide 104 (1.0474 g, 1.13 mmol) was added in one 
portion to 22.25 mL of 95% EtOH in a 100 mL round-bottomed reaction flask, under N2. 
This mixture was stirred for several minutes and NaBH4 (1.1408 g, 29.37 mmol) was 
then added, with cooling, in small portions over several minutes. This mixture was 
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stirred under N2 for approximately 25 before inserting the reaction flask into a CEM 
Discover microwave reactor. Once in the microwave reactor, the reaction flask was fitted 
with an air condenser topped by a water condenser with a nitrogen inlet adapter and the 
open vessel reaction was run under microwave irradiation at 78 °C for 10 minutes. [Note: 
For this experiment the CEM Synergy software method was written such that the 
microwave irradiation is ramped up in 5 stages, shown below in Table 3.3. See the 
Q7 
appropriate reference for further important safety information. ] The reaction flask was 
removed from the microwave and 6M HC1 was added dropwise to the reaction mixture 
(to pH 1), with cooling. The solvent was then removed under reduced pressure to yield a 
white solid, which was dissolved in water (35 mL). The solution was made strongly 
basic (pH 14) by slow addition of KOH pellets, with cooling, and this basic solution was 
then extracted with CHC13 (5 x 30 mL). The combined extracts were dried over Na2SC>4 
and the solvent was removed under reduced pressure to yield crude product as a light 
yellow solid (0.7904 g, >100%): mp 64-68° C; *H NMR (500 MHz, C6D6) 5 2.52-2.63 
(m, 8H), 2.65-3.00 (m, 30H), 3.05 (ddd, 4H, J = 14J, 4.9, 3.7 Hz), 3.31 (s, 4H, 
C//2CONH2), 3.78 (s, 4H, C//2Ph), 5.50 (br s, 2H, CON#H), 7.20 (s, 4H, Ph), 8.98 (br s, 
2H, CONHfl); 13C{!H} NMR (125.68 MHz, C6D6) 8C 51.46, 57.49, 57.64, 57.66, 58.60, 
59.53, 60.01, 128.43, 138.18, 177.27; IR 3424, 3178, 2918, 2815, 1674, 1452, 1373, 
1140, 1106, 1033, 996, 751 cm"1; HRFABMS, m/z (M+H)+ exact mass calcd for 












































Table 3.3 The method, incorporating a ramp in power, used for the NaBH4 MW-assisted reduction of 105. 
(8bif,8,b5,8c5,8'ci?)-rel-6a,6'a-[l,4-Phenylenebis(methylene)]bis[decahydro-
2a-allyl-4a,8a-diaza-2a,6a-diazoniacyclopent[/&r]acenaphthylene] tetrabromide 
[«1:1 mesold/l diastereomeric mixture] (106). Allyl bromide (14.94 g, 123.5 mmol) 
was added dropwise to a stirred mixture of (8b/?,8'bS,8cS',8'ci?)-rel-2a,2'a-[l,4-
phenylenebis(methylene)]bis[decahydro-4a,6a,8a-triaza-2a-azoniacyclopent[/g]-
acenaphthylene] dibromide («1:1 mesold/l diastereomeric mixture) 90a (4.03 g, 6.18 
mmol) in MeCN (97 mL). The reaction mixture was stirred at room temperature for 14 
days in a tightly stoppered flask, in the dark. The solvent and excess allyl bromide was 
then removed under reduced pressure (the rotary evaporator was vented to the hood, and 
an additional cold trap was used to collect the allyl bromide). The resulting solid was 
then transferred to 4 test tubes (25 mL MeCN was used to facilitate this transfer) and 
washed with MeCN (3 x 25 mL). The solid was centrifuged from the wash solutions and 
residual solvent was removed under vacuum to give 5.03 g of a fine white solid (91 %). 
The product was >95% pure after washing. It was taken on without further purification. 
This product was analyzed to be a «1:1 mixture of meso and d/l diastereomers, evident in 
1 1 % 
the H NMR by doubling of the benzyl peaks as well as several doubled peaks in the C 
NMR: crude mp 197-218 °C (dec); *H NMR (500 MHz, D20, Gr73CN secondary ref. set 
to 2.05, all signals meso and d/l) 5 3.07-3.13 (m, 4H), 3.20-3.28 (m, 2H), 3.34-3.40 (dm, 
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2H, J= 13.9 Hz), 3.41-3.47 (dm, 4H, J= 7.1 Hz), 3.55-3.74 (m, 8H), 3.74-3.80 (dm, 2H, 
J= 12.9 Hz), 3.84-4.00 (m, 6H), 4.07 (td, 2H, J= 11.3, 4.1 Hz), 4.23 (dd, 2H, J= 13.4, 
6.6 Hz, C/fHCH=CH2), 4.28 (td, 2H, J= 11.2, 4.4 Hz), 4.41 (dd, 2H, J= 13.4, 7.9 Hz, 
CH//CH=CH2), 4.69-4.72 (m, 2H, CH), 4.71-4.75 (m, 2H, CH), 4.81 (d, 1H, J= 13.4 Hz, 
C/fflPh), 4.82 (d, 1H, J= 13.4 Hz, C#HPh), 5.01 (d, 1H, J= 13.4 Hz, C#HPh), 5.02 (d, 
1H, J= 13.4 Hz, Gf/HPh), 5.78-5.84 (dm, 2H, J= 16.9 Hz, CH2CH=CHflz), 5.80-5.84 
(dm, 2H, J= 10.2 Hz, CH2CH=CH#£), 6.05-6.15 (m, 2H, CH2C/f=CH2), 7.77 (s, 4H, 
P/z); uC{lU} NMR (125.68 MHz, D20, CH3CN secondary ref. set to 1.70) 5C 43.31, 
43.51, 46.85, 46.87, 47.14, 55.86, 55.93, 56.52, 60.84, 61.00, 61.75, 61.79, 61.98, 78.13, 
78.14, 78.52, 78.61, 124.33, 130.12, 130.49, 130.51, 134.50, 134.51; IR (KBr) 3412, 
3004, 2980, 1636, 1440, 1336, 1289, 1199, 1154, 1105, 1043, 958, cm"1; HRFABMS, m/z 
(M-Br)+ exact mass calcd for C s ^ N g B ^ : 811.2022; Found: 811.2042 (error+2.0 
mmu/+2.5 ppm). 
4-AUyl-10-[4-(10-allyl-l,4,7,10-tetraazabicyclo[5.5.2]tetradec-4-ylmethyl)-
benzyl]-l,4,7,10-tetraazabicyclo[5.5.2]tetradecane (107). A («1:1) mesold/l 
diastereomeric mixture of (8b/?,8'b5',8c<S,8'ci?)-rel-6a,6'a-[l,4-phenylenebis(methylene)]-
bis[decahydro-4a,8a-diaza-2a,6a-diazoniacyclopent[^]acenaphthylenetetrabromide 106 
(2.2653 g, 2.5326 mmol) was added in one portion to 146 mL of acetonitrile, under N2, in 
an efficient hood. This mixture was stirred for several minutes and NaBH3(CN) (12.7909 
g, 203.55 mmol) was then added in small portions over several minutes. The mixture 
was stirred at reflux for 24 h. The solvent was then removed under reduced pressure (the 
rotary evaporator was vented to the hood) to yield a white solid. These white solids were 
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completely dissolved by the addition of 95% EtOH (50 mL) followed by 150 mL 6M 
HC1 {caution HCN evolution!), initially added dropwise, to the reaction mixture (to pH 
1). (Decomposition of the excess NaBH3(CN) , with evolution of HCN, may take an 
hour. The absence of bubbles forming in the solution indicates the process is complete.) 
The solvent was then removed under reduced pressure yielding a white paste (the rotary 
evaporator was vented to the hood). Methanol and water were then added in portions so 
as to dissolve all solids (typically requiring a 1.5:1 (vohvol) H20:MeOH solution). The 
solution was made strongly basic (pH 14) by slow addition of KOH pellets, with cooling, 
and the MeOH was then removed by rotary evaporation. After the MeOH had been 
removed, the crude material formed a more distinct separate layer from the aqueous 
layer. The resultant basic aqueous solution was then extracted with toluene. The 
combined extracts were dried over Na2S04 and the solvent was removed under reduced 
pressure to yield white solid product (0.8967 g, 61 %): mp 54-57° C; lH NMR (500 
MHz, C6D6) 8 2.57-2.63 (m, 4H), 2.65-2.85 (m, 28H), 3.05-3.10 (dm, 4H, J= 6.3 Hz), 
3.09-3.21 (m, 8H, AA'BB', ethylene cross-bridge), 3.62 (s, 4H, CH2?h), 5.00-5.04 (dm, 
2H), 5.06 (dq, 2H, J= 17.2, 1.5 Hz), 5.84 (ddt, 2H, J = 17.1, 10.1, 6.3 Hz), 7.32 (s, 4H, 
Ph); 13C{'H} NMR (125.68 MHz, C6D6) 8C 56.92, 57.88, 57.98, 58.31, 58.73, 59.94, 
61.45, 115.97, 129.04, 137.18, 139.29; IR 3073, 2914, 2805, 2415, 1675, 1640, 1509, 
1450, 1419, 1372, 1104, 1033, 9934, 916, 750 cm"1; HRFABMS, m/z (M+H)+ exact mass 
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The first-order non-linear fit (monitored at 585 nm) of the experimental absorbance/time 
data for the acid decomplexation of C112 • 102a 
First-order Non-linear Fit of Experimental Data for Cu2 • 102a 
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The first-order non-linear fit (monitored at 693 nm) of the experimental absorbance/time 
data for the acid decomplexation of C112 • 94a 
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Compound Structure Experimental (p. #) Spectra (p. #) 
7 via N-allyl protecting group 120 N.A. 
cY5 
H .N N 
24 via N-PMB protecting group 121 N.A. 
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H' ^ ^ 
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32 via N-allyl protecting group 124 157-159 
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Compound Structure Experimental (p. #) Spectra (p. #) 
Cu2 • 102a 144 205-206 
Cu2 • 94a 144 207-208 
V N ^NT NT N ^ 
Cu2 • 94b 145 209 
cY) CO 
N N N N 
/ \_J V_7N 
Zn2-94a 146 210-212 
CO CO 
N N N ISL 
Zn2-94b 146 213-214 
N N N N 
' \_l V__/N 
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Compound Structure Experimental (p. #) Spectra (p. #) 
104 147 215-217 
M M© © N N 
o C Y J [ T ] . 
H2N \ — ' 4Br N — ' NNH2 
105 148 218-220 
N N — N N 
o C Y ) ( Y ) ° 
\\ S S^ Sr < // 
H , N ^ V _ ^ ^ NH2 
106 150 221-223 
N N r + v ^ S 
L©JL J
 fl I X,®) 
^ - / V_J 4Br \ _J V^% 
107 151 224-226 
CNYN3 ( Y ) 
S S ^ S T NT' 
^ ^ \_J V-l ^% 
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